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Abstract
This thesis deals with assessment of effects on thrombus structure brought 
about by the addition of carbon nanoparticles to blood in vitro.
Chapter 1 outlines the development of the rheological discipline and dis­
cusses viscoelastic systems. Whole blood is a transient viscoelastic system. 
Methods of locating the point of this change, the gel point, are discussed and 
briefly evaluated.
In Chapter 2 the development of fractal analysis is investigated and the 
method by which a phase angle measured at the gel point can be converted 
into a fractal dimension is outlined.
Carbon nanoparticles are discussed in Chapter 3 along with their methods 
of generation and an outline of the research into any associated health effects 
which has been carried out.
The means by which the nanoparticles, both individually and in suspen­
sion, can be assessed are outlined in Chapter 4. Tests which were carried 
out to determine the best solvent for this work are outlined and the results 
discussed.
Chapter 5 concerns blood and the cardiovascular system. The means by 
which thrombus generation and removal occur are discussed together with 
the TEG and Sonoclot clinical systems used to analyse haemostasis.
Chapter 6  states the hypotheses to be investigated in this work.
In Chapter 7 the materials and methods for the production of suspensions, 
their inclusion into extracted whole blood and the measurements taken on 
the resulting blood sample are outlined.
Chapters 8 - 1 2  present the results from each of the nanoparticles inves­
tigated.
Chapter 13 presents the conclusions drawn from the comparison of the 
results and discussions in Chapters 8 -1 2 . The most important of these con­
clusions is the order of effect of the nanoparticles on the blood: MCOOH > 
SCOOH > LPMN > LPSN > DIESEL.
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1
Chapter 1 
Rheology and Gels
navTa pet 
Everything Flows
Prom the writings of the philosopher Simplicius, commonly 
mis-attributed to Heraclitus
1.1 Rheology
As can be seen from the quote with which this chapter begins, elements of 
the science of Rheology can be traced back as far as Ancient Greece. The 
following section briefly outlines the historical development of the subject 
through the ages to the coining of it as a specific discipline by Bingham and 
Reiner in 1929 [1]. In fact, the term Rheology was coined in reference to the 
quote above.
The development of rheological studies will be broken down into five 
distinct sections according to the particular type of material investigated 
and time periods over which the developments took place, as shown in figure 
1.1. Therefore it is sensible to begin with a look at ideal materials.
1.1.1 Ideal M aterials
This section can immediately be split into two sections, solids and liquids. 
The solids shall be dealt with first. The two types of ideal solid materials 
are at opposite ends of the spectrum. On one hand we have the rigid solids 
and on the other, elastic solids.
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Figure 1 .1 : An illustration of the key times of the developments of the science 
of rheology up to its official inception in 1929
General mechanics is based upon the principles of Euclidean geometry 
such that it considers objects which do not deform. This is the oldest branch 
of mechanics and can trace its roots back to Archimedes (circa 250BC). The 
vast majority of the work in Newton’s Principia [2]was concerned with the 
mechanics of rigid bodies.
Where the solids exhibit pure elastic behaviour, the governing rule was 
coined by Robert Hooke in 1678 [3].
‘The power of any spring is in the same proportion with the
tension thereof’
This can be written mathematically as:
o  oc 7  (1 .1 )
where: a is the applied stress and 7  is the resultant strain. This is more
commonly written as equation 1.2 and is known as Hooke’s Law:
F  ocx (1.2)
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where F  is the applied force and x is the corresponding extension observed 
in the spring. The constant of proportionality between the two variables 
is termed the spring constant, k, and is a property of the material under 
examination. This was identified as an intrinsic property of the material by 
Thomas Young in 1807 in his work on the elastic (known after as the Young’s) 
modulus. The fundamental equations concerning small elastic deformations 
were laid down by Cauchy in 1827 [4], possible largely due to the work 
undertaken by Poisson, Navier and Coulomb [5].
The second set of ideal materials, the fluids, will now be discussed. Again, 
these fluids can be subdivided into two groups; Pascalian and Newtonian 
fluids.
The Pascalian fluids exhibit no resistance to flow. The statement by 
Pascal in 1663 equivalent to the pressure in a liquid being the same in all 
directions is the cornerstone of the field of hydrodynamics, a field dealing 
with the motion of fluids in which viscosity plays no part. This field was 
well developed in the early \§ th Century largely due to the work of Euler and 
Bernoulli in the mid 18th Century.
The Newtonian fluids are so named following a definition by Newton in 
the previously mentioned masterpiece, Principia, in which he stated:
‘The resistance which arises from the lack of slipperiness 
originating in a fluid - all things being equal - is proportional to 
the velocity by which the parts of the fluid are being separated
from each other’
This can also be stated mathematically.
a  oc 7  (1.3)
In this case, the notation 7 , signifies the strain rate - the rate at which 
the parts of the fluid are separated such that the fluid exhibits continuous 
deformation: flow. This flow will continue to occur for as long as the force is 
applied, in comparison to the Hookean elastic solid which will deform a set 
amount, regardless of the timescale over which the force is applied as shown 
in figure 1 .2 .
In fact, the earliest recorded example of rheological application deals with 
the effects of viscosity. The ancient Egyptian Amenemhet (circa. 1600BC) is 
recorded as making a 7° correction in the angle of drainage in a water clock
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Figure 1.2: Illustration of the Hookean (top) and the Newtonian (below) re­
sponse to an applied stress.
to account for the variation in viscosity with temperature. The temperature 
in Egypt can vary from 43°C during the day to 0°C at night.
There has been a massive body of work undertaken on Newtonian fluids, 
the most important aspects of which shall now be briefly covered.
The primary experiments on viscosity revolved around the pressure drop 
across a capillary tube. The seminal works by Hagen in 1839 [6 ] and Poiseuille 
in 1841 [7] were both empirical studies which resulted in the establishment 
of the proportionality of the flow rate to the pressure gradient and the radius 
raised to the fourth power.
Both Navier [8 ] and Stokes [9] undertook pioneering work on laws of 
motion for fluids with finite viscosities. While the Navier-Stokes combination 
provided a means by which, for example, a prediction of velocity distribution 
across cylindrical pipes, Stokes was unable to verify his work empirically. It 
was not until 1856 that another researcher, Weidemann [10], was able to show 
agreement between the prediction of Navier-Stokes and the data generated 
by Hagen-Poiseiulle.
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1.1.2 Linear V iscoelasticity
Viscoelastic materials are those which exhibit both Hookean and Newtonian 
properties dependent on the timescale over which a force is applied. Vis­
coelasticity will be discussed in greater depth later in this chapter.
Prior to the rapid growth of the polymer industry, studies into viscoelas­
ticity were focused on metallic behaviours of creep and relaxation. The first 
systematic study of viscoelastic behaviour in non metallic materials was un­
dertaken on silk threads by Weber in 1835 [11]. (While this may seem a 
strange avenue to pursue, silk threads were widely used in the instrumenta­
tion of electromagnetism). In this way Weber was able to identify the stress 
relaxation phenomenon of viscoelasticity prior to the work undertaken by 
Stoke and Poiseuille.
In 1867, Maxwell [12] postulated the first-order differential equation which 
relates the shear stress to deformation and stress relaxation in a fluid-like 
viscoelastic material. This can be readily understood through the use of a 
model containing a spring and viscous damper in series as illustrated in figure 
1.3. Interestingly it was Maxwell who came up with the definitions of the 
classical extremes of the Hookean solid and Newtonian fluid which enabled 
the study of materials in the region between the two.
‘W hat is required to alter the form of a (soft) solid is sufficient 
force, and this, when applied, produces its effect at once. In the 
case of a viscous fluid, it is time which is required, and if enough 
time is given, the very smallest force will produce a sensible ef­
fect.’
This process timescale is now seen as critically important in the behaviour of 
viscoelastic materials.
If we now define the stress and strain components in the model in figure
1.3 thus:
^Total =  &D +  &S (1-4)
iT o ta i =  I d  +  7s (1-5)
Where the subscript S  signifies the spring and the subscript D refers to
the viscous damper. From equations 1.4 and 1.5 we get:
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Figure 1.3: The Maxwell model of a viscoelastic material E  is the elas­
tic modulus of the spring and 77 is the coefficient of viscosity for the given 
material. N B : The spring and damper analogy for the Maxwell model was 
introduced by Thomson in 1902
diTotai _  d jD . dys _  <? 1 da
dt dt dt 7] E d t  1 ]
As such it can be shown that the rates of change of stress and strain with 
respect to time are:
(L7)
However, the Maxwell models’ ability to predict creep is limited. The in­
troduction in 1874 of the Kelvin-Voigt model of viscoelasticity in a solid-like 
material went someway to address this. It is interesting to note as an aside, 
that the equations for this system were in fact introduced by Meyer, a rhe- 
ologist from Poland and as such has an equal claim to that of Lord Kelvin 
and greater than that of Voigt. However, Meyer was embroiled in a dispute 
with Boltzmann which led to Meyer’s discreditation.
The Kelvin-Voigt model is again much easier to comprehend through the 
use of the spring and viscous damper. In this instance they are connected in
7
aFigure 1.4: The Kelvin-Voigt model illustrated using the spring and viscous 
damper.
parallel as shown in figure 1.4. This results in both the spring and damper 
having identical strain components in response to the applied stress, while the 
total stress will now be the sum of the stresses in each component. Therefore 
equations 1.5 and 1.4 for the Maxwell model become:
iT o ta l =  I d  = I s  (1.8)
& Total = C T D + V S  (1.9)
These equations can then be used to obtain an equation for the rate of 
change of stress and strain with respect to time for the Kelvin-Voigt model.
cr(t) =  E*{(t) +  (1-10)
Each of these models will be discussed in more depth later in this chapter.
One of the means by which a process can be defined as being linearly 
viscoelastic is by determining whether the function is separable in both creep 
and load, using a Volterra equation:
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cr{t) = Einst- reiaxy(t) + [  F (t — t ,)Ai{t')dt' (1.11)
Jo
or, in terms of strain
7 (t) = ° {t) + I* K {t -  t')a(t')dt' (1.12)
J-'inst—creep J 0
Where: K(t) is the creep function, F(t) is the relaxation function and 
Finst-creep and Einst- reiax are the respective instantaneous elastic moduli.
The final important development to mention in this section concerns one 
of the scientist mentioned above, Boltzmann. The work of Weber in 1835 en­
abled Boltzmann to develop the superposition principle in 1878. This enabled 
him to arrive at a linear integration of viscoelasticity in three dimensions [13].
‘The value of a characteristic function of a system is equal to the 
sum of all changes induced in the system by the driving functions 
which have been applied to it throughout its history.’
Superposition will also be dealt with further later in the chapter.
1.1.3 V iscous Fluids in General
One of the first pieces of experimental work on non-Newtonian fluid proper­
ties was underaken by Schwedoff in his studies of solutions of colloidal gelatin 
in 1890 [14]. His data indicated a non-linearity in the velocity profile and also 
required the consideration of a yield value in order that the results be accu­
rately described. Viscosity was postulated to be a function of rate of shear 
by both Hess in 1910 [15] and Hatchek in 1913 [16], both of whose work was 
based on results analogous to those of Schwedoff. Following work on pitch 
by Trouton in 1904, in which they identified the need to take into account 
a small initial stress in order that the strain response be proportional, Bing­
ham in 1922 [17] proposed his now famous yield stress in his descriptions of 
paint flow. These materials have since become known as Bingham plastics.
1.1.4 N on-linear V iscolelasticity
Many viscoelastic materials only exhibit linear behaviour within a certain 
range specific to the material under consideration. This is termed the Linear 
Viscoelastic Range.
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Figure 1.5: The strain responses of various fluids to applied stress: a)
Bingham plastic material with a yield stress, ay; b) A Thixotropic fluid; c) 
A Newtonian fluid; d) A Rheopexic fluid. (Fluids (b) and (d) are covered in 
later sections)
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Outside of this range the function in equation 1.12 is not separable into 
creep and load. The function will normally become inseparable due to large 
deformation of the material or if the material undergoes structural changes 
during the time over which the deformations occur. The early work was 
largely focussed on non-linear deformation in wires and so is not particularly 
relevant to this body of work.
1.1.5 T he description o f K ey M aterials
The important descriptions made prior to 1929 in terms of this thesis were 
those concerning polymers and suspensions. In the case of the former, the 
ability to define polymers and their formation is particularly critical.
The vast majority of the early work on polymers revolved around rubber 
and gutta percha due to the rapid expansion of the rubber industry.
The nature of suspensions is also of supreme importance as this is of di­
rect relevance to blood. Blood can be viewed as a multicomponent colloidal 
suspension. The definition of colloidal dispersions as those comprising par­
ticles with diameters less than l^rni was made by Thomas Graham in the 
mid 18th Century. This work was expanded by Einstein in 1906 [18] who 
developed an equation describing the effective viscosity in suspensions of less 
than 5%.
1.2 V iscoelasticity
The subject of viscoelasticity is of critical importance to the work in this 
thesis and shall now be discussed in more detail.
1.2.1 R esponse to  A pplied Stress or Strain
The strain responses representing the Maxwell and Kelvin-Voigt models out­
lined above will now be discussed. As described earlier, the process timescale 
is of critical importance in determining the nature of the measured response.
As can be seen from the dimensionless plots shown in figure 1 .6 , the 
responses to the application of a sudden force is markedly different between 
the Maxwell and Kelvin-Voigt models.
The Maxwell model experiences an immediate deformation limited by the 
elastic constant of the Hookean spring (figure 1.3). The stress in the system
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Figure 1.6: Classic model responses to applied stress/strain: (a) Maxwell 
model, dimensionless stress against dimensionless time; (b) Kelvin-Voigt 
model, dimensionless strain against dimensionless time under constant stress.
is then reduced as the process timescale increases by flow within the viscous 
damper. An im portant point to note here is th a t the viscous element of 
the system is unable to return to its original length and so a component of 
the deformation is irreversible. As the process timescale is increased, this 
irrecoverable deformation becomes increasingly dominant. This marks the 
Maxwell model as a viscoelastic fluid.
In comparison, the response of the Kelvin-Voigt model is deformation 
governed by the flow in the viscous damper, up to  the limit imposed by the 
spring. If the stress is then suddenly released at time t\, then the Kelvin- 
Voigt model will undergo a complete relaxation, i t ’s speed governed by the 
viscous component. As all the deformation is reversible the Kelvin-Voigt 
model is a viscoelastic solid.
These two models are the extremes of viscoelastic material response. As 
such all viscoelastic materials will exhibit responses somewhere between these 
two. However, due to the dependence of the response upon the process 
timescale it can be difficult to accurately quantify a viscoelastic material 
through the application of a simple uni-directional stress or strain.
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1.2.2 Oscillatory Stress Response and its Uses
In order to effectively study viscoelastic materials, dynamic measurement 
techniques are very useful. In these instances, either a small oscillatory 
stress or strain is applied. If the material is purely elastic the response 
will be completely in phase with the applied force, while if the m aterial is 
a Newtonian fluid its’ response will be 90° out of phase. All viscoelastic 
m aterials will have oscillatory shear responses somewhere between these two 
extremes, governed by whether they are elastically or viscously dominated.
Driver
Couple
S H
N e w to n ia n  resp o n s e90
Viscoelastic
Region6
o
Figure 1.7: Illustration of a simple plate-plate rheometrical device. The 
graphs on the right show: Top - The phase angle, 5, between the force ap­
plied by the driver and that measured by the couple as the response from  the 
material: Bottom - The viscoelastic region of response as bounded by the 
Newtonian response at 9(T and the Hookean at (T.
The relationship between the applied oscillatory stress and the resultant 
strain can be described using the complex dynamic modulus, G*, through the 
following equation:
G* = G' + G"i (1.13)
Where G ’ and G ” are the storage and loss moduli respectively, defined
as:
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/m/ *0 cG = — cos o 
7o
(1.14)
(1.15)
i2 =  - 1  (1.16)
thus
^  = tan  <5 (1.17)
Where: a 0 is the amplitude of the stress, 7 0  is the amplitude of the strain 
and S is the phase angle between them.
1.2.3 Linear V iscoelastic R ange
In order that the theory of linear viscoelasticity proposed by Ferry in 1970 
[19] may be invoked, the rheometrical measurements must be made within the 
specific linear viscoleastic range (LVR) of the material under investigation.
Each measurement made outside of this range will be under a non-linear
regime and thus will reveal a different behavioural aspect of the material.
When under dynamic testing systems such as oscillatory shear, the tran­
sition point between the linear and non-linear regimes is dependent upon 
the applied strain amplitude. This transition point is a characteristic of 
the material undergoing investigation, and is termed the critical strain, j c. 
Above this value the material will behave in a non-linear fashion. The linear 
viscoelastic response is therefore observed during low amplitude oscillation.
The above is of use when controlled-strain rheometrical techniques are to 
be used. In the event that a controlled stress rheometer is to be used, then 
the linear- non-linear transition will be governed by the critical stress, <rc.
In order to determine the value of the critical stress or strain, the classical 
method is through the use of a stress or strain sweep respectively. The LVR 
is determined through analysis of the dynamic moduli defined earlier; G ’ and 
G”. W ithin the LVR, the dynamic moduli are independent of the magnitude 
of the applied stress or strain.
/ 7jj ^0 • rG =  — sin 0  
7o
and
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This method is not appropriate for use with systems which exhibit tran­
sient behaviour due to the fact that the dynamic moduli are then time- 
dependent. Location of the LVR therefore requires analysis of the response 
waveform measured at different levels of imposed stress or strain. This anal­
ysis is performed through the application of a single frequency of imposed 
stress or strain to the material under investigation. An appropriate fourier 
transform is then used to analyse the response waveform generated to deter­
mine linearity. If the test is the linear range, then the fourier analysis will 
result in a frequency spectrum with a clearly defined peak corresponding to 
the frequency of the test waveform applied. If the test occurs outside the 
linear range, the frequency spectrum will yield a distinct peak at the test fre­
quency together with a number of additional peaks at harmonic frequencies.
1.2.4 Transient M aterials
Transient viscoelastic materials are those which experience a change in struc­
ture, and as such a change in response, while under stress or strain. The 
material studied in this work, blood, exhibits transient behaviour and thus 
can be loosely described as a gelling system.
1.3 Gelling System s
A gelling system is one which undergoes a structural, and thus behavioural, 
change from viscoelastic liquid to viscoelastic solid due to an external insti­
gator, be it the addition of a chemical reagent, a change in temperature or 
the application of a particular stress or strain.
1.3.1 T ypes o f G el
Gels can be broadly categorised into a number of distinct groups: chemical 
gels, physical gels and colloidal gels. These groups are defined by the manner 
in which the gel is formed.
The formation of a chemical gel is characterised by gelation brought about 
through the formation of covalent chemical bonds between monomer func­
tional groups. These bonds are highly stable and indeed can only be broken 
down by the addition of a suitable chemical agent, if at all. As such, these 
gels are termed thermosetting.
Physical gels are characterised by the formation of thermoreversible bonds 
such as Hydrogen bonding and Van der Walls interactions. Due to the fact
15
that these bonds can be broken by the application of heat, physical gels are 
termed thermosoftening.
1.3.2 Percolation  T heory
The process of percolation was initially developed by Flory in 1941 [20] and 
Stockmayer in 1943 [21]. This process was used to describe the formation 
of large macromolecules within a system due to the reactions between small 
branching molecules.
The key concept behind percolation theory is the formation of a sample 
spanning network of chemically bonded molecules. The work of both Flory 
and Stockmayer was limited by the fact tha t all the theoretical development 
for their model of gelation was undertaken on a Bethe lattice, illustrated in 
figure 1.9.
Percolation Theory was further developed in 1957 to deal with fluid flow 
in random media. Rather than the direction and type of flow being defined by 
the fluid itself (a diffusion process), the randomness is defined by the media 
through which the flow occurs. If the medium is considered as a set of regular 
lattice points, then there can be two types of percolation. A site percolation 
considers the lattice vertices as the relevant entities for investigation, while 
a bond percolation process considers the lattice edges as important.
If the occupation of each site within the lattice is random and occurs with 
a probability, p, at low values of p (low concentration of fluid solution) the 
occupied sites are either isolated or form small clusters of ‘nearest neighbour’ 
sites.
As such, two occupied sites will belong to the same cluster if they are 
connected by a path of occupied nearest neighbour sites.
If the theory is applied to a viscoelastic gelling system, then at low values 
of p, the system will be a pre-gel fluid as no sample-spanning paths exist. At 
high values of p, the lattice is then traversed by paths connecting the sample 
edges and so the system will be a gel.
Therefore, a threshold concentration pc must exist between low and high 
p values and is defined as the point at which, for the first time, a connection 
is made for one lattice edge to the other.
This is termed p^ in the case of a site model and Pd, in the case of a bond
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( a ) (b)
Figure 1.8: Illustration o f percolation types; (a) site percolation, (b) bond 
percolation.
model. In general, pcb < pcs
The state in which the solution will be is dependent upon the timescale 
over which the reaction takes place. If this process time is shorter than the 
characteristic gel time, tg, for the material then a number of finite branched 
polymer clusters within the solution, usually termed a ‘sol’. This will be 
increasingly viscous as the process time approaches tg. Once the process 
time exceeds tg, then a solid, sample spanning network is formed. At this 
point the material is term ed a ‘gel’. The time at which the first sample 
spanning network appears during the transition from ‘sol’ to ‘gel’ is known 
as the Gel Point.
1.3.3 Lattice formation
The type of lattice formed will depend upon the coordination number, which 
defines the number of bonds made at a given vertice. All of the examples 
given above are shown as two-dimensional. It can be noted also th a t the 
Bethe lattice can be split into three symmetrical branches, each of which 
can be defined by the Caylee Tree. This states th a t from the end of each 
individual section, two more shall sprout.
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(C)
Figure 1.9: Illustration o f regular lattices with increasing coordination num ­
bers; (a) Bethe Lattice (Z = 3), (b) Honeycomb Lattice (Z = 3), (c) Square 
Lattice (Z = 4), (d) Kagome Lattice (Z = 6), (e) Triangular Lattice (Z = 
6).
The addition of more layers of lattice to the standard square lattice will 
enable the formation of either a diamond lattice or a standard cubic depend­
ing on the orientation of the extra lattice ‘sheets’. Another diamond lattice 
can be formed from the addition of further sheets to the triangular lattice.
1.3.4 De Gennes’ Ant and the Random Walk
The idea for comparing the manner in which bonds form in a percolation 
network to a person taking a random walk was first suggested by Brandt 
in 1975. In this instance the walker is placed on an occupied site within 
the network. The walker then takes a step to one of the unoccupied nearest 
neighbour sites to its current position. If it is assumed tha t all bonds have 
the same diffusion conductance, then the selection of the site to which the 
walker will go is dependent upon the coordination number of the lattice. 
B randt used this idea to study diffusion of noble gases through glasses when 
modeled by a percolation network.
In 1976 the idea was expanded upon and popularised by de Gennes [22]
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who compared the movement of the random walker to that of an ant in 
labyrinth.
The phenomenon of the random walk as explained by de Gennes ant has 
been modeled by a simple program developed by Langton, which utilises a 
square grid and an ‘ant’. The grid begins with every square white. Simple 
rules control the motion of the ant: it always moves one square at a time, if 
it encounters a white square the square becomes black and the ant turns to 
the right, if it encounters a black square the square becomes white and the 
ant turns to the left.
Using this program, three distinct phases of order can be seen as the 
system develops:
1. Simplicity
During the first two to three hundred moves, the ant creates tiny inde­
pendent patterns which are very simple and often symmetric.
2. Chaos
In this phase of the evolution of the system, the patterns degenerate 
into a large irregular patch of black and white squares without any 
discernable structure.
3. Emergent Order
Finally, the ant locks into a particular kind of repetitive behaviour and 
builds a ‘highway’ over a cycle of 104 steps, at the end of which the ant 
has moved out two squares diagonally. The shape and colours along 
the edge of this highway are now the same as when the cycle began so 
the highway will now be rebuilt forever.
1.3.5 Backbone Form ation
The backbone of any sample spanning network is that part which directly 
binds one edge to the other, such that transport can occur along it. For 
example, current in the case of an electrical network or material flow in 
the case of a diffusion process. Indeed, transport can only occur along the 
backbone as the rest of the structure consists of dead ends and loops which do 
not carry any flow. The structure of this backbone will define the transport 
properties of the network due to its tortuosity.
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The formation of the backbone during the point at which the percolation 
threshold pc is reached is very important. Work by Stanley [23] showed that 
the bonds in the backbone can be split into two distinct groups; those within 
the multiply connected backbone sections, and those termed red bonds. The 
cutting of any of these red bonds would result in the severing of the backbone 
into two distinct parts. They are termed red due to the fact that Stanley 
was working with electrical systems and these bonds carried all of the current 
causing them to become very hot.
1.4 Sol-Gel Transition and A ttem pts to  M ea­
sure the Gel Point
Once the percolation threshold has been reached and a sample spanning 
network formed, the material exhibits increasingly Hookean behaviour with 
respect to its response to any applied force. As discussed earlier, the point 
at which the material changes from sol to gel is defined as the Gel Point. 
Identification and characterisation of the Gel Point, both in terms of time 
and with reference to the resultant gel structure has required a large degree of 
investigation. There have been a number of Theological methods put forward, 
involving both steady and dynamic techniques.
The steady state measurements have been used to investigate the changes 
in the zero-shear viscosity, 770, as the material progresses towards the Gel 
Point. This is due to the fact that at the Gel Point the value for 770 will tend 
towards infinity, coupled with a tend towards zero observed in the residual 
shear rigidity modulus, Ge such that at the Gel Point:
77 —> 0 0  (1-18)
Ge ► 0 (1.19)
This is due to the conversion of the isolated molecular-scale clusters into 
a sample spanning network at the Gel Point.
In terms of dynamic investigation, it was postulated that at the Gel Point 
the dynamic moduli, G ’ and G”, would be equal. Thus the Gel Point could
be determined by this ’cross-over’. From the definition given in equation 1.17
the Gel Point occurs where tan<5 =  1, or at a phase angle, <5, of 45°.
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0Figure 1.10: Development of mechanical properties within a material as it 
undergoes gelation. The Gel Point is here determined by the critical values 
of reaction time, tc, and the conversion, pc
Two other methods involved the linking of the Gel Point directly to 
changes in the values of G ’ and G” . It was suggested that the rheological 
definition of the Gel Point occurs with the first development in the storage 
modulus, G \ However, this point is often indistinguishable from process noise 
when in practical use. This method therefore leads to a very rough approxi­
mation of the Gel Point as occurring at the point at which G ’> Experimental 
Noise. The second of these methods defined the Gel Point as the point at 
which G” is at a maximum. This is based on an analogue of the Kronig- 
Kramers equation which connects the real and imaginary components of any 
complex function. While a maximum G” value has been measured in gelatin 
immediately following an inferred Gel Point, the maximum is often drowned 
in experimental noise.
The most widely accepted method for the rheological determination of 
the Gel Point is based upon the rigorous work undertaken on polymer gels 
by Winter and Chambon in 1986 [24]. They characterised the transition of 
the material from sol to gel as exhibiting a power-law behaviour of Gt the 
linear, time-dependent shear stress relaxation modulus, such that at the Gel 
Point:
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G(t) = S ta (1.20)
Where: S  is the gel strength of the three dimension network formed at
the Gel Point and a  is the stress relaxation exponent.
This equation was developed from the equation describing the extra stress 
at constant density in any viscoelastic material:
=  (*) =  r  G(t -  t') i  (t')dt' (1 .2 1 )
J —oo
Introducing the kinematics of oscillatory shear into the above equation 
allows analysis of the dynamic moduli:
fO O
G'(lj) = uj G (t)sin(ut)dt (1 .2 2 )
Jo
fO O
G”(lj) = u  /  G(t)cos(cjt)dt (1-23)
Jo
In order for equations 1.22 and 1.23 to achieve congruency they must be
equal and proportional to uj1/2. Fourier transforms were then used to obtain
equation 1 .2 0 .
G(t) is calculated using a preset shear strain, 7 0 , and the stress relaxation 
function, r(t).
G(t) =  (1.24)
7o
Winter and Chambon demonstrated tha t their gel definition fulfilled the 
criteria for the Gel Point outlined by Flory in 1953 [25]. They followed 
this with work on gels of both balanced and unbalanced stoichiometry, and 
showed that their definition was applicable to both cases.
Their definition shows tha t the response of the dynamic moduli to an 
imposed oscillatory shear stress or strain is dependent upon the frequency 
of oscillation when the material is within the linear viscoelastic range. This 
allowed them to characterise the critical gel at the Gel Point as:
G'(u>), G"(uS) oc u a (1.25)
From equation 1.17:
tanS(u) = (1.26)
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Prom equations 1.25 and 1.26, it can be seen that at the Gel Point, the 
phase angle, <5, is frequency independent. This thereby enables the Gel Point 
to be characterised in terms of the gel equation given in equation 1.20.
Following this work, Winter [26] assessed the validity of the definition 
suggested by Tung et al[27] as outlined earlier. It was found that the location 
of the Gel Point only coincided with the G’-G” crossover when the stress 
relaxation modulus, a  is equal to 0.5. The Gel Point occurs prior to the 
crossover if a<0.5, and after the cross over if a>0.5.
1.5 Rheological Techniques
1.5.1 H arm onic Frequency P hase A ngle R esponse
The basis for this method is the speed at which different frequencies travel 
through solids and liquids: lower frequencies travel faster through solid ma­
terials, while higher frequencies travel faster through liquids.
As such the method involves the application of a base frequency and a 
number of harmonics (within the LVR) to the system under investigation. 
The materials’ response to the applied frequencies will generate a different 
pattern of phase angles pre-gelling to the response pattern perceived when 
the same set of frequencies is applied to the system post gel.
The difference in the magnitude of the phase angle responses is due to the 
materials’ response being dominated by the viscous and elastic components 
of the forces during the liquid and solid states respectively. The frequency 
response inversion enables the identification of the transitional point between 
the two states: the Gel Point, as discussed above.
1.5.2 Fourier Transform M echanical Spectroscopy
However the above set of data can be time consuming to collect if the fre­
quencies are applied and analysed independently. Completely individual fre­
quency application is only possible when the gelation in the sample can be 
completely reversed and then initiated once again.
In order to facilitate faster application of the frequencies, and thereby 
a reduction in the time required for the measurements to be completed, 
Boltzmann’s superposition principle which states that within the linear vis­
coelastic range the stress responses to successive strains are additive as are
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Figure 1.11: The phase angle, 6 response patterns observed pre- and post­
gelation to a base frequency and a set of harmonics
the strain responses to successive stresses. This allows for the combination 
of the base frequency waveform and the harmonics into a single compos­
ite waveform through fourier transform methods as shown in figure 1.12. 
The response waveform can then be separated into its component frequency 
responses through fourier transformation.
However, it was found to  be very difficult to get good data  from exper­
iments on blood using this method. As such frequency sweep experiments 
were required. These procedures are outlined in the M aterials and Methods 
chapter later in this thesis.
1.5.3 Increasing Sensitivity
Initial trials for this work were carried out on an ARES rheometer using a 
bob and cup geometry with a 1mm gap so as to replicate the geometry of the 
TEG machine. However, it was found th a t this set up was not sufficiently 
sensitive in Gel Point detection. The same geometry was trialled on an AR 
G2 rheometer with corresponding sensitivity issues. As such it was decided 
to  use a double-gap geometry as outlined in figure 1.13.
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Base 1st Harmonic 3rd Harmonic
Composite
Figure 1.12: Composite waveform created from the superposition of base and 
harmonic frequency components
1.6 N om en cla tu re
a stress
°c critical stress
Gy yield stress
7 strain
7 strain rate
F applied force
X extension
k spring constant
E elastic modulus
rj coefficient of viscosity
Vo zero shear viscosity
K (t) creep function
f(t) relaxation function
6 phase angle between applied force and response
G ’ storage modulus
G” loss modulus
G* complex modulus
Ge shear rigidity modulus
P probability
Pc threshold concentration
P cb bond thp&fchold concentration
Pcs site threshold concentration
z co-ordination number
t time
.^9 gel time
t c critical (reaction) time
s gel strength
Figure 1.13: Cutaway diagram of double gap concentric cylinder geometry. 
Labeled parts as follows: a - suspending rod mounted on an air bearing, b 
- detachable geometry, c - removable cup, d - temperature controlled water 
bath, e - blood sample, f  - internal cylinder
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Chapter 2
Fractal geom etry as a tool for 
structural analysis
The existence of these patterns challenges us . . .  to investigate 
the morphology of the amorphous.
Benoit Mandelbrot, The Fractal Geometry of Nature, 1982.
2.1 Background
The worth of fractal geometry comes from the fact that it enables the char­
acterisation and therefore comparison of structures which are scale-invariant 
and as such lie beyond the realm of standard Euclidean geometrical concepts. 
The term fractal was coined by Mandelbrot in 1975 while working on itera­
tive processes for IBM [28]. It comes from the Greek fractus meaning broken 
or fractured.
It is to the principles of Euclidean geometry we refer when looking at the 
manner in which the volume, for regular objects such as a cube, changes with 
respect to length of the sides. In this instance, a doubling of the length of 
the sides of the cube would result in a fourfold increase in the area of each 
face, while the volume increases eightfold. The standard integer dimensions, 
d, (1,2 and 3) can be used to relate the way in which the mass, M, of the 
object alters as the linear size L, is changed, as long as certain conditions are 
met by the system such as constant density. In this instance, the dimension 
is characteristic. For example, if the value of d is 1 then the object is a line 
(thickness is taken to be infinitesimally small such that the only dimension 
is length), if d is equal to 2 then the object is a square, while if d is 3 then 
the object is a cube.
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If a smaller part of the system is then studied, with a length, aL, such 
th a t a < 1 then an alteration in a will result in a change in M  proportional 
to ad.
M (aL) = adM  (L) (2.1)
However, scale invariant systems cannot be characterised by integer di­
mensions. The term  scale-invariant means th a t the system has 110 characteris­
tic length scale. A classic example of this is an overhead view of a coastline. 
A number of images of the coastline at different scales presented together 
without a scale reference will be relatively indistinguishable. A wide number 
of systems can be identified which possess fractal nature, for example bio­
logical structures as diverse as the Romanesco cabbage and the mammalian 
cardiovascular system. The examples of fractal expansion presented in figure 
2.2 are constructed using set theory.
Figure 2.1: Examples of natural fractal structures. Top row: The fractal 
cabbage chou Romanesco, and the Lena river delta. Bottom  row; the fractal 
structure of the vascular and bronchial networks in the lung
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2.2 Set Theory in Brief
Before fractal systems can be looked at in depth, a brief introduction to set 
notation must be made.
The following definition of a set was made by Georg Cantor:
By a set we understand any collection M of definite, distinct 
objects m of our perception or our thought (which will be called 
elements of m) into a whole.
As such, some examples of sets are: the Z  set of all whole numbers (inte- 
gers)and the sets Q, R  and C of all rational, all real and all complex numbers 
respectively. Other sets can then be defined at will. Consider the words: set, 
collection and aggregate as synonymous in this instance. The elements of a 
set may be termed its members. If A is a set and if an object a is an element 
of A this can be written as;
a e A  (2.2)
This symbolism means a belongs to A , while if a is not a member of A 
then this is written as;
A  (2.3)
Sets can be described by listing their members between pairs of curly 
parenthesis '{}' although sets containing an infinite number of members are 
clearly impossible to describe in this way. On such occasions it is possible to 
write x  : P(x) where P is a property which characterises only those elements 
of the set in question.
If A and B are both sets and if each element of A belongs to the set B 
then it can be said that A is a subset of B  or B contains A. This can be 
written as:
A C  B  (2.4)
Given the above, if we know that B contains elements not in A then this 
must be written as:
A c  B  (2.5)
This last term is the most important for the fractal structures presented 
in figure 2.2 as it allows them to be described mathematically.
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For example, the mathem atical description of the Sierpinski Triangle pre­
sented below is as follows. Starting with a triangle with vertices (0,0) (1,0) 
(0,10) call it T0, another three edges are included in the form of a middle 
triangle to get T\. The process is then repeated in the three outer triangles 
thus created to get T2. The limiting case of this expansion is the Sierpinski 
Triangle.
Figure 2.2: Examples of Fractal Expansion; (a) Sierpinski Triangle, (b) Koch 
Curve
The Koch curve presented above is perhaps one of the most famous m ath­
ematical fractals [29]. Both the Koch curve and the Sierpinski triangle are 
examples of deterministic fractals, systems which can modeled using com­
puter algorithms. A comparison between the curve and the cube discussed 
above can now be undertaken using equation 2.1. Each step of the Koch 
curve iteration results in an increase in the length of the structure by 4/3. 
If a smaller segment of the structure is now considered in the same manner 
as above, a 1/4 decrease in the mass of the structure will be caused by a 
decrease in the segments’ linear size of a = 1/3, such that:
T0 C 7i C T2 C T3 . . .  C Tn . . . (2 .6 )
(a)
G«b«i«Ioi
(2 .7)
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In order tha t both equations 2.1 and 2.7 can be satisfied is through the use 
of non-integer fractal dimensions. The initial equation must now be altered 
to enable the inclusion of the fractal dimension thus:
M{aL) = ad'M (L )  (2.8)
Such that
M(L)  oc Ldi (2.9)
A return to the Euclidean geometrical concepts can be used in order to 
enable an instinctive evaluation of fractal structures. Again considering a 
standard 3-dimensional cube, if a cube of side b is expanded by a factor L 
then the original cube may be fitted into the resulting larger cube Ld times, 
where, d, is the dimension such that:
This then enables the assessment of the fractal dimension of the Koch
curve. If the generator structure as shown in figure 2.2 is considered it can
be seen that it is composed of a single cluster of 4 lines. The next iteration is 
composed of 4 clusters, each of which contains 4 lines, giving a total cluster 
size of 16 lines. The third iteration contains 16 clusters of 4 lines, giving a 
total cluster size of 64 lines, 4 times the number in the last iteration. As such 
it can be seen that for each iteration the number of lines in the total cluster 
increases by a factor of 4, while the maximum length increases by a factor of
3. If the iterations are continued to the Nth degree, then the number of lines 
will be equal to 4N while the length will be equal to 3N. It can therefore 
be stated that the Koch curve possesses a hierarchical structure. From the 
discussion above and with reference to 2.2, following the expansion of the 
curve by a factor of 3, 4 replicas of the original curve will be required to cover 
the new structure. Hence, the fractal dimension can be calculated as below:
d} = p ! l x  1.26 (2.11)
’ logS v '
In comparison,the fractal dimension of the Sierpinski triangle is;
d/=gH '58 (2i2)
Structures of a fractal nature are typically low density. The growth in 
the molecular weight of the fractal as the length is increased is smaller for
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structures with a low fractal dimension than structures with high fractal 
dimension values.
2.3 Random  Fractals
The method above, however, is only applicable to randomly generated frac­
tals over a limited range of iterations. The fractals such as those used to 
mimic natural biological systems such as the cardiovascular system due to 
the fact that the structures cannot be directly mapped onto themselves fol­
lowing expansion or contraction outside of these upper and lower limits.
A method of statistical evaluation of self-similarity is therefore required. 
Two methods which enable the calculation of a statistical self-similarity av­
erage on fractal images are box-counting and the sandbox method.
2.3.1 B ox-counting
The box-counting method utilises a rectangular grid consisting of Ni squares 
which can be overlayed upon the fractal structure. The number of grid 
squares which are required to completely cover the structure, S(N i), can 
then be calculated. The size of the squares which make up the grid is then 
progressively reduced and the number of grid squares required to cover the 
structure at each iteration of the grid is then noted, S(N \),S(N 2 , etc. S(N \) 
can be scaled with df such that:
S(N)  N ~ df (2.13)
This enables the use of a plot of log[S(N)] against log[l/N], which will 
generate an asymptotic slope at df for large N. The minimum size of the 
squares which can be used in this method are limited to those which are 
greater than the size of the pixels which make up the image of the structure 
under investigation. This method is illustrated in figure 2.3.
2.3.2 Sandbox m ethod
This method, shown in figure 2.4, utilises n circles of set radii, r\<r2 < .. ./rn, 
placed over a single site on the fractal image. In order to enable collection 
an adequate level of data for statistical evaluation, a number of origin points 
must be used. The number of pixels, M j(Ri) where j=2,3 , . .. within each of 
the circles is then assessed. The number of pixels around each point of origin 
can be averaged using the following formula:
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Figure 2.3: Iterations of the box counting method for fractal dimension as­
sessment, left to right: Using an Ni grid; next iterative step, an N2 grid.
1 771
M ( R j ) = - Y , M j (Ri) (2.14)
j=l
When using the above method, a plot of log[M(R*)] against log[R?] for 
large values of will give a slope of d /.
2.4 Fractal m od els o f gel netw ork stru ctu res
The relationship between the relaxation exponent, a , as defined in Chapter 
1.6, and the fractal dimension, df , has been investigated in term s of various 
theories concerning both cluster growth and gelation. The im portance of this 
work in understanding the structural nature of the gel network is shown in 
this quote taken from the work of M artin [30].
. . . the incipient gel, th a t fluid formed just at the sol-gel
transition, is a viscoelastic intermediate between the liquid and 
solid state and a paradigm of fractal structure and fractal time.
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Figure 2.4: Iterations of the sandbox method fo r  fractal dimension assess­
ment, left to right: Using circles of radius R\ ; following two iterative steps, 
including circles of radius R 2 and R3.
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2.5 Aggregation M odels
The first of the aggregation models to be discussed here is the Smoluchowski 
Method [31], shown in equation 2.15. This theoretical approach to the 
modeling of gelation as an aggregation process is based upon the kinetic rate 
equation of Doi and Edwards [32]. The method utilises a reaction rate, 
which is used to determine the probability of a successful collision between 
the monomers (labeled i and j) extant in the system. The combination of 
these monomers results in the formation of m-mers. The equation expresses 
the rate of formation of N(m). The right hand side of the equation can be 
readily split into two distinct sections: the first section is concerned with the 
creation of the 772rmers, while the second section deals with their annihilation.
P -  = 1 E  mi)KvNti)-N(m)jpKvNj (2.15)
i + j —m j = 1
While this method is able to provide some level of qualitative analysis 
through the use of a mean-held description it is hindered by the difficulty 
in the determination of the form of the reaction kernel and its inability to 
predict the structure of the resulting cluster in part due to a number of 
underlying assumptions such as the use of a spatial average to represent 
the concentration of clusters with a given mass, and that the reaction rate 
between any two clusters is always the same.
2.5.1 D iffusion Lim ited A ggregation
This model for gelation involves the growth of a sample spanning cluster from 
a single seed within the middle of a lattice. Subsequent particles are released 
in turn from a random point located at a large radius from the seed point 
such tha t r=rmax. This particle proceeds upon a random trajectory (with a 
path possibly defined using the Langton - de Gennes ant defined in Chapter 
1.6). If the introduced particles’ trajectory is such tha t it approaches a point 
directly adjacent to the seed then the two are joined, in contrast, if the 
trajectory takes the particle on a course that is divergent from the seed to 
such an extent that a boundary r  rmax then the particle is considered to 
be destroyed. In this way a particle is prevented from continuing on its path 
ad infinatum. Only once a particle has either joined with the seed at the 
origin or been destroyed is the next particle introduced into the lattice. This 
is illustrated in figure 2.5.
This method is not confined solely to standard square lattices, work has 
also been carried out a number of off-lattices such as the triangular and hexag­
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onal which have been shown to generate more realistic structures. Bunde and 
Havlin [33] have published fractal dimensions for structures generated on off- 
lattices: where (1=2, d/=1.71, while for d=3, d /= 2 .4 .
max
seed particler»r,max
killed particle added particle
Figure 2.5: An illustration of diffusion limited aggregation on a sguare lattice.
2.5.2 Diffusion Limited Cluster Aggregation
In this case, the growth site for the fractal structure is not unique. When 
two particles come into contact, a cluster is formed. This cluster is not 
spatially fixed and so is able to diffuse throughout the lattice. This enables 
a wide variety of cluster sizes to be formed early on in the process. However, 
as the timescale increases, the number of clusters reduces as the clusters 
increase in size. At this point random branches begin to appear within the 
larger clusters. This continues until a single macroscopic structure is formed. 
DLCA results in much looser structures than simple DLA, with a d /= 1 .4  
when d= 2  and a d /= 1 .8  when d=3.
2.5.3 Reaction Limited Cluster Aggregation
While the two aggregation models described above assume th a t all contacts 
between particle and cluster or cluster and cluster result in a successful bond, 
a Reaction Limited aggregation allows for the possibility tha t a collision
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will not result in a bond. This is assessed through the use of a stickiness 
coefficient, £, set between 0 and 1. This is used to decide whether or not a 
particle sticks to a cluster through the use of a random number generator. 
W hen the particle reaches one of the nearest neighbour sites on the lattice 
to the existing cluster, a random number between 0 and 1 is generated. If 
the number is greater than the stickiness coefficient then the particle sticks, 
if it is less then it continues to move. As the value of £ approaches zero the 
likelihood tha t a given particle will stick when it reaches an adjacent site to 
the cluster becomes greater, leading to the formation of increasingly dense 
structures.
Figure 2.6: An on-lattice fractal structure grown using RLA with a £ value 
of 1.
This sticking coefficient will also affect the rate at which the fractal struc­
ture is formed, and this has an impact on the nature of the structure. The 
faster the process of aggregation, the lower the fractal dimension of the re­
sulting structure. It has been shown th a t the cluster radius in a reaction 
limited aggregation model follows an exponential growth curve and as such 
the fractal dimension values are higher than those found with diffusion lim­
ited aggregation, giving a d / =  1.56 when d=2 and d /= 2  when d=3
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2.5.4 M ean Field and P ercolation  Theory
Percolation Theory was discussed in detail in the previous chapter and so 
only merits further mention in terms of its use in the development of frac­
tal dimension assessment. The theory predicts power-law behaviour for the 
development of the molecular weight, MW1 and the radius, Rz of the clusters 
thus:
Mw <x e~k (2.16)
R z oc e~v (2.17)
where:
e =  b ~  Pel (2.18)
The variables p and pc were defined in the previous chapter. The theory 
predicts that the exponents are t>=0.5 and k = l. The theory has also been 
used to develop predictions for the changes in the dynamic viscoelastic prop­
erties 770 and Ge which show that the viscosity grows logarithmically at the 
Gel Point:
7]0 (xe~s P  <  pc (2.19)
Ge oc e2 P >  Pc  (2.20)
Given that z=3 and s=0. Both z and s can be related to the stress
relaxation component, a , as defined in the previous chapter through the
following equation:
a  =  (2 .21)
z + s v
As such, this gives a value for a  of 1 from the s and z values stated above 
which are derived from the classic mean-field Flory-Stockmayer theory. How­
ever, this was found to predict non-physical results for branched polymers 
and so was developed into percolation by De Gennes and others as discussed 
in the last chapter.
Percolation theory predicts different theoretical values for the various ex­
ponents, dependent upon the structural model being considered. The Rouse 
dynamic model [34] considers the structure as a series of spheres (represent­
ing mechanical drag due to the friction factor) linked by springlike chains 
(representing Gaussian entropy).
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Figure 2.7: Illustration of polymer chains as viewed with the Rouse dynamic 
model
Using this model, together with hydrodynamic screening effects and rigid 
chains, enabled M uthukumar [35] to relate df and a  by:
a = jp T 2  <2-22>
This was then developed to consider a mono-disperse system with flexible 
chains:
And finally to consider a poly-disperse system with complete hydrody­
namic screening:
=  d{^ + 2 -
2(d  +
W here d is the dimension of the system, in this case 3. Therefore, equation 
2.24 becomes:
15 -  6df
a =io^4<2-25)
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Solving for df gives:
J  1 0 "  "  1 5  CO i f i - l
d f =  ~ 2 ^ < r  ( 2 - 2 6 )
From Chambon and Winter, as discussed in the previous chapter, at the 
Gel Point a  is equal to the phase angle, 6, divided by 90.
df = i t ?  <2-27)
90  °
All fractal dimensions given in the results chapter are calculated using 
equation 2.27.
From this it can be seen that the transition from sol to gel is not a process 
purely reliant on percolation, but is also dependent on partial or complete 
hydrodynamic screening, dependent on the polymer under investigation.
A method by which a fractal dimension can be derived for a mature clot 
has been developed by Avrami[36] and Liu[37]. However, this method is 
unsuitable for use with blood due to the fact tha t it relies upon a value for 
G’oo- This is not possible to measure, or even reliably infer in the case of 
thrombosis due to lysis, the means by which the clot is broken down, which 
occurs far before a value of G ’^  is approached.
2.6 Nom enclature
d dimension
L length
M mass
d/ fractal dimension
a stress relaxation exponent
6 phase angle between applied force and response
N square side length (box counting)
R circle radius (sandbox)
K y reaction rate
C RLCA stickiness coefficient
molecular weight
R z cluster radius
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Chapter 3 
Carbon Nanoparticles
‘Take carbon then, what shapely towers it constructs’
A.M Sullivan, Atomic Architecture
Carbon compounds and structures have been put to use in every stage of 
civilisation, from the charcoal drawings of the Neanderthal and Homo Erec- 
tus to the charcoal driven development of metallurgy, the rapid coal fueled 
mechanisation of the industrial revolution to the dependence of modern hu­
manity on the internal combustion engine and hydrocarbon derived plastics. 
In this manner, humanity can be described as carbon based on far more than 
just an internal cellular level.
Carbon as an element is unique in that it can form widely varying struc­
tures which comprise of nothing but the element itself. The two most 
startlingly disparate examples of this are graphite and diamond.
The former consists of multiple sheets of Graphene, made of six sided 
carbon rings. Each sheet is weakly bonded to its neighbours through Van 
der Waal’s interactions. This results in graphite being very soft, as the Van 
der Waal’s forces can be easily overcome allowing the sheets to slide over 
one another. Diamond, on the other hand, is formed from tetrahedrally 
bonded carbon such that the single unit formed by 5 carbon atoms is a 
triangular pyramid with a central carbon atom and the other four located at 
the vertices. This results in an incredibly strong matrix structure, and has 
allowed diamond to be put to use in the drill bits used in mining operations. 
While tougher, diamond is less thermically stable and will decompose to 
graphite if heated to 1800°C.
W ith the advent of technologies which allow for the study of materials at 
ever smaller scales, the investigation into the differences in the structures of
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carbon compounds together with the possibility of their manipulation became 
an ever more important goal. The rapid descent of science and technology 
into smaller and smaller scales of reference was first identified, and predicted, 
by Richard Feynmann in a talk given in 1959, in which he discussed the 
manufacture of substances within biological cells and urged his audience to 
consider the possibility that we, too, can make a thing very small, which does 
what we want - that we can manufacture an object that maneuvers at that 
level. The term Nanotechnology was not coined until the publication of the 
book ‘Engines of Creation’ by Eric Drexler in 1986 [38]. The term nano is 
derived from the Greek nanos meaning dwarf and is used to define a scale, in 
this instance of 1 0 ~ 9 meters, approximately 1/80,000 the width of a human 
hair.
Two distinct types of nanoparticles have been investigated for this thesis 
and so merit further discussion within this chapter. The first of these are the 
combustion generated carbon particulates which are one of the by-products 
of the internal combustion engine, whilst the second are the accidentally 
discovered and now deliberately engineered carbon nanotubes.
3.1 Urban Particulates
3.1.1 C om position and G eneration
Atmospheric and urban particulate m atter include a wide range of chemicals, 
covering particle sizes from diameters of one hundred micrometers down to a 
few nanometers. Elemental and organic carbon, sulphates and nitrates, both 
man-made and natural, along with various other minerals dependent on ge­
ographical location, maybe emitted directly into the air. Further particulate 
m atter is also created through secondary reactions between both particulate 
and non-particulate material extant in the atmosphere. Some of the geo­
graphic deviation between chemical concentrations in urban particulate is 
due to the use of different fuels and indeed additives to fuels, such as the use 
of lead as a lubricant in petrol which is still the practice in few countries, 
while it has been phased out and now banned in others. This banning of 
lead was due to the health effects caused by the increasing levels of lead in 
the bloodstream of those exposed to exhaust.
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3.1.2 Toxicology  
Historical Cases
Airbourne particulate carbon can come from a variety of sources. While the 
coal industry still flourished in Britain, the effects of prolonged exposure to 
coal dust were well documented, with the respiratory problems being known 
commonly as black lung. These effects varied depending on the location 
of the mine, as the makeup of the coal and thus its dust were markedly 
different. The coal dust from South Wales was found to be the most toxic. 
It was suggested by Seaton et al [39] that this increase in toxicity was due 
to the shape of the particles within the Welsh coal dust. These were found 
to be flat and plate like, as opposed to the more spherical particles from 
mines in Yorkshire. This difference in shape may be what enabled the Welsh 
coal dust particles in certain orientations to penetrate deeper into the lungs, 
causing localised inflammation and a greater systemic response, and perhaps 
even some penetration into the bloodstream.
Effects of coal dust were largely limited to respiratory problems. This 
was due to the large size (PMi0 (10/mi diameter) or greater) of the parti­
cles produced. The effects of particle size are twofold; firstly, as mentioned 
above, particles of 10/im diameter and above will be more readily expelled 
by the lungs prior to their reaching the alveoli. Secondly, for a given mass 
of particles, a decrease in particle size will result in an increase in particle 
numbers and surface area, this is illustrated in figure 3.1.
This increase is most easily understood through the consideration of 
cubes. Taking a cube with sides of length ten as the initial particle (equiva­
lent to PMio). Each of the faces of the cube will have an area of 100 resulting 
in a total surface area of 600. If the cube is now divided into equal pieces 
such that each resulting cube has a side length of 1 , then the surface area 
of each particle will be reduced to 6. However, there are now 1000 particles, 
resulting in a total surface area of 6000, with no change in volume. If this 
procedure is undertaken a third time, resulting in cubes with a side of 0.1, 
then the surface area of each particle is reduced to 0.06. However, there are 
now 1,000,000 particles, resulting in a total surface area of 60000.
Prior to the toxicological investigation into the effects of increased surface 
area, the hypothesis of the increased numbers of smaller diameter particles 
for a given mass was postulated by Seaton et al. in 1995 as being the cause 
of increased cardiovascular and cardiopulmonary mortalities during certain 
pollution incidents. This paper is partly credited with the creation of the
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Figure 3.1: Illustration of relative particle diameters. Left to light; PM  10, 
PM \ '0  and PMq.i .
nanotoxicology discipline. However, it had long been known within the chem­
istry discipline, especially by those studying reaction kinetics and catalysis, 
tha t a decrease in the particle sizes of the reactants (for example by grinding 
into powders) increased the rate of reaction as larger areas were available by 
which the materials could come into contact.
It had long been recognised th a t London had a particular problem with 
air pollution. The earliest attem pt to deal with this was the banning of the 
burning of sea coal by Royal Proclamation in the Thirteenth Century. The 
problem persisted, and in 1661 John Evelyn presented a treatise to Charles II 
entitled, ‘Fumifugium: or the Inconvenience of the Aer and Smoake of London 
D issipated’, in which he suggested th a t the lives of London’s population 
would be shortened by smoke pollution.
The first time in which urban pollution was directly linked to  respira­
tory and cardiovascular problems, and even mortalities, was in London in 
December 1952.
A large drop in winds together with the prevalent weather patterns on 
the night of the 4th of December resulted in the formation of a tem perature
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inversion over the Tham es Valley [40]. This occurs when warmer air moves 
on top of cold air, trapping the colder air at lower altitudes. This prevented 
the dissipation of smoke and pollutants from all sources, coal fires used for 
heating and power stations for example.
This caused a rapid and dramatic increase in ambient pollution concentra­
tions. On the 4th, the concentrations of smoke and sulphur dioxide measured 
at 12 sites across London were both between 0.12 and 0.44mg/m3. As the 
fog began to appear and the smoke was prevented from dissipating, concen­
trations on the 5th reached 2.46mg/m3 of smoke and 2.15mg/m3 sulphur 
dioxide. The peak was not reached until the 7th and 8th however, when con­
centrations of smoke and sulphur dioxide rose to 4.46m g/m 3 and 3.83m g/m 3 
respectively.
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Figure 3.2: Increase in levels o f smoke and sulphur dioxide during 1952 smog 
compared to average data from the same period in 1951. (LCC 1953)
This smog forced a number of schools to close due to fears th a t children 
would become lost between their houses and the school gates, together with 
recommendations th a t no journeys be undertaken unless completely neces­
sary. In fact, the smog was so thick tha t fire engines were forced to employ 
men canying flares to walk in front of them to enable the firemen to find the 
desired destination.
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A Ministry of Health committee formed in 1953 estim ated tha t the num­
ber of deaths during the incident were between 3,500 and 4000 more than 
would be expected under normal conditions. In fact, the number of deaths 
a ttributab le to the smog were similar to those th a t occurred over the same 
time period caused by the cholera epidemic in London of 1854, and the pan­
demic of influenza in 1918.
5.000 
4,500
4.000 
■g 3,500
3.000Ol
£  2,500to
% 2,000 
°  1,500
1.000 
500
0
1947-1951 average in corresponding w eeks
 r  1   r » i i i i i 1
15 Nov 22 Nov 29 Nov 6  Dec 13 Dec 20 Dec 27 Dec 3 Jan 10 Jan 
Weeks ending
Figure 3.3: Increase in mortality during London smog of 1952. (M inistry o f 
Health 1953).
Following this incident and the evident link between the high levels of 
black smoke fog or smog, a term  coined by Dr. Des Veoeux in 1905 to describe 
the combination of smoke and natural fog which London frequently suffered, 
measures were made to reduce airbourne pollution levels within towns and 
cities. This was done prim arily by relocating industry (both manufacturing 
and power generation) away from urban areas. However, while these steps 
reduced respiratory disorders as the levels of black smoke were brought down, 
the numbers of cardiovascular and cardiopulmonary related mortalities were 
not reduced. This was due to  the fact th a t black smoke largely consists of 
particles in the PM ]0 range and larger, which are unable to penetrate as 
far into the lung. The largest generator of airbourne particulates following 
the relocation of the factories was exhaust gases from internal combustion 
engines, particularly diesels. These particulates however were much smaller, 
with an average of PM0.i- As such these particles could penetrate deeply
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into the lung, where they would be retained within the mucous membrane 
and alveolar tissue far more readily than the larger particles from the black 
smoke.
Another air pollution episode occurred over central and western Europe 
during 1985. Over a 13 day period in January, high concentrations of to­
tal suspended particles and sulphur dioxide were recorded with means of 
98/ig/m3 and 200/zg/m3 and peaks of 238/ig/m3 and 176/ig/m3 respectively. 
High concentrations of carbon monoxide were also recorded. During this pe­
riod, a pronounced increase in ambulance requests, hospital admissions and 
mortalities were recorded. People suffering from cardiovascular diseases were 
most affected with an increase in hospital admissions of 19%.
Data was taken from a MONICA survey carried out in Augsberg be­
tween 1984 and 1985 [41]. The authors investigated the hypothesis that the 
increases in cardiovascular mortalities associated with air pollution episodes 
were due to changes in the blood coagulability by comparison of blood plasma 
viscosity measurements taken during the episode and on less polluted days. 
The viscosity of the blood plasma is determined by large asymmetrical plasma 
proteins such as fibrinogen and immunoglobulin M. It was found that the pol­
lution incident led to an increased risk for both men and women of extreme 
high values of plasma viscosity. The high concentrations of carbon monox­
ide were associated strongly with increased plasma viscosity in the women 
sampled.
The majority of the studies thus far have been made in developed coun­
tries. It cannot be assumed that the effects recorded in developed countries 
will match those in developing countries. This is true for a number of reasons. 
Firstly levels of air pollution will be markedly different due to industry types, 
location and local government emission limits. The chemical composition and 
size of the airbourne particulate particles will also differ depending on local 
industries. The prevalent meteorological conditions play a large part in ambi­
ent particulate concentrations: strong winds will tend to disperse particulate 
matter, while temperature inversions will contain any particulates close to 
the ground. The effects of particulate exposure will also differ depending 
upon local societal disease patterns, the age structure and socio-economic 
status of the populace.
A number of studies have recently attempted to address this lack of data, 
such as the work by Huang carried out in Shanghai between the 4th of March 
2004 and December 31 2005 [42] [43]. Prior to this work, most studies under­
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taken in Asia had focused on total suspended particles or occasionally PM 10 
as particle measures.
At present, China only sets limits for levels of PMio, at 50/zg/m3 for 
a 24 hour average and 150/zg/m3 for an average annual exposure. This is 
despite the fact that particles in the PM2.5 range and smaller have been 
shown to be of far more dangerous. Work by Oberdorster et al in 1994 [44] 
and Venkataraman et al in 1999 [45] showed that most of the particles that 
deposit in the alveolar region of the lungs are PM2.5 or smaller. These areas 
are cleared far more slowly than in the conducting airways. It has also been 
shown that PM2.5 can cause oxidative stress due to lung inflammation.
The Shanghai study measured 24 averages of P M 2 . 5  at 56.4/ig/m3 and 
P M 1 0 - 2 . 5  at 52.3/Lfg/m3, with P M 2 . 5  constituting 53% of the total PM i0 mass. 
The study found that P M 2 . 5  was associated with all causes of mortality, 
especially cardiovascular diseases. No significant effect was noticed from 
particles in the P M 1 0 - 2 . 5  range. The effects from PM i0 were attenuated and 
thus less precise. The results revealed an increase in P M 2 . 5  levels of 1 0 /ig/m 3 
corresponded to a 0.36%, 0.41% and 0.95% increase in total, cardiovascular 
and respiratory mortality within the Shanghai area.
An additional issue that arises from the increase in finer airbourne partic­
ulates is environmental penetration. While larger particles can be prevented 
from entering internal living spaces by window and door seals for example, 
the same is not true for particles smaller than 1/ma. This means tha t peo­
ple are under a relatively permanent exposure regime to very fine airbourne 
particulates.
There are two main factors which affect the amount of urban particulates 
a person is exposed to: location and seasonal variation.
Location
A study was carried out by Roemer and van Wijnen [46] in Amsterdam over 
the autumn and winter of 1998 and 1999 into the variations in levels of black 
smoke and fine particulate m atter (PM10, PM2.5 and PM 1.0) between three 
measurement locations. The first of these was a background reading. A 
background site was defined as being at the center of a circle of radius 35m 
through which fewer than 2,750 motor vehicles passed over a 24 hour period. 
The second location was at an intersection with traffic lights of a pair of 
central urban streets with speed limits of 50km per hour. The final location 
was at the side of the 6  lane motorway which encircles Amsterdam.
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The black smoke was measured for two reasons. Firstly because black 
smoke is historically linked with mortalities in Amsterdam more closely than 
particulate m atter, and secondly because black smoke levels are a good in­
dicator for the concentration of diesel traffic. As would be expected, a much 
higher average level of both black smoke and fine particulate m atter was 
recorded on the 6 lane motorway compared to the background site.
Exposure is also dependent on global location. This variation in exposure 
levels is due to a number of factors, the most im portant of which is economic 
and industrial development.
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Figure 3.4: airbourne particulate levels in major cities (WHO).
3.1.3 Seasonal Variations
The variations exhibited between seasons are due to a number of factors: the 
ambient meteorological variations; seasonal variations in road traffic together 
with variations in the levels of particulates generated from other sources such 
as oil fired heating for buildings; and pollutants released from industrial pro­
cesses. In 2005 Peng at al. [47] ran an investigation to determine the seasonal 
variance in urban particulate levels (PM 10) and m ortality in one hundred 
different cities in the United States. The cities were divided into seven cate­
gories depending upon their location: the Industrial Midwest; the Northeast; 
the Northwest; Southern California; the Southeast; the Southwest; and the 
Upper Midwest.
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3.1 .4  Ingress Into B od y
In order for the ambient particulates to enter the body they must be inhaled.
The mechanisms by which airbourne particulates enter the cardiovascular 
system have been studied using ultrafine carbine particles chemically labeled 
with radioactive isotopes of Iridium which were then aerosolised. Healthy 
volunteers were exposed to the aerosolised particulates and the distribution 
of radioactivity within them was then measured.
Work undertaken by Seaton involved the exposure of healthy volunteers 
to airbourne particulates with diameters less than 1 0 /un (PMi0) over a three 
day period. A negative correlation was found with the haemoglobin levels, 
packed cell volume and red blood cell count as the exposure level increased. 
The subjects were also exposed to larger diameter particles. These did not 
result in inflammation of the alveoli or cardiovascular tissue, perhaps due to 
their ejection by cilia or mucous membrane as described earlier.
Calculation of Exposure Levels
The levels of daily exposure can be roughly calculated using an average tidal 
lung volume. While the human lung capacity can vary from 4 to 6  litres 
depending on age, health and sex, it is very rarely fully utilised. At rest, 
only a very small proportion is used during respiration. This is the air that 
is actually exchanged with each breath in a tidal flow, hence being known 
as tidal lung volume. An average tidal lung volume for an average size (5’8, 
80kg) adult male is 500ml. At rest, an average respiration rate is between 
10 and 20 breaths per minute. Given an average ambient fine particulate 
concentration of 30//g/m3, a daily exposure can now be calculated.
Taking an average of the resting breaths a minute as 15, the total air 
respired over a 24 hour period is 10800L, or 10.8m3. W ith an average ambient 
particulate concentration of 30/xg/m, this gives a daily intake of 324//g. It has 
been postulated, that while short term  exposure to high levels of pollution 
(during an incident) are of concern, the long term effects of low level exposure 
are more important for an assessment of the risks posed to population health. 
In this instance, a yearly exposure may be relevant. Following on from the 
previous calculations then, the yearly intake of particulate m atter into the 
lung is approximately 118mg.
Very little research has been undertaken into how effectively these fine 
particles can be removed from the intratracheal system. However, should a
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significant amount remain entrenched local build up may then ensue, possibly 
resulting in similar effects to that found from tobacco smoke. In fact, it has 
been shown that the mortality risk increases as the age bracket considered 
is increased. While age has an effect on general health and thus susceptibil­
ity to the detrimental effects of exposure, it will also increase the exposure 
timescale. For example, a 30 year old will have been exposed to approxi­
mately 3.5g of particulate matter, while a 60 year old will have been exposed 
to 7.1g. While these may seem like very small amounts it is once again im­
portant to stress the minuscule size of the particles involved, and thus the 
incredibly massive numbers of particles and the corresponding surface area.
In contrast to this, the daily particulate intake (assuming continuous 
exposure) during the worst period of the London smog mentioned above was 
approximately 48.2mg.
Particulate Reduction
Various proposals have been made for the setting of particulate level targets 
to be reached by 2010. These latest targets are focused on the reduction of 
levels of particles in the PM2.5 range as these are a better marker for health 
effects, as put forward by the CAFE (Clean Air For Europe) programme 
in 2005. The suggested targets are the reduction to levels of 25, 20, 15 or 
1 0 /zg/m3. These reductions have been proposed by a new European Direc­
tive, European Parliament, the US EPA, and the World Health Organisation 
respectively. While the differences in reduction levels may appear minuscule, 
the difference in the accompanying reduction in mortality rates is worth men­
tioning. These reductions occur in people aged 30 years and over are 0.4%, 
1.0%, 1.6% and 3.0% respectively.
Epidemiological studies published between 1989 and 1996 showed that 
even at unexpectedly low concentrations of particulate pollution adverse 
health effects were still reported. Following these studies, the US Environ­
mental Protection Agency adopted new standards for ambient air quality 
which imposed limits on the levels of P M 2 . 5 .  These new standards were 
contested by industry, whose case was upheld in a Federal Appeals court. 
The standards were ratified by the US Supreme Court, forcing industry to 
comply. It has since been shown that for each 10jUg/m3 increase in fine par­
ticulate air pollution is associated with a 4%, 6 % and 8 % increase of all cause, 
cardiopulmonary and lung cancer mortalities respectively.
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3.1 .5  A m bient C oncentration M easurem ent Procedures
The necessity for methods by which levels of urban particulates could be 
measured arose to enable the application of regulatory limits by governmen­
tal authorities. A comprehensive government maintained monitoring site 
network was already in existence. The problem with the network was that 
different measurement devices gave systematic differences in results. In order 
to combat this in Europe, a European Union directive (EN12341) has been 
put in place, specifying three reference methods for determination of PM i0 
levels. High- and low-volume samplers are used to obtain daily samples both 
for weighing and subsequent chemical analysis.
Many collection and analysis methods involve the collection and assess­
ment of all particulate matter, termed Total Suspended Particles. This col­
lected material can then filtered and fractionated to enable investigation of 
composition, thus giving data for levels of PMi0 and PM2.5 .
3.1.6 Effects o f Exposure
Pollutants in environmental tobacco smoke (ETS) include many found in 
ambient air due to combustion of bio-derived organic material and are tox- 
icologically very similar. Indeed, a number of papers report effects on the 
peripheral and coronary circulation systems following inhalation of diesel 
particulates which are similar to those recorded in patients with a history of 
smoking. Indeed, a number of papers report effects on the peripheral and 
coronary circulation systems following inhalation of diesel particulates which 
are similar to those recorded in patients with a history of smoking.
The following hypothesis has been put forward for the effects of chronic 
exposure. Firstly, that inhaled particulate m atter, with individual particle 
diameters small enough to reach the alveoli, may set up inflammation in the 
lung. This inflammation would then lead to changes in the control mech­
anisms that govern the formation of clots within the blood. Any changes 
caused in the chemical factors within the blood can affect the stability of 
atherosclerotic plaques in the arterial walls - especially those which supply 
blood to the muscular tissue of the heart itself.
A large body of research has recently been undertaken with respect to 
ascertaining the toxicological effects of both urban and purely diesel exhaust 
particulate upon the cardiovascular system. The hypotheses under exami­
nation are that transient exposure to traffic derived air pollution may be a 
trigger for acute myocardial infarction, especially where an individual has a
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Figure 3.5: Global deaths linked to aiboume particulate exposure.
previous history of the problem.
A study by Mills et al published in Circulation in 2005 [48] investigated 
the effects of diesel exhaust inhalation on the vascular and endothelial func­
tion in 30 adult males. They exposed the volunteers to either clean air or 
dilute diesel exhaust at particulate concentration of 300/jg/m 3 for one hour 
during interm ittent exercise. They found th a t inhalation of diesel exhaust 
particles at concentrations found within urban environments impair two im­
portant complementary factors in the human circulation system. These are 
endogenous fibrinolysis and the regulation of vascular tone. These findings 
suggested a potential mechanism by which air pollution may enhance or ex­
acerbate atherothrombosis and acute myocardial infarction.
3.2 C arbon N a n o tu b es
The synthesis of micro- and nanoscale carbonaceous compounds did not be­
gin with carbon nanotubes. They were discovered by accident among the 
deposited carbon formed in the creation of another, now widely known, car­
bon compound: fullerenes.
Fullerenes, named after the geodhesic structures of architect Buckminster- 
Fuller, take the form of highly stable spherical or ellipsoidal structures. They 
are based on the graphene sheet of which graphite is constructed but contain 
a number of pentagonal rings together with the standard hexagonal rings
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which allow them to form the three dimensional structures. They were first 
discovered by Kroto and Smalley in 1986 [49], by subjecting graphite to arc 
evaporation within a helium atmosphere. This process will be discussed in 
more detail later in this chapter. The most famous fullerenes are C60 and 
C70, which resemble a football and a rugby ball respectively. Carbon nan­
otubes were discovered by Iijima in 1991 [50] while undertaking microscopic 
analysis of the carbon soot produced using the methods of Kroto and Smalley.
For experimental purposes, carbon nanotubes can be split into two dis­
tinct groups; as-produced (which will be referred to as AP), and function- 
alised. As the functionalisation of nanotubes is a process which takes place 
after the initial generation, it shall be discussed later in the chapter.
3.2.1 A s-Produced  N anotubes
As-produced nanotubes can be readily split into two subsets determined by 
structure; multi-walled and single-walled. Each subset, while structurally 
similar, has differing methods of generation. As such, the underlying struc­
ture of as-produced nanotubes will first be discussed, followed by the pro­
duction methods of the two subsets which will be discussed chronologically 
with reference to their discovery.
Structure
The basic structure from which nanotubes are derived is the graphene sheet 
mentioned previously. A nanotube consists of cylinders capped at both ends 
with hemispheres containing precisely six pentagonal rings as defined by Eu­
ler’s Law which states tha t a flat hexagonal sheet can only be made into a 
sealed three dimensional object by the inclusion of twelve pentagonal rings. 
These hemispheres are formed by the splitting of a Ceo- This method of 
formation leads to the generation of nanotubes with structures commonly 
described as ‘armchair’ and ‘zig-zag’, The type of nanotube formed is deter­
mined by the way in which the Ceo molecule is split. If the split is along the 
3-fold axis then the nanotube formed will have a zig-zag configuration, while 
a Ceo split along the 5-fold axis will form an armchair nanotube.
However, nanotubes can exist with structures in between the two extremes 
presented above and so a method of characterisation known as the chiral angle 
is used. In order to understand the chiral angle, firstly a single graphene layer 
needs to be considered. The atoms at each of the vertices are given coordinate 
numbers using (n,m) vector notation.
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Figure 3.6: Representation o f the two extremes o f nanotube structural varia­
tion; (a) armchair, (b) zig-zag. The structural arrangements from  which the 
names are derived are highlighted in red.
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Figure 3.7: Illustration o f n,m  vector notation as applied to a single layer of 
graphene.
The armchair and zig-zag nanotubes presented in figure 3.6 can now be 
described in term s of the vectors of their unit cells [51], the structural area 
of the sheet from which they are constructed, and thus their chiral angle can 
be calculated using the formula given below.
0  =  arcsin
\ / 3 771
(3.1)
2 \Jn2 +  nm  +  m 2
It can be shown tha t m =  n for all armchair tubes, while m =  0 for all
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zigzag tubes. All the tubes in between are defined by their chiral angle. For 
example, taking a nanotube composed from a unit cell (7,3) the chiral angle 
0  can now be calculated using equation 3.1 thus:
given: n =  7, m =  3
0  =  arcsin v/9 3
2\/72 +  21 +  32
=  arcsin
2^79
0  =  arcsin 0.169 =  9.73°
The structures described above only deal with single-walled nanotubes, 
multi-walled consist of a number of tubes arranged concentrically. However, 
while successive cylinders will exhibit the same orientation with respect to 
the unit cell, they will differ in their structures slightly due to the increase 
in diameter between the inner tube and its surrounding neighbour. It has 
also been suggested that multi-walled nanotubes contain both concentric 
cylinders and some scroll like elements. These scroll like elements occur due 
to edge dislocations and in fact, multi-walled nanotubes can only have a 
zig-zag structure if dislocations are present.
Multi-walled Nanotubes
It was multi-walled nanotubes which were identified by Iijima during the 
microscopic analysis carried out on carbon soot produced using the process 
developed by Smalley as outlined earlier.
Synthesis
There are three main methods through which multi-walled nanotubes are 
synthesised: Arc ablation; Laser ablation; and chemical vapour deposition.
Arc Evaporation
This is the classic method of production identified by Iijima in Nature 1991. 
It involves the use of two graphite electrodes (not necessarily of very high
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purity) held a small distance apart w ithin a stainless steel vacuum cham­
ber. This differs from the method used for fullerene production in which the 
electrodes are in contact. The chamber is connected to a supply of helium 
and a vacuum line. The electrodes are not similar. The anode is usually 
a thin rod with a diameter of 6mm, while the anode is shorter and thicker 
with a diameter of 9mm. It has been shown th a t water cooling the cathode 
is essential in high quality nanotube production. The arcing is usually un­
dertaken at a voltage of 20V resulting in a current between the electrodes 
of 50 - 100A. Presented in figure 3.8 is a basic schematic diagram of the arc 
ablation apparatus.
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Figure 3.8: Basic Schematic Diagram of Arc Evaporation Apparatus
A number of other factors have also been shown to be im portant to the 
quality of arc discharge nanotubes: chamber helium pressure and current. 
The optimum pressure for a good yield of high quality nanotubes has been 
identified as 500 Torr. This is markedly different from the pressures of 100 
Torr used by Kroto for the production of fullerenes.
The current on the other hand needs to be kept as low as possible, both 
in order to maintain a stable plasma and to prevent the generated material
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being sintered and thus containing very few free nanotubes.
While the cathode is cooled as standard, it has been shown that effective 
cooling of both the anode and the chamber itself is important both to the 
quality of the nanotubes produced and to reduce sintering.
The arc ablation method tends to produce relatively long, straight nan­
otubes.
Laser Ablation
Described by Chernozatinskii et al in 1994 [52], this method evaporated 
graphite by subjecting it to an electron beam while under a high vacuum. The 
material was then condensed onto a quartz substrate and collected. This film 
of condensed material was shown to contain some imperfect multi-walled nan­
otubes following examination using high magnification electron microscopy. 
This method was further developed at Rice University by a group lead by 
Smalley, which resulted in the report of carbon nanotube synthesis using 
oven laser vaporisation in 1995.
Smalley’s technique involves the mounting of a graphite target in a controlled- 
environment oven held at 1200° C in a carrier gas of argon. The laser is then 
used to vaporise the graphite target which then condensed onto a cooled 
copper substrate. Upon investigation the collected condensed carbon film 
was found to contain a significant amount of structurally perfect nanotubes. 
This technique was further developed for the production of single-walled nan­
otubes .
Chemical Vapour Depostion
This method consists of a quartz reactor that is heated in two zones;: a 
preheater and a furnace. A carbon source such as xylene is mixed with a 
catalyst such as iron or cobalt and fed continuously into the reactor. In the 
preheating section the liquid carbon compound is vapourised, followed by 
decomposition in the furnace section at temperatures beween 600° and 1200°
C. The nanotubes grow around the catalyst particles and form mats on the 
walls of the quartz tube had on the substrate. They are then harvested once 
the process has been terminated. By including a plasma chamber, better 
control over length, diameter and structure of the resulting nanotubes can 
be achieved together with straighter and more uniformly aligned mats.
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Figure 3.9: Basic Schematic Diagram for the Chemical Vapour Deposition 
Process.
P u rifica tio n
There are three main m ethods in use for the purification of multi-walled nan­
otubes [53]: selective copper catalysed oxidation; flocculation and filtration; 
and size exclusion chromatography.
The oxidation process can be broken down into a number of distinct steps.
Firstly, the crude cathodic deposit is immersed in molten CuC12-KC1 
held at 400°C for one week. The resultant material is then washed in ion- 
exchanged water, following which it is heated to 500°C in a combination of 
He and H2 for one hour. The product is then oxidised in flowing air through 
a ramped tem perature of 10°C/min up to 550°C.
The flocculation and filtration method uses Sodium Dodecyl Sulphate 
(Lauryl Sulphate) to solubilise the nanotube/nanoparticle blend in water. 
The nanotubes are then allowed to flocculate, leaving the nanoparticles in 
suspension. The sediment is then removed and further flocullation allowed 
to occur. This enables removal of the nanoparticles from the sample, and 
some initial degree of length separation of the nanotubes. This separation
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is then further heightened using microfiltration membranes with a pore size 
corresponding to the upper end of the desired length spectrum.
Size exclusion chromatography [54] again involves the dispersion of the 
nanotubes in water using sodium dodecyl sulphate. This technique is widely 
used in the biological sciences for separation of macromolecules. This method 
is based upon the fact tha t molecules of different sizes will diffuse through 
a medium at different rates. The apparatus consists of a column, typically 
packed with gel beads which serve to provide a variety of pore diameters. 
Evidently, larger particles will be unable to pass through many of the pores 
and so are separated out of the eluate. However, this technique is more useful 
for separating an already purified sample of nanotubes into fractions defined 
by length.
Single-walled Nanotubes
The discovery of single-walled nanotubes stemmed from work undertaken 
by several groups in early 1993 [55]. It was found that by using modified 
electrodes during arc evaporation, foreign materials could be encapsulated 
within carbon nanotubes.
This work was of great interest to a group at IBM led by Bethune, who 
were working on the application of magnetic materials for the storage of 
data, particularly that of ferromagnetic metal crystals embedded in carbon 
shells. By enclosing the metal crystals, the magnetic moments of the indi­
vidual crystal would be maintained while isolating it both magnetically and 
chemically from its neighbours.
This had been attem pted using a very small number of crystals encap­
sulated within fullerenes. It was felt that increasing the crystal cluster size 
inside the shells may be important. As such Bethune et al doped electrodes 
with nickel, cobalt and iron prior to arc evaporation [56]. The resulting 
soot showed completely unexpected properties. When this soot was exam­
ined at high magnification using electron microscopy it was found to contain 
single-walled nanotubes. Similar experiments were also being undertaken 
concurrently by Iijima et al who also investigated the effect of the local at­
mosphere on single-walled tube production, finding that a blend of methane 
and argon was more productive than the standard helium.
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Synthesis
Arc Evaporation Developments
The methods discovered by Bethune and others have been further developed 
using a wide variety of catalysts for the doping of the electrodes. These 
catalysts affect the diameter of the resultant tubes and will be briefly outlined 
here. As described above, cobalt was initially used as a doping agent. This 
was found to produce single-walled nanotubes with diameters between 0.6 
and 2nm. The inclusion of a small amount of sulphur, lead or bismuth into 
the anode along with the cobalt was shown to increase this range of diameters 
to between 1 and 6nm.
In late 1993 Subramoney et al [57], working for Du Pont, grew single­
walled nanotubes using electrodes doped with gadolinium. The structures 
formed by these tubes were markedly different from those achieved using 
other catalysts. The formations were described as ‘sea-urchins’ and consisted 
of a large number of single-walled nanotubes growing outwards from a single 
particle of gadolinium carbide. These tubes were much shorter than those 
grown using ferric metals, but exhibited a similar spread of diameters.
Using a similar technique to that pioneered by Bethune, a high yield of 
single-walled nanotubes was achieved by a French group in 1997 using an 
yttrium/nickel catalyst in place of the cobalt and utilising a slightly different 
geometry for the reactor. This method achieved a 70 - 90% yield and sub­
sequent investigation revealed multiple tube bundles, with individual tube 
diameters of 1.4nm.
Laser Vaporisation
This technique was developed and improved upon the technique of laser 
vaporisation described above in order to produce a high yield of single-walled 
nanotubes. This led to the formation of nanotubes with incredibly uniform 
diameters. Instead of the pure graphite target used in the formation of 
multi-walled nanotubes, a composite target of graphite and a blend of cobalt 
and nickel was used. An improvement in the evenness of vaporisation was 
achieved by utilising a double laser pulse. Due to the increased uniformity of 
diameter these nanotubes exhibit a tendency to form ’ropes’, highly aligned 
bundles, which occasionally were found to have formed in the direction of the 
beam. This enabled them to be imaged end-on in an electron microscope. 
Further investigation of these ropes using both electron microscopy and X- 
ray diffraction showed the bundles to primarily consist of armchair structure
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nanotubes with diameters of 1.38nm.
Catalytic M ethods
Further work by Smalley et al has shown that single-walled nanotubes can be 
grown using a method tha t is purely catalytic [58]. This method is broadly 
similar to chemical vapour deposition as described above. In this case, the 
catalyst was nanometer sized particles of molybdenum which were supported 
on alumina. The furnace was run at 1200°C, through which carbon monoxide 
was passed. This is higher than the initial temperatures defined earlier, as 
at lower temperatures multi-walled nanotubes are preferentially formed.
The single-walled nanotubes produced in this manner were markedly dif­
ferent in a number of ways from those produced by the vaporisation methods 
described previously. The wide range of particle diameters, l-5nm, was de­
termined for each tube by the size of the catalyst particle around which it 
had grown. Each of the tubes still contained the catalytic particle, embedded 
in, or attached to, one end. These nanotubes were more often to be found 
individually rather than formed into bundles.
Through the use of a magnetic field, and the careful location and sizing of 
the catalyst particles, it is possible to grow a mat of highly regularly spaced 
and uniform single-walled nanotubes. These are currently being investigated 
for their electronic properties with proposed uses as lighting and television 
screens using field emission.
Purification
Due to the nature of the single-walled nanotubes, the harsh oxidation meth­
ods available for the purification of the multi-walled nanotubes are not viable. 
The challenge is further increased due to the metal contamination within the 
produced nanotube containing carbon soot. As such, purification methods 
have focused on filtration [59].
One such method has been described by a Japanese group [60]. This 
method involves the refluxing of the soot in distilled water for 12 hours after 
which it is filtered and dried to remove the amorphous carbon. Toluene was 
then used to remove the fullerenes followed by treatment with concentrated 
hydrochloric acid to remove the metal particles. While this method was 
shown to have removed most of the contaminants, some nanoparticles, both 
filled and empty, remained.
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A method pioneered by Smalley involved the use of microfiltration. This 
used a cationic surfactant in which the nanotubes were suspended prior to 
filtration, followed by passing the resulting solution through membrane fil­
ter in order to trap the tubes. The required multiple filtration and sample 
resuspension rendered this procedure very inefficient and time consuming. 
By incorporating ultrasonics in order to keep the material suspended, these 
drawbacks were overcome, allowing the continuous filtration of large amounts 
of sample. This technique enables the purification of material to a final prod­
uct containing over 90% singlewalled nanotubes.
Nanotube Properties
The initial assumptions made were that the nanotubes would exhibit similar 
properties to macro-scale carbon compounds, the most important of which is 
chemical inertness. A number of scientifically important properties of nan­
otubes have been identified in the two decades since their discovery. However, 
the vast majority of these properties are of little or no importance to the work 
undertaken for this thesis and so merit only a very brief discussion here.
Carbon nanotubes exhibit an electrical conductivity that is either metal­
lic or semi-conductive. Which category a given nanotube falls into is deter­
mined by its helicity as described by the chiral angle defined earlier. Metallic 
nanotubes can have an electrical conductivity as high as copper.
Nanotubes have a strength one hundred times that of steel at less than 
one sixth the weight, rendering them one of the strongest materials known 
to man. This also means that nanotubes have an incredibly high strain to 
failure ratio. The thermal conductivity can be as high as diamond, again 
this is determined by helicity, and this property has enabled the targeting of 
tumours with infrared.
The most important properties for the possibility of application in the 
medical field are: chemical inertness and internal storage space. This in­
ertness presents opportunities within drug delivery and imaging due to the 
possibility of attaching molecules to the surface by which the nanotube may 
be targeted to a specific organ or location within the body. The ability to 
both open and seal nanotubes, thus gaining access to the space inside them 
enables the nanotubes to be used to carry drug molecules internally (provided 
the tubes are sealed with a molecule that will allow to reopen at the desired 
destination). This also enables the inclusion of radioactive molecules incor­
porated within the nanotubes to enable medical imaging, while preventing
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chemical interaction between the radioactive material and the surrounding 
tissue.
However, the interaction with blood and tissues within the body will also 
be affected by the surface roughness exhibited by the nanotube. This surface 
roughness characteristic will determine the both the contact and wetting 
angles between the blood and the nanotube.
The property which has thus far presented the largest problem to progress 
in many fields of nanotube research is that of their solubility. This difficulty 
in getting nanotubes into solution may be in part due to their electronic 
interaction properties. Both multiwalled nanotubes and bundles of single­
walled nanotubes are stabilised by the competition between long range van 
der Waals binding, intermediate range dipole-dipole interactions and kinetic- 
energy induced repulsion. It is important to note that the term long range 
when used to describe van der Waals forces is 3 - 3.5A
Due to the low electron density exhibited by nanotubes, they exhibit a 
localised screening effect. This may be another factor which limits their 
interaction with surrounding solvent molecules causing hydrophobicity.
Nanotube Functionalisation
The ability to functionalise nanotubes by the adsorption of molecules, whether 
biological or simple organic, to their surface is of massive importance. The 
attachment of these surface molecules is at present mainly used to change the 
interaction of the nanotubes with solvents, both water and organics, allowing 
them to be effectively dispersed. The use of poly(propionelthylenimine-co- 
ethylenimine) and poly (vinyl acetate)-co-(vinyl alcohol) for the functionalis- 
tion of singlewalled nanotubes and a polysterene co polymer for the function­
alisation of multi-walled nanotubes have resulted in the nanotubes becoming 
soluble in water. This change in interaction and thus solubility may be due 
to the effect on charge and electron density. By wrapping the nanotubes 
in polymers which present effective dipoles or other systems to the solvent 
while inhibiting the local screening effects of the nanotubes the hydrophobic 
tendencies of unaltered nanotubes are overcome.
Functionalisation is also being investigated as a method of targeting the 
nanotubes to specific regions within the body, both for drug delivery and 
medical imaging, and to attem pt to disguise them from the bodies immune 
system.
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In the case of the work carried out for this thesis, the ability to solubilise 
the nanotubes is the most critical. The functionalisation methods have been 
selected to enable the ready dispersion of the nanotubes into water or low 
concentration medical salts solution.
A number of functionalisations of both single-walled and multi-walled 
nanotubes have been developed to enhance the solubility of the nanotubes in 
various solvents. The following chemical groups are bonded to the nanotubes 
in order to enhance solubility in water: carboxyl groups, Poly Ethylene Gly­
col (PEG) and poly-(m aminobenzene sulfonic) acid (PABS). These groups 
are attached over the entire length of the nanotube. The spacing between 
attached carboxyl groups can be specified and is often only one or two atoms.
(b) o
SO.H
Figure 3.10: Single-walled nanotubes showing funcionalisation with; (a) - 
COOH (b) PABS and (c) PEG.
Another form of functionalisation which will be important for medical 
imaging and would also enable a study on confocal further to the work here, 
is fluorescent labelling. One method for this utilises enzymatic biotinylation 
to bond isomers of a biotinyl tyramide radical which can then be bonded to 
a singlewalled nanotube.
The main problem with the attachment of flourophores directly to  the 
nanotube is that of quenching. This is yet to be overcome. In contrast,
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attached quantum  dots do not undergo quenching. This may be due to the 
differences in magnitude between the dots and the nanotubes - quantum  dots 
are an order of magnitude larger than the nanotubes, while the fluorophores 
are of similar dimensions. The low electron density properties mentioned 
above may also have a quenching effect on the flourophores as the electrons 
may be removed from the higher energy states by the nanotubes, thus pre­
venting them  from releasing the photons which would normally be ejected 
during the transition of the electrons to the lower energy states.
Isomers
Biotin
p eroxid ase
h2 o ^
Figure 3.11: Reaction mechanism using peroxidase to create isomers of a 
biotinyl-tyramide radical. These radicals are then able to bond with single­
walled nanotubes.
The reaction proposed above may enable the fluorophore, in this case 
Biotin, to remain active as it is not directly attached to the nanotube. This 
mechanism is based upon work undertaken by Gross et al in 1959 [61].
N an o tu b e  Toxicity
The study of the toxicological effects of carbon nanotubes, in fact all nanopar­
ticles, is still in its infancy. This is shown most starkly by the material safety 
data  sheets supplied with carbon nanotubes by the producing companies.
66
On these sheets, exposure is broken down into the following categories: in­
halation; skin contact; eye contact; and ingestion. For exposure in each of 
these categories medical advice is recommended. For skin and eye contact, 
washing the area with soap and water or rinsing with running water are rec­
ommended. As the nanotubes are insoluble in water the most this will result 
in is a smearing of the particles over a larger area.
The most important point to note with regards to nanoscale particulate 
toxicology is that the effects are not due to mass as would be the case with 
macroscale compounds, but are due to the high surface area exhibited.
There are two methods by which nanotubes may be caused to enter the 
bloodstream: injection and inhalation.
While injection is evidently a deliberate act and thus assumes the nan­
otubes are placed within the immediate area of the target organ or system, 
inhalation requires the presence of airbourne nanotubes. However, in or­
der for any nanotubes which enter the respiratory system to pass into the 
bloodstream, the systems defensive measures must be passed. These defences 
consist of: the cilia - the tiny hairs lining the trachea; and the mucous mem­
brane lining the alveolal wall. Particulate materials caught by these hairs 
are ejected from the body via the cough reflex. In order for a particle to 
pass the cilia and reach the membrane it has been shown that it must have 
a diameter less than 10/im (PM10). This has been calculated using spherical 
particles. Evidently nanotubes themselves are not spherical, however, due to 
the tendency of nanotubes to agglomerate, some spherical particles may re­
sult. Even so, the transport of individual nanotubes through the respiratory 
system may well be length determined, assuming that the largest dimension 
is the most critical for rejection.
The presence of nanoparticles within the lung has also been hypothesised 
to cause localised inflamation within the alveoli, thus triggering a corre­
sponding effect and the systems of control within the blood which regulate 
the clotting process.
It has also been suggested that changes in the chemical factors in blood 
due to the presence of nanoparticles can affect the stability of the atheroscle­
rotic plaques (fatty deposits) found in the walls of arteries, especially those 
which supply the blood to the heart muscle itself.
The change in plaque stability causes the uptake of lipids into the en­
dothelium resulting in lesion formation. It is the rupture of these lesions
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which is suggested to then induce localised clotting of the blood, potentially 
leading to embolism or deep vein thrombosis if the clot cannot be readily 
removed.
It has been hypothesised that inhalation of nanoparticles may be of a 
greater danger than injection due to the fact tha t the nanoparticles embedded 
within the mucous membranes within the lung will remain there for a much 
greater time as they cannot be removed effectively, compared to those in the 
blood stream.
Following intratracheal nanotube installation in mice, inflammation and 
the formation of epitheloid granuloma have been recorded. These reactions 
are dose dependent.
Once the nanotubes have made ingress to the blood, clotting may po­
tentially be induced in a number of other ways. If the surface roughness of 
the nanotubes causes the contact angle between them and blood to resemble 
collagen then platelet aggregation may be induced.
It has recently been shown that nanotubes produced using arc discharge 
can resemble asbestos fibres and ehibit similar proerties when placed into the 
bodies of mice [62]. This not only poses the risks associated with asbestos, 
but due to the structural nature of these nanotubes (long and straight), 
lymphocytes and phagocytes are unable to effectively engulf them and thus 
enable their removal from the bloodstream.
The response of the immune system to the introduction of nanotubes 
into the cardiovascular system is under only preliminary investigation. It 
is likely that further functionalisation utilising specific antigens and other 
protein molecules will be required to prevent the nanotubes coming under 
attack. Any large scale response could be potentially life threatening to the 
patient and thus it may be found to be necessary to suppress the immune 
system if treatment with nanotubes is decided upon. This course of action 
carries its own health risks.
Another issue with the use of nanotubes within the body is that the blood 
may well transport the nanotubes to undesired locations. While function- 
alised nanotubes can be tailored somewhat to concentrate to a particular 
point in the body, AP nanotubes have a relatively free reign.
It has been shown recently that nanoparticles may have the ability to cross 
the blood-brain boundary (BBB), which may be both a blessing and a curse.
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Medical science has for many years been attempting to effectively enable 
certain drugs to more readily cross the BBB and this finding may allow the 
development of delivery systems that can achieve that. However, the ability 
of nanoparticles to cross the BBB has serious implications. The effect of 
nanoparticulate build up within the brain has obviously never been studied. 
It seems to have been assumed that once the drugs have been delivered the 
nanotubes will either somehow be ejected from the brain (although if targeted 
proteins have been used to concentrate them to a location this seems unlikely) 
or that they will simply exist in dormancy within the cortex.
While not an accurate allegory for primates in any way, work on earth­
worms has found that nanotubes can accumulate within the reproductive 
system. In the case of the earthworms this led to the nanotubes being passed 
on the next generation. The effect on primate reproductive systems should 
the nanotubes be found to accumulate there is unknown.
The three locations within the body which function to remove foreign or 
otherwise unwanted material are also likely sites for accumulation. These 
organs are the liver, the kidneys and the spleen. Effects on these three or­
gans are disputed, with some studies finding very little effect whatsoever and 
no evidence of nanoparticle storage, while other studies have found clear evi­
dence of nanoparticle storage together with localised inflammation. However, 
these studies have so far focused on rats and mice. No atherosclerotic lesions 
have been found, however, rodents are far less prone to the developments of 
plaques than primates.
The non biodegradability of the nanotubes due to their chemical inertness 
is another cause for concern linked to build up within a given bodily system 
if exposure occurs over a longer timescale. While functionalisation has thus 
far been studied in order to facilitate solubilisation or targeting, the issues 
of the interactions between the resulting nanotube-polymer compound and 
blood are not well understood. Wrapping the nanotubes in heparin has been 
suggested as a means of allowing them passage through blood. However, 
heparin is well known to affect the clotting cascade, causing differences in 
clot structure. Interestingly, it has been shown that the ability of blood to 
clot around multi-walled nanotubes is greatly reduced following wrapping 
with heparin.
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3.3 The Effects of Nanoparticles on Blood
The seminal study on the effects of various carbon nanoparticles on blood 
was carried out by Radomski et al [63]. The similarities between carbon 
nanotubes and the carbon particulates generated from combustion led to 
questions arising as to the toxicology of the newly discovered material. Stud­
ies have been carried out to attempt to ascertain the effects of exposure to 
exhaust particulates with regards to haemostatic function.
3.3.1 Studies on U rban Particulates
A number of papers [64] [65] demonstrate that diesel exhaust inhalation can 
impair vascular function in humans. They show an impairment of both vas­
cular tone regulation and endogenous fibrinolysis. The impairment of vaso­
motor function in the forearm bed is associated with increased risk of acute 
cardiac events including cardiac death. The inhalation of exhaust had an 
immediate pro-ischemic effect:: an important mechanism for the observed 
increase in myocardial infarction in the hour after exposure to heavy traffic. 
A second peak for myocardial infarction 5-6 hours after exposure to traffic 
is reported by Peters et al [6 6 ], also at this point in time reductions in tPA 
were recorded as presented in the second paper. These reductions reduced 
the efficacy of endogenous fibrinolysis. For discussions of all terms relating 
to blood and thrombosis please refer to chapter 5.6.
3.3.2 Expansion o f Investigation
The study by Radomski et al mentioned above expanded this research to 
cover a broader spectrum of carbon nanoparticles: single and multi walled 
nanotubes; fullerenes; standard urban particulate m atter (average size 1.4/im); 
and a mixed carbon nanoparticle blend. This study used in vitro platelet 
function assays and in vivo vascular thrombosis in rats as means of assessing 
deviations in haemostatic function.
Platelet Assessment M ethods
The following methods were used to assess platelet function: lumi aggrega­
tion; phase contrast,; immunofluorescence; transmission electron microscopy; 
flow cytometry; zymography; and pharmacological inhibitors of platelet ag­
gregation.
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Sample Preparation Techniques
The desired nanoparticle was added to Tyrode’s solution. Samples are then 
sonicated for 2 minutes. While this aids in dispersing the nanoparticles, 
the ultrasonic vibrations result in rapid heating of the sample. This leads 
to solvent boil off, changing the sample concentration. This is overcome in 
the current work by immersing the sample tube in a cold water bath. The 
samples were then vortexed for 20 seconds. This was found in the current 
work to have the opposite effect to that stated as centrifugal forces caused 
the nanoparticles to migrate to the edge of the sample container resulting in 
very high localised concentrations and thus rapid agglomeration.
Some of Radomski et al’s suspensions were filtered through O.lum filters. 
Studies of the filtrate concentration using photospectrometry has shown that 
the final concentration of the samples following filtration fall on the almost 
vertical region of the calibration curve, meaning that accurate concentration 
assessment is very difficult. Nanoparticle concentrations in the range 0.2 - 
300raug/ml were investigated.
Radomski et al obtained blood from healthy volunteers. This blood was 
then spun down to obtain platelets which were washed prior to re-suspension 
in Tyrode’s solution. Nanoparticles were added following pre-incubation of 
the platelets at 36°C. No mention is made of any alteration of particle concen­
tration pre-injection to account for the dilution due to the Tyrode’s solution 
already present in the platelet solution.
The various platelet assays showed that, bar the C60 fullerenes, all the 
nanoparticles induced platelet aggregation with an order of efficacy as fol­
lows: mixed carbon nanoparticles =  single walled nanotubes > multi walled 
nanotubes > urban particulate matter.
Rat carotid arteries were used as models for the effects of nanoparticle in­
fusion in vivo. The nanoparticles caused an increase in the rate of thrombosis 
with a rank order of efficacy matching that found from the work undertaken 
on platelets in vitro.
3.4 Nom enclature
PM* particle diameter (//m)
© chiral angle
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Chapter 4
N anoparticle Characterisation  
and D ispersion
Nanoparticle characterisation is undertaken to assess a number of vari­
ables: particle size (both individual and as agglomerates),; particle composi­
tion; and surface roughness. The instruments most commonly used for these 
measurements are scanning and transmission electron microscopy, EDX and 
atomic force microscopy. There are also methods available for the investiga­
tion of the particles once they are in a suspension: particle size analysis; zeta 
potential assessment; and photospectroscopy.
4.1 Procedures
4.1.1 E lectron  M icroscopy
Electron microscopy involves the study of the products of the interaction 
between an applied electron beam and a solid sample. The type of electron 
microscopy used will depend on the size of the sample. A bulk sample will 
require the use of scanning electron microscopy (SEM) while if the sample is 
a thin foil or a single layer of particles then transmission electron microscopy 
(TEM) may be used.
A visualisation of the interactions and the material responses with ref­
erences to SEM and TEM can be seen in figure 4.1. A number of issues 
must be overcome to enable successful imaging of carbon nanoparticles with 
electron microscopy. These issues can be separated into those arising from 
the sample preparation and those arising from the machine itself.
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Figure 4.1: Interactions between an applied electron beam and a solid sample
The issues arising from sample preparation techniques are primarily due 
to the selected solvent. The selection of solvents which are compatible with 
biological materials (critical for the work in this thesis) results in a common 
problem when samples are viewed under the SEM; residual solvent surface 
structure. This structure may take the form of distinct crystals or dendritic 
structures depending on the solvent, but always results in prevention of nan­
otube location. Examples of residual solvent surface structure are presented 
below.
Due to these issues, harsher solvents were required. This resulted in 
the use of ethanol as a solvent for this part of the characterisation process. 
Another advantage of ethanol is the rapidity of evaporation, reducing the 
time at which the sample is at risk from external contamination. Sample 
preparation is discussed in more detail in a later chapter.
4.1.2 Energy Dispersive X-ray Spectrometry
This technique allows the assessment of the composition of nanoparticles 
through the interaction between m atter and a beam of charged particles 
such as electrons. This interaction causes the release of X-rays. The number 
and energy level of the X-rays em itted are measured by an energy dispersive 
spectrometer. These X-rays are released to remove energy allowing electrons
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Figure 4.2: Residual surface structure from  biologically viable solvents at 
varying magnification on the SEM.
within the element to return  to their ground states following excitation by 
the applied particle beam. The difference between the excitation energy level 
and the ground state of the electron is a characteristic of the element and 
will correspond directly to the energy present in the X-ray.
In the case of carbon nanopartic.les, this technique provides composition 
data  for diesel particulates and enables assessment of contamination of nan­
otubes by catalyst materials used in some production methods.
4.1.3 Atomic Force Microscopy
Atomic force microscopy can be used to study the surface topography of 
nanoparticles and their agglomerates and to provide dimensional analysis. 
However, it was found to be incredibly difficult to obtain good images using 
this equipment.
4.1.4 Particle Sizing
The main technique used for particle size analysis for suspensions is scattering 
spectrophotometry. This method measures light scattered through a set angle
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Figure 4.3: Changes in electron energy states corresponding to particle beam 
application and x-ray release in ED X analysis.
as a function of its wavelength. Through the use of a broad spectrum  of 
light, from ultraviolet to infra red, with a wavelength variation of llOOmn to 
190nm, it is possible to measure particles in the size range of 5nm to 15/xg. 
The process of measurement relies upon the variance in the amount through 
which light is scattered due to the size of the particles (Mie scattering).
The uses of this method in respect to this thesis are twofold. Firstly as an 
assessment of the size of the particles within suspension to ascertain whether 
the particles are in suspension individually or as agglomerates. Secondly, by 
taking particle size measurements over a period of time, the rapidity with 
which the particles agglomerate can be assessed.
However, particle sizing has limited applications to nanoparticles in the 
case of nanotubes due to the fact tha t the aspect ratio between the diameter 
and the length is so massive, and in terms of all nanoparticles, due to the 
rapidity with which agglomeration occurs. While this may suggest th a t the 
technique would lend itself to the assessment of the rate at which agglomer­
ation occurs in various solvents, the risk of blocking the inlet or outlet tubes 
due to agglomerates severely limits this possibility.
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4.1.5 Zeta P oten tia l
Study of the zeta potential enables an assessment of the stability of particles 
in a suspension. This reflects on the rapidity with which the particles will 
agglomerate, and therefore how rapidly sedimentation will occur. Interac­
tions between particles and a solvent are dependent on the surface charge of 
the particles. This surface charge may be a function of the ionic charges at 
the surface of the particle itself due to dissociation of surface groups, or may 
be brought about by the presence of ions adsorbed onto the particle surface. 
The interactions between particles due to surface charge do not occur at the 
particle surface itself, rather they are felt at a distance. These interactions 
are a resolution of two forces: attractive molecular forces (Van der Waal’s 
attractions) , V^; and the repulsive electrostatic BORN forces, V r . It is the 
resolution of these forces that is termed the zeta potential.
This potential cannot be measured directly. In order to obtain a value 
for it, the mobility of the particles is studied. The most common method for 
this is electrophoresis. This method uses laser doppler velocimetry (LDV) 
to study the particle migration rate upon application of an electromagnetic 
field. The elecrophoretic mobility, /i£, is a function of the particle velocity, 
v, and the applied electric field, E.
LDV machines utilise two beams, a reference and a ‘scattering’ beam. 
Obviously, Brownian motion may result in a smearing of the velocity profile 
obtained. This is addressed by reducing the angle in which the scattering 
beam and reference beam cross in the sample vessel to approximately 1 2 °. 
The electrophoretic mobility is related to the zeta potential through the 
Henry equation.
Where e and 77 are the dielectric constant and the viscosity of the solvent 
medium respectively, f(/c.a) is a correction factor to take into account the 
particle diameter and the thickness of the double layer. For dispersions in 
polar media (water, saline solutions etc.) f(/c.a) is approximately 1.5. This 
is the Smolochowski approximation and reduces the Henry equation (4.1) to 
the following (4.2).
*  = (4-2)
This can be further simplified in practice to the approximation at 25°C:
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*  =  K 85 (4 3 )
In order to remove the effect of Brownian motion on the determined 
mobility, measurements are carried out both with and without the applied 
field. This reduces the width of the velocity profile measured in the presence 
of the field to purely account for the electrophoretic mobility. This peak is 
then analysed using Fourier transforms to obtain spectra corresponding to 
particle velocity and zeta potential.
The stability of the particles in the suspension can be broadly charac­
terised by the zeta potential in the following way:
Zeta Potential Suspension Stability
mV
0 to ±5 Rapid Flocculation
±10 to ±30 Incipient Instability 
±30 to ±40 Moderate Stability
±40 to ±60 Good Stability
>±61 Excellent Stability
4.1.6 Transm ission Spectrophotom etry
Transmission photospectrometry involves the measurement of the percent­
age of light tha t is able to pass through a solution or suspension, termed the 
percentage transmission. It can be used to assess nanoparticle suspensions 
in a number of ways. Firstly, once a calibration curve has been obtained 
using set concentrations, concentrations of nanoparticles remaining in sus­
pensions following treatments such as vortexing or filtration can be assessed 
by comparison between the transmission percentage measured for the sam­
ple and the calibration curve. Secondly, the effectiveness of a given medium 
for keeping the nanoparticles within suspension can be assessed through a 
timelapse method. This involves taking a number of readings on a sample 
containing a set concentration over a given time. As the particle agglomerate 
and sink over time, the transmission percentage will increase. Again, these 
readings can be compared to the calibration curve to assess the change in 
the concentration of nanoparticles remaining in suspension.
77
Figure 4.4: SEM  images of the nanoparticles used in this work. Top row 
L-R; Diesel, As-produced single walled nanotubes, As-produced multi-walled 
nanotubes. Bottom rotv L-R; COOH-functionalised single-walled nanotubes, 
COOH-functionalised multi-walled nanotubes.
4.2  C haracterisation  R esu lts
4.2.1 SEM and TEM
Figure 4.4 shows scanning electron micrograph images of the nanoparticles 
used in this thesis. While the diesel particulates proved relatively simple to 
image, the location and capture of images of the nanotubes was markedly 
more difficult.
Figures 4.5, 4.6 and 4.7 show transmission electron micrograph images 
of the three types of diesel particulates in the blend supplied by Cardiff 
University. The images were taken by the Cardiff Materials Engineering 
departm ent.
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Figure 4.5: TEM  image of combustion derived particulates of standard diesel
4.2.2 EDX
Nanoparticle
Carbon
Composition (%)
Sulphur Metallic Impurities
Diesel 90 10 0
AP-SW NT 99.9 0 0.01
AP-M W NT 99.9 0 0.01
SW NT-COOH 99.9 0 0.01
MW NT-COOH 99.9 0 0.01
Presented above are the compositional values for the nanoparticles as 
measured on the EDX. It is im portant to note however th a t carbon is not 
considered to be heavy enough for the EDX to give absolutely accurate values 
for it. However, in the case of the nanotubes, the incredibly low value for 
the metallic im purities suggests tha t the carbon reading can be considered 
reliable.
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Figure 4.6: TEM  image of combustion derived particulates from bio-diesel
4.3 P o ten tia l Solvents for N an op artic le  Solu­
b ilisa tion
Strictly, the issue of nanoparticle solubility is a misnomer, as the nanoparti­
cles do not dissolve. A more accurate view would be to refer to the resulting 
blend as a colloidal suspension. This aside, the fluid into which the nanopar­
ticles were suspended prior to their introduction into blood required careful 
investigation. As discussed in nanotubes section above, getting carbon nan­
otubes into suspension is incredibly difficult. Standard strong solvents such 
as ethanol or acetone do achieve results but cannot be considered for this 
research due to their effects on blood.
As such, the following fluids were evaluated for use: lw t%  sodium do- 
decyl sulphate; Tyrode’s solution; medical saline solution; gelofusine plasma 
replacement solution; H artm ann’s Solution; tris buffered saline; and rpmi 
1460 cell culture medium. The fluids were evaluated using the following
criteria:
1. Literature usage
2. Ease of solubility
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Figure 4.7: TEM  images o f combustion derived particulates from  red diesel 
3. Effect on blood 
4.3.1 Literature Usage
Very few of the solvents used in literature to attem pt to achieve a quasi­
stable nanoparticle suspension are appropriate for the work in this thesis. 
The two which can be readily identified as possible solvent candidates are 
sodium dodecyl sulphate (SDS), which has been used both as a solvent and 
for nanotube functionalisation, and Tyrode’s solution used in the work of 
Radomski et al. O ther solvents were tested following discussion with medi­
cal professionals, identified from use in fibrinogen (an im portant component 
of blood clots) gelation work undertaken by colleagues or recommended by 
colleagues working with nanoparticles.
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Figure 4.8: Zeta Potential measurements for each of the nanoparticles when 
suspended in each of the solvents investigated.
4.3.2 Ease of Solubility 
Z eta  P o te n tia l M easu rem en ts
Figure 4.8 presents the da ta  from the assessment of the zeta potential of each 
of the nanoparticles in the solvents under examination. As can be seen, a 
suspension of nanoparticles in either Tyrode’s solution or rpmi 1640 is highly 
unstable leading to rapid agglomeration and either sedimentation or flotation 
resulting in the rapid removal of the nanoparticles from suspension. Sodium 
dodecyl sulphate and gelofusine produced the most stable suspensions.
P a rtic le  Sizing
The particle sizer was of very limited use for the sizing of individual nan­
otubes. The results from timelapse experiments showed very good agreement 
with the results from the agglomeration rate experiments discussed below.
A g g lom era tion  R a te
Figure 4.9 presents the results of a time lapse assessment of each of the 
potential solvents using photospectrometry. In each case, a suspension of
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Figure 4.9: The variance in % transmission in a photo spectrometer over time 
fo r the solvents under investigation.
lOOmg/1 was made up with the solvent to be tested. As-produced single 
walled nanotubes were used for this as they had proved to be the least stable 
in suspension.
Each sample was made up directly prior to testing and was sonicated 
for 20s at an amplitude of 60 units. This was done while the sample was 
immersed in a water bath in order to minimise solvent boil off. Each sample 
was then placed into the photospectrometer for 30 minutes, with transmission 
readings taken every 5 minutes. The best results occurred with sodium do- 
decyl sulphate, used in the literature for solubilisation of nanoparticles, and 
gelofusine, a plasma substitute suggested by medical colleagues. However, 
SDS is unsuitable for inclusion into blood as it is a detergent. Gelofusine 
was found to denature somewhat following sonication and I was advised by 
medical consultants tha t it would punch holes in the clot. As such it too was 
discounted.
Radomski et al utilise Tyrode’s solution, a culture medium, as is rpm 
1640. It was found tha t both these solutions were incredibly bad at retain­
ing any nanoparticles in suspension due to the tendency of the particles to 
flocculate and float very readily. It was very difficult to prepare samples for
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the tests above for these two potential solvents.
Medical saline seemed to offer a viable possibility but while it was fairly 
good at getting nanoparticles into suspension it proved to be very difficult 
to get good gel point data upon inclusion of even pure saline into blood.
Hartmann’s solution is another medical drip solution. Again this was 
found to be very difficult with which to get good gel points. It was also more 
difficult to obtain a ready supply of this solution.
TBS was chosen due to i t’s use in work on fibrin gelation. It performed 
reasonably well as a solvent, showed no complications with sonication and, 
importantly, did not inhibit the ease of gel point detection.
4.3 .3  Effect on B lood
As sodium dodecyl sulphate is a surfactant and a detergent, it is not suitable 
for inclusion into blood. Preliminary gel point trials with both Tyrode’s 
solution and the culture medium rpmi 1640 showed that each of the solvents 
had a marked effect. Both produced much looser gel points that were thus 
much harder to obtain an accurate phase angle value for.
4.3 .4  Conclusions
Tris buffered saline was selected as the most suitable solvent for this thesis.
4.4 Nom enclature
attractive Van der Waal’s forces 
V r repulsive Born forces
C zeta potential
fie electrophoretic mobility
v particle velocity
E applied electric field
e dielectric constant
f(/ea) correction factor for particle diameter and double layer thickness
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Chapter 5 
Blood
‘Once more unto the breach’
Henry V, William Shakespeare
5.1 The Cardiovascular System: An Overview
The cardiovascular system is the means by which bodily tissues can be sup­
plied with fuels and oxygen and the waste products of carbon dioxide and 
lactic acid can be removed. It also enables the transport of control com­
pounds such as hormones throughout the body.
It can be split into two distinct sections, the pulmonary circulation in 
which carbon dioxide rich blood is circulated to the gas exchange surfaces of 
the lungs where the gas is exchanged for oxygen, and the systemic circulation 
which feeds the body. In the systemic circulatory system oxygen-rich blood 
is pumped from the heart throughout a network of arteries to the tissues of 
the body. Oxygen-depleted blood is then carried back to the heart through 
a network of veins.
5.1.1 A rterial and Veinous C onstruction
The structure of the arterial and venous components within the cardiovas­
cular system is markedly different. This is due to the nature of the flow 
within them. Higher pressures are experienced within the arteries requiring 
a thicker wall containing a larger percentage of elastic and muscular tissue 
than is found in a comparable vein.
Components of the vessel construction can become triggers of thrombus 
formation following disruption or injury to the endothelial lining of the Tu-
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Figure 5.1: Basic schematic representation o f the cardiovascular system.
nica Intim a and the muscular Tunica Media. Injury to these two layers can 
result in exposure to the collagen fibres which make up the Tunica Adventita. 
The roughness of these collagen fibres trigger a response from the platelets 
resulting in the commencement of the clotting cascade described later in this 
chapter.
5.2 M ain  B lo o d  C on stitu en ts
5.2.1 Red Blood Cells
The red blood cells or erythrocytes (from the Greek, erythros meaning red 
and kytos now taken to  mean cell although originally meaning hollow) are 
the gas transport cells within the blood. They are bi-concave in order to 
maximise the surface area available for gas exchange.
5.2.2 W hite Blood Cells
Leukocytes are immune system cells which hunt down foreign materials such 
as bacteria, fungi and parasites in the blood system. There are five distinct
types of leukocyte, each of which is focused on the removal of a particular
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Figure 5.2: Left, Arterial Structure: a) External arterial wall; b) Tunica 
Adventita composed of collagen fibers; c) Tunica Media, composed of smooth 
muscles cells and elastic fibers; d) Tunica Intima, the endothelium that lines 
the lumen of all vessels; e) elastin sheath. Right, Veinous Structure: a-e 
are the same as fo r  the artery (note the much thinner Tunica Media); f )  
Non-return Valve.
foreign body or bodies. These five are: Eosiniphils, Basophils, Lymphocytes, 
Monocytes and Neutrophils.
Eosiniphils’ prim ary function is the removal of parasites from the system 
and are the prim ary cellular response in allergic reactions.
Basophils are also largely involved in the allergic and antigenic response 
through the release of the inflammatory chemical histamine.
While more common in the lymphatic system, there are three distinct 
types of lymphocyte which are found in the blood:
1. N atural Killer Cells
These are able to  directly kill cells of the body which display signal 
markers designating them as infected or cancerous.
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2. B Cells
The function of the B Cells is the manufacture of the antigens by which 
the body combats invading pathogenic bodies. A small number of 
these cells which survive a pathogenic attack will retained the ability 
to produce the required antigen in order that a level of immunity to a 
repeated attack is achieved.
3. T Cells
T Cells have two main functions: the coordination of the immune re­
sponse; and the ability to kill cells infected with viral parasites or which 
are cancerous.
4. Monocytes and Neutrophils
These cells are discussed together as they can both be described as 
phagocytes. This is due to the way in which they attack and remove 
pathogens such as microbial infections. This is done by engulfing the 
invading foreign body (phagocytosis). The difference between the two 
types of cell lies largely in their lifespan. The monocytes are much 
longer lived than the neutrophils which are unable to regenerate and 
thus die after they have engulfed relatively few microbes. In contrast, 
the monocytes live longer to enable them to fulfill their secondary role; 
the presentation of pieces of the pathogens to the T Cells mentioned 
above, in order that a repeated invasion by the microorganisms can be 
readily repelled.
5.2.3 P la te le ts
Also known as thrombocytes, the platelets are irregularly shaped cells with­
out nuclei, with a typical lifespan of between 8  and 12 days. They are between 
2 and 4/zm in diameter and are derived from the products of the fragmen­
tation of megakaryocytes within the bone marrow, with each megakaryocyte 
fragmentation resulting in the generation of between 5 and 10,000 platelets. 
This process is regulated by thrombopoietin, a hormone produced by the 
liver.
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5.2.4 C lotting  Factors
Blood contains a large number of clotting factors which act at different stages 
during the coagulation process.
1. Factor I (Fibrinogen)
Fibrinogen is a soluble non-globular plasma glycoprotein generated in 
the liver [67]. It is a hexameric molecule consisting of two sets of 
three different protein chains, a , f3 and 7 . The chains terminate in N- 
terminals at one end and C-terminals at the other. The a  and (3 chains 
have small protein molecules, fibrinopeptides (A and B respectively), 
bound to them. These molecules prevent the spontaneous bonding of 
the fibrinogen chains to themselves.
Normal concentration of the protein within blood is between 1.5 and 
2.77g/l. The protein is able to form bonding bridges between platelets 
when in i t ’s natural state by binding to the G pIIb/IIIa membrane pro­
teins exhibited on the platelet surface. Thrombin causes the fibrinogen 
to cleave and to begin to form an insoluble fibrin mesh, the basis for 
the thrombus structure. These reaction steps are discussed in more 
detail later.
Disfunctionality of the liver can lead to abnormal levels of fibrinogen 
production or to the production of fibrinogen molecules with abnormal 
structure leading to reduced activity levels. In either case, this decrease 
in the levels of viable fibrinogen available causes a reduction in the 
ability of the blood to form thrombi, resulting in a raised potential for 
haemorrhage following injury.
2. Factor II (Thrombinogen)
The gene for thrombinogen is located on the eleventh chromosome. 
Thrombin, the active form of factor II is the most important of the 
bioregulation enzymes involved in haemostasis. However it is only rel­
atively recently tha t this has come to be accepted in both arterial and 
venous thrombosis. It was widely thought in the 1960s and -70s tha t 
an arterial thrombus was of the nature of a primary plug formed due 
to the action of platelet aggregation alone, exclusive of the rest of the 
clotting system [6 8 ]. In contrast, a thrombus formed within the venous 
network would more closely resemble a complete clot. Despite attem pts
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to maintain the importance of thrombin generation within thrombus 
formation it was not until 1980 that opinions were largely changed due 
to the publication of a study by Loeliger et al [69]. It has since been 
shown that thrombin is the most potent of all platelet activators, and 
activated platelets result in the explosive generation of thrombin which 
serves to promote secondary haemostasis.
The mechanism by which thrombin activates the platelets was resolved 
in the work by Vu et al [70]. They showed that thrombin acts upon a 
trans-membrane molecule within the lipid bilayer of the platelet mem­
brane. The exposed N-terminal of this membrane is cleaved by throm­
bin, with the resulting new N-terminal acting as a ligand for protein 
receptor molecule on the platelet surface. This binding enables the 
transference of a procoagulant protein from the inside of the platelet 
membrane to the outside. This protein is phophatidyl serine (PS), a 
procoagulant phospholipid. In common with all other cells, this protein 
is located on the inside of the plasma membrane of the platelet. It is 
this fact which prevents intact cells from having procoagulant effects, 
as opposed to ruptured or lysed cells in which the protein is then able 
to contact the surrounding plasma. However, the actions of thrombin 
and collagen enable the translipid migration of the PS protein, causing 
the intact platelet surface to become an active coagulant. At normal 
concentrations of the platelets within the plasma, this migration can be 
brought about through the action of thrombin alone, with any increase 
in rate due to simultaneous collagen exposure being negligible.
Thrombin, as mentioned above, also acts to cleave fibrinopeptide A 
(FpA) from the ends of the a  chains on fibrinogen molecules. The 
resulting molecule is termed fibrin I. The new a  terminals on fibrin I 
can then bind to complementary sites on the fibrinogen chains which 
require no activation. The complexing of fibrin with fibrinogen enables 
the former to be kept in solution as long as the local concentration does 
not exceed a critical level. As such, these complexes are termed soluble 
fibrin. Once the critical concentration is passed the fibrin I molecules 
will aggregate to form fibrin I polymers. These polymers can then be 
cross-linked by factor XHIa which causes isopeptide formation between 
adjacent a  and 7  chains.
While a slower process than the cleavage of FpA, thrombin cleaves 
fibrinopeptide B (FpB) from the terminal of the (3 chain. Fibrinogen
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molecules which have been cleaved at both the a  and (3 terminals are 
termed fibrin II. Fibrin II will aggregate and form cross-links between 
polymers in the same manner as fibrin I.
The conversion of fibrinogen to fibrin produces a lattice of strands that 
is not inert, in that approximately 40% of the thrombin which has been 
generated within the plasma is bound within the latice. Therefore this 
bound thrombin cannot be deactivated due to the inabiliy of inhibitors 
to penetrate through the lattice. As such, the fibrin strands themselves 
play an additional thrombin inhibitor role. These lattice bound throm­
bin molecules may then cause further localised thrombosis following 
the removal of the encasing fibrin strands during fibrinolysis.
Three types of thrombin formed following prothrombin activation have 
been identified: a-; /?-; and 7 -thrombin. The latter two are formed 
following autodegradation of the a-thrombin, and as such have very 
limited physiological function. This degradation can be brought about 
by elastase: an enzyme released by activated neutrophils which also 
serves to degrade the structure of the fibrin clots themselves.
3. Tissue Factor
This surface glycoprotein is present in platelets, leukocytes and suben- 
dothelial tissue, and serves to activate thrombin during the extrinsic 
pathway of secondary haemostasis [71]. Tissue factor was incorrectly 
thought to be thromboplastin, a laboratory produced glycoprotein de­
rived from placental blood and used in the prothrombin time (PT) 
assay, a method for measuring the rate of thrombus formation when 
the extrinsic pathway was activated. A derivative of thromboplastin 
was subsequently generated, termed partial thromboplastin and used in 
the investigation of the intrinsic pathway through an assay termed acti­
vated partial thromboplastin time (aPTT). Further study enabled the 
identification and separation of two components within thromboplas­
tin; phospholipids and tissue factor, both of which are required for the 
activation of the extrinsic pathway. Investigation of the composition 
of the partial thromboplastin determined that partial thromboplastin 
only contained the phospholipid component, thus showing that tissue 
factor was not required for the activation of the intrinsic pathway.
When presented on cellular surfaces, tissue factor serves as a receptor 
of high-affinity to factor VII. Following the binding of factor VII a
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complex is formed which serves as a catalyst for the subsequent protease 
reactions within the coagulation cascade. Tissue factor also exists in a 
soluble extracellular form, which is no less effective once activated.
4. Calcium
The calcium ion (Ca2+) is critical as a catalyst for all of the protease 
reactions tha t constitute the coagulation cascade.
5. Factor V (Proaccelerin)
This large soluble plasma protein is critical for haemostasis to occur 
normally [72]. Indeed, the factor was discovered by Owren in 1943 
following the study of a patient who exhibited a bleeding disorder which 
was unexplainable with the knowledge of coagulation at the time. It 
was concluded that a deficiency in an activity which affected the rate 
of conversion of prothrombin to thrombin.
By the 1940’s, improvals in the assays for prothrombin had shown that 
the two stage theory proposed by Morawitz demonstrated that there 
were other factors required for the protease reaction initiated by tissue 
factor which converted prothrombin to thrombin. Factor V was the first 
of these to be identified[73]. It was termed proaccelerin or labile factor, 
the latter name referring to its ex vivo instability when in storage in 
plasma and its subsequent absence from blood serums.
It has since been shown that the catalytic action on the protease re­
action resulting in thrombin generation is due to a complex formed 
between the active forms of factor V and factor X (Va and Xa respec­
tively) on the negatively charged phospholipid surface of the platelets 
when in the presence of calcium ions. This complex, known as pro- 
thrombinase, enables an increase in the rate of generation of thrombin 
by 300,000 times when compared with the rate of development due to 
factor Xa alone.
6 . Factor VII (Stable Factor)
The second factor to be identified following the work by Owren. This 
was initially named stable factor due to the fact that the protein re­
mained stable when in plasma storage and thus was found to exist in 
high levels in blood serums [74]. However, the identification of the 
separate actions of factor VII and factor X was not accomplished until 
Telfer et al in 1956[75],
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Once activated, factor VII binds to the expressed tissue factor on the 
platelet surface when in the presence of calcium ion. The formation 
of the factor VU-tissue factor complex has two critical results. Firstly, 
the bound factor VII is far more sensitive to the actions of activating 
proteases increasing the rate at which i t ’s activation occurs. Secondly, 
the formation of the complex increases the efficacy of factor V ila with 
the respect to the cleaving of factor IX and factor X into their active 
forms by three orders of magnitude.
Individuals suffering from acute myocardial infarction have been re­
ported to have increased levels of factor VII, although separate reports 
have stated that factor VII levels do not provide an independent means 
for the prediction of cardiac events or the formation and progression of 
atherosclerosis.
7. Factor VIII (Antihaemophilic Factor A)
Factor VIII is one of the largest of all the coagulation factors, and also 
one of the least stable [76].
The critical role of factor VIII in coagulation cascade is evidenced by 
the severe bleeding seen in any mammal which is deficient. This defi­
ciency is known as haemophilia A.
Factor VIII has been found to have a marked catalytic effect on the 
activation of factor X by factor IXa. While this activation can occur 
in the absence of factor VIII, it is comparatively slow. In the presence 
of factor VIII however, the rate of the protease reaction is increased 
200,000 times.
This factor is therefore part of a feedback loop within the cascade, for 
while it is activated by thrombin, it is also activated by factor Xa.
8. Factor IX (Antihaemophilic Factor B)
Pavlovsky showed in 1947 tha t the mixing of blood in vitro from differ­
ent patients with haemophilia would occasionally result in the clotting 
time being brought back within the normal range. This resulted in the 
identification of two types of haemophilia, stemming from deficiencies 
in separate clotting factors. Haemophilia B is markedly less common 
than A and results from a deficiency in factor IX, also known as Christ­
mas factor after the surname of the index patient [77].
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Activated Factor IX serves to catalyse factor X activation by the cleav­
ing of a peptide bond within the factor X chain which releases a gly­
coprotein fragment with an N-terminal. In order for the activation to 
occur at the required rate, interaction is required between the activated 
factor IX and platelet surface membrane molecules together with the 
activated factor VIII. Each of these reactions occur at different regions 
within the factor IX molecule. Factor IX also has a strong affinity for 
binding sites on the surface membranes of the endothelial cells which 
line the blood vessels. Indeed, as the activation of factor IX by either 
factor V illa  or factor XIa can occur at these binding sites, resulting 
in activation of factor X and thrombin generation, they clearly play an 
important role in the process of coagulation.
9. Factor X (Stuart-Prower Factor)
The factor X enzyme is critical to both the intrinsic and extrinsic co­
agulation pathways, in fact it is at this activation step that the two 
pathways converge [78].
It is a glycoprotein consisting of both light and heavy chains bound by 
disulphide bridges. Activated factor IX serves an important role as the 
main generator of thrombin following the initial burst during primary 
haemostasis.
10. Factor XI (Plasma Thromboplastin Anticendent)
Factor XI is a homo-dimeric plasma protein which exhibits a half-life of 
52 days. It is part of the intrinsic pathway, serving to activate factor IX. 
Deficiency of this factor causes the very rare Haemophilia C, a condition 
in which there is little spontaneous bleeding following trauma, but the 
potential for rapid fatal blood loss during surgical procedures. The 
typical concentration of factor XI is approximately 5mg/l, with higher 
concentrations being linked to thrombosis.
11. Factor XII (Hageman Factor)
Hageman factor is a plasma protein produced in the liver. It was discov­
ered in 1955 following the assessment for operation of a patient named 
John Hageman who exhibited clotting times greater than 200s despite 
having no symptoms of haemorrhage.
Factor XII serves to activate prekallikrein and factor IX. It is itself 
activated through contact with a negatively charged surface. Factor 
XII plays no part in the extrinsic pathway.
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Despite the increase in clotting times found in patients who are factor 
XII deficient, the deficiency poses no risk of haemorrhage as the factor 
has no direct role in the generation of thrombin. However, deficient 
patients stand a higher risk of thrombosis. This is due to a reduced 
activation of fibrinolysis which can lead to fatal embolism.
12. Factor XIII (Fibrin Stabilising Factor)
This factor circulates within the blood. A protransglutinase molecule 
which acts in the final stages of coagulation, factor XIII is activated 
by thrombin and serves to stabilise the forming fibrin clot through 
the catalisation of intermolecular bonds within the lattice. A large 
molecule, factor XIII consists of a pair of a and a pair of b protein 
chains which form a complex with fibrinogen and calcium ion. The 
cleavage of factor XIII by thrombin produces three distinct molecules 
determined by the protein chains of which they are constructed. In 
terms of the thrombi stabilisation, the most important of these is the 
active a \  dimer which is fibrin bound and it is this molecule which 
begins the cross-linking of the polymerised fibrin strands bound within 
the clot.
13. von Willebrand Factor (vWF)
This factor is a multimeric glycoprotein which circulates in a free float­
ing state within the plasma. It forms a non-covalent complex with 
activated factor VIII. Indeed, vWF serves as a carrier for factor VIII 
enhancing its stability. In locations where high shear regimes are dom­
inant, it is vWF which enables platelet adhesion by binding to the 
subendothelial collagen matrix. The factor then binds to the platelet 
glycoprotein G pIIb/IIIa. The formation of this bond is dependent on 
the presence of calcium cations and is governed by ADP secreted from 
the platelets.
5.2.5 P lasm a
Blood plasma constitutes 55% of the volume of blood. It is the slightly yellow 
liquid in which the blood components are suspended and serves as the main 
transport for all the excretory compounds within the blood including carbon 
dioxide.
95
5.3 Haem ostasis
Haemostasis is the means by which the cardiovascular system is able to un­
dergo self repair. It can be readily split into two distinct phases: Primary 
and Secondary haemostasis. While this body of work is mainly concerned 
with the changes occurring in the blood during the secondary phase, for 
completeness, the primary phase shall be briefly discussed first.
5.3.1 H istorical D evelopm ents in U nderstanding
The observation of the coagulation of blood is recorded in antiquity [79]. 
The Ancient Greek philosopher Hippocrates stated that the coagulation was 
brought about by the cooling of the blood once outside the body. It was not 
until 1627 that Mercurialis reported finding blood clots forming in veins with­
out cooling, although this was largely considered to be impossible, leading 
to his work being ignored, with the majority of belief being that blood clot­
ted only when not in motion and died upon removal from the body. Other 
explanations linked to proposed chemical interactions were proposed such 
as the absence of ammonia of the formation of acid resulting in thrombus 
formation.
The induction of the clotting cascade by tissues was first reported in 1819 
by Thackrah. This was later confirmed by de Blainville in 1834, whose work 
involved the infusion of a suspension formed of brain m atter into animals 
resulted in the formation of a multitude of widespread thrombi within blood 
vessels, resulting in the death of the animal. The suggestion that tissues 
contained a substance (later named thromboplastin) which would directly 
convert prothrombin to thrombin was put forward by Schmidt in 1892.
The next critical development occurred in 1905, with the proposal of a 
theory of coagulation by Paul Morawitz based upon the four factors that 
had thus far been identified. The theory stated that prothrombin could be 
activated in the presence of calcium and thromboplastin (this was prior to 
the identification of tissue factor), and that the generated thrombin could 
convert fibrinogen into insoluble fibrin thus forming a clot.
In 1944 factor V was described by Paul Owren and the following years 
saw a flurry of activity in the investigation of coagulation resulting in the 
identification and description of the majority of the remaining coagulation 
factors. The intrinsic and extrinsic coagulation pathways were proposed in 
the mid 1950’s, dependent on the requirement for tissue factor.
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In 1964 Macfarlane et al produced the description of the reactions involved 
in thrombus generation which is still in use today: a cascade of protease 
reactions in which each proenzyme is activated by the previous factor.
5.3.2 Prim ary H aem ostasis
This phase of haemostasis is characterised by the adhesion of platelets to the 
area of vessel damage and their subsequent localised aggregation [80].
Adhesion occurs due to the exposure of the sub-endothelial matrix fol­
lowing damage to the endothelial layer lining the vessel. The mechanism 
by which the platelets adhere is dependent upon the nature of flow in the 
area of the damage. If the damage occurs in a region of low flow then the 
platelets will adhere to local fibronectin and collagen strands exposed from 
lower layers. If the damage occurs in a region of high flow, then the platelets 
will adhere to Von Willebrand Factor. In either case, this adherence results 
in the platelets changing to their activated state.
Following activation the platelets undergo a number of changes resulting 
in the initial stages of signaling by which aggregation is brought about. These 
changes result in the platelets becoming increasingly spherical and causes the 
formation of pseudopods on the platelet surface.
The most important points from figure 5.3 are the release of fibrinogen 
from the a  granules together with the adenosine di-phosphate (ADP) and 
the seratonin from the dense granules. These are released due to the in­
creased levels of calcium and promote further activation and aggregation of 
the surrounding free platelets.
The third stage of primary haemostasis is platelet aggregation. At this 
point the direction of signaling reverses to run from outside the agglomerating 
platelet structure to the inside. The outside-in signaling is due to the binding 
of fibrinogen between the platelets causing a cross-linked aggregate. The 
platelet-platelet aggregation itself is enabled by the aub{33 receptors in the 
surface membrane of the platelets. The initial aggregation, termed primary 
aggregation, is reversible and is a direct systemic response to stimulation. 
Subsequent, termed secondary, aggregation includes the secretion of granules 
from the platelets and cytoskeletal rearrangements of both the platelets and 
the embedded fibrinogen. This secondary stage of aggregation is irreversible.
Both thrombin and collagen are strong agonists for the aggregation of 
platelets, causing a rapid local response. ADP and epinephrine are also
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Figure 5.3: Primary Haemostasis steps following platelet activation.
T e r m s : I - Inositol triphosphate, DAG  - Diacylglycerate, PLA 2 - Phospho- 
lipase A 2, AD P - Adenosine diphosphate, PK C  - Protein kinase C, T X A 2 - 
Thromboxane A2.
agonists but their effects are much less pronounced.
H aem o sta tic  B alance
This is a means of viewing the manner in which the initial steps of coagu­
lation are regulated in order to remove unwanted thrombi at an early stage 
[81]. Consider a beam upon a fulcrum. At one end of the beam are the fac­
tors which regulate the primary phase of haemostasis. Platelets and plasma 
factors are the triggers, while antithrom bin III, the protein C - protein S 
complex and heparin cofactor II are inhibitors.
At the other end of the beam are the triggers and inhibitors of fibrinol­
ysis (discussed later in this chapter). Plasminogen activators, both tissue- 
and urokinase-tvpe, factor XII and fibrin serve as the triggers, plasminogen 
activation inhibitor, a 2-antip lasmin and histidine-rich glycoprotein acting as 
inhibitors.
98
5.3.3 Secondary Haemostasis
Following the formation of the initial platelet plug, secondary haemostasis 
involves the formation of the complete thrombi, together with the mecha­
nisms by which the rate of thrombosis is controlled. A number of pathways 
may be followed in the formation of the clot depending on the nature of 
the activation: these are the intrinsic and extrinsic pathways. The method 
by which the clot is formed and the rapidity of thrombosis is regulated can 
most easily be shown through the use of a diagram of the coagulation cascade 
process presented in figure 5.4.
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Figure 5.4: Secondary Haemostasis cascade reactions leading to clot form a­
tion. Blue arrows refer to the intrinsic pathway, while green refer to the 
extrinsic pathway.
In tr in s ic  P a th w ay
This pathway is dominant in the case of any external stimulus such as tha t 
due to removal of blood from the body. The fact th a t thrombi can sponta­
neously form following the removal of blood from the body suggests tha t all 
necessary components for haemostasis are contained within the blood. It is 
thought th a t the intrinsic pathway is started by the activation of factor XII 
through contact with activators such as negatively charged surfaces.
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Extrinsic Pathway
This pathway is initiated by the presence of raised levels of active factor VII 
and presented cellular Tissue Factor. Normally, only 1% of all factor VII is 
present in the active form. Together with presented Tissue Factor, activated 
factor VII serves to activate factor factors IX and X. The main role for the 
factor VH/tissue factor complex is to enable the generation of sufficient levels 
of factor Xa that small amounts of thrombin can be created.
Generated thrombin begins the activation of platelets, however further 
Xa production is limited by Tissue Factor Pathway Inhibitor (TFPI). TFPI 
and antithrombin are much less efficient at inhibiting the generation of factor 
IXa which is then able to diffuse through the plasma to the platelet surface 
where the main process of thrombin generation occurs.
High concentrations of Tissue Factor bearing cells are found in the Tu­
nica Adventitia. Blood borne Tissue Factor is also generated in order that 
thrombus growth is not halted when the original area of vessel wall in which 
Tissue Factor was exposed has been covered.
Common Pathway
The common pathway begins with the formation of a complex containing 
calcium, thrombin, cofactor Va and factor Xa on the negative platelet surface. 
This complex is called prothrombinase. This complex results in the cleaving 
of prothrombin, which causes the release of thrombin into the surrounding 
area. This reaction is limited by the availability of factor Xa. The thrombin 
then acts upon the soluble fibrinogen to fibrin monomers by removal of the 
fibrinopeptides FPA and FPB. These monomers then form long fibrin strands 
which may be branched following polymerisation at the FPB site. This 
branching enables cross linking between the fibrin strands to occur. The 
resulting mesh is able to trap  blood cells and thus cover vessel damage.
The structure of the fibrin network which is formed is highly dependent 
on the conditions under which it formed. A fine network comprising a large 
number of fine fibrin strands is far more rigid than a network composed of 
thick fibrin strands encompassing larger liquid filled voids within it. This is 
of importance due to the fact that men suffering from myocardial infarction 
at a young age have been found to form finer, more rigid fibrin clots in vivo. 
These finer clots have been shown to be far more difficult for the body to 
break down through fibrinolysis, despite the fact that thin fibres can be 
cleaved more rapidly than thicker ones, the massively larger numbers of the
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fine fibres in clots of comparable size require a much longer lysing time.
It is important to note tha t only 15% of the thrombin available acts upon 
the fibrinogen; suggesting the importance of thrombin through a number of 
points within the cascade. It is also suggested that due to the fact that only 
35-40% of FPA is released the majority of available fibrinogen at the clotting 
site is trapped within the initial thrombus. This is backed up by an 80% 
reduction in the levels of fibrinogen within the blood plasma.
5.3 .4  C lot R etraction
The retraction of the thrombus occurs once i t’s formation has been com­
pleted. There are three major reasons for the desirability of retraction: firstly, 
retraction aids in concentrating the plug to the damaged area; secondly it 
enables the edges of the wounded area to be drawn together and finally it 
aids in the opening of an otherwise occluded vessel to flow.
Retraction is mediated by the platelets and is highly dependent on the 
platelets binding to the polymerising fibrin strands. The platelet binding 
is in part regulated by the glycoprotein Ilb /IIa  receptor which forms a link 
between the fibrin strands and the network of actin and myosin which forms 
the cytoskeletal structure of the platelets.
5.3.5 F ibrinolysis
Once the damaged section of the vessel has been repaired it is imperative 
tha t the clot can be readily removed. The removal is carried out by the 
fibrinolytic system which utilises plasmin to degrade the fibrin network into 
fibrin degradation products (FDP) and D-dimers.
The term stems from the earliest studies into the breakdown or lysis of 
thrombi when it was thought that the action of plasmin was limited to the 
lysing of fibrin in circulation. As discussed above, the haemostatic and fibri­
nolytic components in a state of mutual compensation. This is maintained in 
terms of fibrin through the binding of tissue plasminogen factor (tPA), plas­
minogen and a 2-antigen onto the surface of the fibrin molecule itself. The 
complex formed from these fibrinolytic precursor enzymes produces plasmin 
which then causes the cleavage of fibrin through a hydrolytic reaction.
Control and regulation of the fibrinolytic system has been widely linked to 
tPA. This protein is synthesised in the endothelial lining of the blood vessels.
101
Once released into circulation however, the protein has a very short half life 
of only a few minutes. Indeed, if an individual responds poorly to stimuli, 
such as venous occlusion, which would normally result in a marked increase 
in localised tPA concentrations within the blood, then they are likely to be 
at far greater risk from Deep Vein Thrombosis.
5.4 Flow Pattern Com plications
Localised changes in the nature of the flow throughout the cardiovascular sys­
tem can lead to the generation of undesired and potentially harmful throm­
boses [82]. The means of generation is dependent upon whether the vessel in 
question is an artery or a vein.
5.4.1 A therosclerotic P laques
These plaques are preferentially formed at points in the arterial vessel net­
work such as bends and bifurcations. This is due to the nature of the flow in 
these locations, which results in eddy formation and other low flow regimes 
resulting in the adhesion of both leukocytes and platelets to the vessel wall, 
together with wall penetration by lipoproteins.
The lesions typically begin as accumulations of macrophages that have 
taken up the low density lipoprotein once it has been oxidised. These are 
found in some children prior to the age of 1 and in all children after the age 
of ten. These deposited macrophages become known as foam cells once they 
have accreted a certain amount of cytoplasm. Upon the death of the foam 
cells, the release of the cell contents causes the attraction of further num­
bers of macrophages resulting in the formation of an extracellular lipid core 
within the growing plaque. In contrast the outlying plaque regions become 
increasingly calcified and exhibit a greatly reduced metabolic function as the 
lifetime of the plaque increases.
The swelling itself is not directly on the internal surface of the artery 
but rather in between the Intima and Media layers. As the size of this 
swelling increases, the arterial tissue will undergo stretching in order that 
the internal bore of the vessel can remain as unchanged as possible. This 
stretching can continue until the point where the plaque constitutes 50% of 
the cross sectional area of the arterial wall.
Once the ability for the artery to expand at a rate matching the growth 
of the plaque is exceeded, narrowing of the area available for flow will begin
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to occur. This will result in localised areas of high shear in the region around 
the narrowing potentially causing the plaque to rupture. The occurrence of 
a rupture in the endothelium separating the plaque growth from the blood 
flow results in the initiation of a rapid platelet and hence clotting response. 
However, the rupture may result in a shower of debris being ejected into the 
blood stream.
The narrowing of the artery due to the clot formed over the rupture causes 
a further degree of localised high shear and narrowing of the available flow 
area. However the more dangerous region is now the area of localised low 
shear downstream from the plaques. Eddy formation in this region results 
in the formation of strong secondary fibrin clots which are rich in red blood 
cells. The low flow regimes can also result in the deposition of debris in 
smaller vessels locally causing further blockages. The combination of these 
complications can result in the complete occlusion of the arterial vessel re­
sulting in the loss of blood flow to regions after the location of the plaque. 
This is the principal cause of myocardial infarction (heart attack).
This is not the sole danger posed by the formation of atherosclerotic 
plaque. If the arterial wall is caused to stretch to between 2 and 3 times 
its original size to accomodate the growing plaque the elastic tissue in the 
vessel walls can become increasingly weak. At this point even the minor 
pressure increase due to the pulse can cause a rupture of the vessel leading 
to a potentially fatal haemorrhage. The atrophy of the muscular support 
in the Medial region of the wall can result in the formation of an aneurysm 
where the vessel balloons out at the weakened region resulting in massive 
localised pressure on the surrounding tissue.
It has been postulated that atherosclerotic plaques may be generated 
due to oxidative stresses on the cell wall, possibly caused by the presence of 
foreign nanoparticles (such as diesel particulates or carbon nanotubes) within 
the blood.
5.4.2 D eep  Vein Throm boses
These develop most often in the areas of eddying flow directly after the venous 
valves. This flow pattern can cause the aggregation of platelets within the 
valve ‘pockets’ resulting in the initiation of coagulation.
They can become particularly dangerous in the small, deep veins (hence 
the name) where an expanding thrombus may become lodged. This can
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result in death largely due to the separation of all or parts of the thrombus 
from the initial generation site, followed by their lodging in the pulmonary 
system resulting in pulmonary embolism.
5.5 Procedures for H aem ostasis Analysis
The work in this thesis involves two systems which are used for the clinical 
analysis of haemostasis; the Thromboelastograph (TEG) and the Sonoclot.
5.5.1 Throm boelastograph
Thromboelastography was first conceived following the Is* World War. In 
the intervening years it has been developed as a clinical tool for the diagnosis 
of pro-coagulant states as well as the assessment of coagulation function in 
patients following major traum a such as serious injury or surgery.
The TEG machine utilises a cuvette heated to 37° C which is filled with 
360^1 of blood (work has been carried out on both whole and citrated blood). 
This cuvette is oscillated through an angle of 4° 45’ over a period of 10 seconds 
to provide a low shear regime which resembles sluggish venous flow. A pin, 
freely suspended in the cuvette from a torsion wire, is monitored for motion.
As the fibrin strands form, the motion of the cuvette is coupled to the 
pin, causing a transfer of torque. The rate of the formation of the clot 
together with the clots’ strength affect the motion of the pin. The electrical 
signal generated by the coupling is amplified to generate the TEG trace. The 
deflection of the trace from the baseline increases as the strength of the clot 
increases and decreases as the clot is lysed.
However, false readings can be generated due to the nature of the force 
which the TEG applies, which results in a stress tha t is outside the linear 
viscoelastic range of blood. Due to the fact that the applied torque is con­
stant, this can lead to false lysis readings due to separation of the clot from 
either cuvette or pin surface during retraction, or to an increase in measured 
clotting times as the growing fibrin strands may be sheared apart.
Variables Measured
1. rtim e
This is a measurement of the period of latency taken from the com­
mencement of the test until the deflection of the plot is 2mm. The
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Figure 5.5: Simple schematic o f the thrombolestograph, hob and cup system. 
normal range for the r time is between 15 and 23 minutes.
The value of the r time may be increased due to defficiency in clotting 
factors, the addition of anticoagulants into the blood or by cases of 
severe hypofibrinogenaemia of thrombocytopenia.
The r time is decreased in patients with hypercoagulability syndromes.
2. k time
The k time is the time taken after the detection of the initial fibrin to 
achieve a defined level of clot strength equivalent to a clot amplitude of 
20mm. The normal range for the k time is between 5 and 10 minutes.
As with the r time, the k time will be increased in patients with a 
deficiency in clotting factors, hypofibrinogenaemia, throm bocytopenia 
and also thrombocytopathy.
Values for the k time are also reduced in patients exhibiting hyperco­
agulability.
3. a  angle
105
FibrinolysisCoagulation
20mm
T M A 30 min
Figure 5.6: A n example o f a TEG plot of haemostasis showing the points at 
which values are recorded
The a  angle measures the rapidity of the build-up of the fibrin clot and 
the level of cross linking as this relates directly to clot strength. I t ’s 
normal range is between 22° and 38°.
The a  angle is increased in individuals exhibiting hypercoagulability 
and decreased in patients with hypofibrinogenaemia and throm bocy­
topenia.
4. Maximum Amplitude (MA)
The maximum amplitude value is a direct function of the maximum 
dynamic properties of the bonding of fibrin and platelets through the 
G pIIb /IIIa  receptors and represents the ultim ate strength of the clot 
formed. It correlates to platelet function as 80% of the clot consists of 
platelets. The normal range for the MA is 47 to 58mm.
It is again increased in cases of hypercoagulability and decreased in 
cases of throm bocytopenia, throm bocytopathy and hypofibrinogenaemia.
5- LY30
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LY3o refers to the percentage of lysis which has occured 30 minutes 
after the clot has reached maximum amplitude. It is calculated using 
the following formula:
_  M A  -  Aw
M A   ^ ’
Where A30 is the amplitude 30 minutes after maximum amplitude has 
been reached. The normal range is <7.5%.
The variables which the TEG system records are illustrated in figure 5.6.
Explanation of Disorders Mentioned
Thrombocytopenia refers to disorders which result in a reduced platelet count 
due to the fact that platelets are lost from circulation at a higher rate than 
they can be replaced.
Thrombocytopathy refers to disorders in which platelet function is re­
duced or compromised.
Hypofibrinogenaemia is a deficiency in levels of fibrinogen in blood. This 
deficiency may be congenital, due to liver disease or brought about following 
complications in pregnancy. While the normal fibrinogen range is between 
1.5 and 2.77g/l, clotting deficiencies only occur when the concentration has 
dropped below the threshold of 750mg/l.
5.5.2 Sonoclot
The Sonoclot was developed by Sienco in 1986. The mechanical components 
of the machine consist of: a 360/d cuvette, which is maintained at 37° prior 
to the addition of blood by the use of the top of the machine as a pseudo hot 
plate; a disposable hollow cylindrical probe; and an electronic oscillator.
The probe is affixed to the oscillator and lowered into the blood sample. 
The probe is oscillated over a 1mm distance at a rate of 200Hz. The machine 
then monitors the impedance of the oscillation in order to determine the 
development of the clot.
No reason has been found by the author for the selection of the frequency 
or range of the movement, certainly the operating parameters are outside the 
linear viscoelastic range for whole blood.
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Figure 5.7: Simple schematic of the Sonoclot system.
The Sonoclot presents the results through a graphical display. The pre­
sented curve as shown in figure 5.5.2 can be split into four distinct sections:
1. Liquid Phase: this phase ends at the point at which throm bin gen­
eration within the blood sample causes initial fibrin strand formation 
resulting in the sample viscosity beginning to  increase rapidly.
2. Clot Rate: The slope of the signature during fibrin formation together 
with the final value of the signature when the gel formation is complete 
enable the rate of fibrin formation to  be assessed.
3. Clot Retraction: This phase can be split into two. The first is char­
acterised by the upward slope which corresponds to the retraction of 
the clot, w'hile the second phase involves the clot pulling away from the 
surfaces of the sonoclot and is characterised by the downward slope 
after the final peak.
4. Time to Peak: While not strictly a distinct phase unlike the three listed 
above, this measurement provides a useful means of assessment for clot 
retraction, and can be used to determine platelet function. In general, 
the faster the time to peak, the greater the platelet function.
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Figure 5.8: A typical example o f a Sonoclot trace.
The frequency of use of the sonoclot in literature is much lower than 
th a t of the throm boelastograph and the validity and relevance of results is 
somewhat debated.
The first investigation of a calibrated version of the machine was under­
taken by Chandler and Schmer [83] who found it to  be a useful technique for 
providing information on the viscosity of whole blood and plasma. This was 
followed by an investigation by H ett et al who reviewed the operation and 
performance, determining th a t while the sonoclot could provide useful data  
on platelet function, further testing was required before the machine could 
be adopted for clinical use.
McKenzie et al [84] discussed the sonoclot with reference to the other sys­
tems available for clinical use. They highlighted two main advantages with 
the system: its ’ high level of convenience due to the small size, both of the 
machine and the volumes of sample required, and the short time required 
for the procedure; and the ability to immediately infer the location of the 
abnorm ality within the clotting cascade through changes in the plotted out­
put curve. They also highlighted a pair of disadvantages in the potential for 
subjective analysis of the results curve and the lack of supporting evidence 
for physical correlation.
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Following studies undertaken by Tucci et al [85] it was found that the Son­
oclot glass bead activated test could reliably detect inhibition of the glycopro­
tein Ilb /IIa  receptor by tirofiban in unheparinised whole blood. Miyashita et 
al [86] were able to show that approximate platelet function can be assessed 
through the investigation of the time to peak value on the Sonoclot. The 
time to peak was found to be predicted by the platelet count, whole blood 
platelet aggregation measurement and the fibrinogen level.
5.5.3 R heological Techniques
The techniques utilised in this thesis are discussed in Chapter 1.
5.6 Rheology of B lood
The rheological properties of blood are extremely difficult to accurately quan­
tify due to the continuing interaction between the cellular and molecular 
species which it contains and the fact tha t the system is sensitive to any dis­
turbances or external stimuli. Theoretical calculation of properties in vivo 
is almost impossible due to the pulsal nature of the flow and the nature of 
blood vessels themselves.
Blood rheology has an impact upon the location and nature of thrombi 
formed within the circulation.
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Chapter 6 
H ypothesis
1. The addition of any of the nanoparticle types into whole blood will 
have a prothrombotic effect. This will become increasingly marked as 
the concentration of nanoparticles is increased.
2. The Carboxyl functionalised Nanotubes will have a greater prothrom­
botic effect as they will be able to disperse more readily throughout 
the blood sample due to their increased solubility.
3. The relatively insoluble nature of the as-produced nanotubes may result 
in their being less well dispersed and thus the effects of the contact 
activation due to them being confined to a much smaller region of the 
blood sample resulting in a reduced prothrombotic effect.
4. As the diesel samples exhibit a solubility between the functionalised and 
as-produced nanotubes it is expected that the prothrombotic response 
from the blood will lie between the two extremes above.
I l l
Chapter 7 
M aterials and M ethods
7.1 Nanoparticles Used
The following nanoparticles were used in this work: Blended Combustion 
Derived Diesel Particulates (red, bio- and ) provided by Cardiff Univer­
sity Mechanical Engineering Department; As-produced Single- and Multi­
walled Carbon Nanotubes provided by SES Research (as used by Radomski 
et al); Carboxyl functionalised Single- and Multi-walled Nanotubes provided 
by Cheap Tubes.
7.2 Sample Preparation
7.2.1 C oncentrations
Following initial gel point studies it was found that a 5% spike of the de­
sired nanoparticle solution into freshly drawn whole blood provided the best 
results. As such it was required that the concentration of nanoparticles in 
suspension be 20 times greater than the desired final concentration once 
added to blood. The final concentrations investigated of nanoparticles per 
litre of whole blood were O.Olg, 0.005g, O.OOlg, 0.0005g and O.OOOlg.
7.2.2 TB S P reparation
TBS was prepared as required from a stock solution of 10 times standard 
concentration. This was diluted using de-ionised water.
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7.2.3 A ddition  o f N anoparticles
The required amount of nanoparticles was carefully weighed using an analyt­
ical balance. 10ml of TBS was then decanted into a vial using a pipette. The 
vial was placed in a water bath set to 15°C. The nanoparticles were added in 
small increments. Following each addition of nanoparticles the sample was 
sonicated for 15 seconds at an amplitude of 60 units.
The water bath was used to cool the sample in order to provide some 
mitigation of the boil-off of the solvent, caused by the heat generated by 
sonication thus enabling the maintenance of accuracy in the final sample 
concentration.
The samples were used as soon as possible due to the fact that TBS 
denatures over time when at room temperature. Cold storage was not ap­
propriate as this caused all nanoparticles to agglomerate and thus be removed 
from suspension incredibly rapidly.
7.2.4 Final Treatm ent
Prior to the drawing of blood, the desired sample of nanoparticles was son­
icated for 30s at an amplitude of 60 units. 0.7ml was then drawn off and 
decanted into a vial.
7.3 Blood Collection
All drawing of blood was taken from healthy volunteers and performed by a 
trained phlebotomist from the Accident and Emergency department of Mor- 
riston Hospital. Blood was drawn using a 21G standard bevel hypodermic 
needle affixed to a 20ml syringe. 15ml of blood was drawn for each complete 
experiment.
Once the blood had been drawn, the final 1ml was discarded. The remain­
ing 14ml of blood was gently injected into the vial containing the nanoparticle 
suspension. The vial was then sealed and then gently inverted 4 times in or­
der to mix the nanoparticle sample into the blood and also to ensure that 
the blood cells were evenly spatially distributed.
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7.4 Experim ents Run
7.4.1 O scillatory R heom etry
Upon arrival each day and between each experiment the geometry was re­
moved from the G2 machine and cleaned using soap and water to remove 
any surface contaminants that may have accumulated. The geometry was 
then dried using lint-free material. Once dry the geometry was reassembled 
and placed back in the machine. The G2 uses a ‘smart-swap’ programme 
to identify the geometry upon attachment. Following this identification the 
geometry was then rotationally mapped using 4 iterations to enable accurate 
assessment of the inertia of the geometry.
Once this was completed a specifically designed oscillation procedure was 
selected. This procedure utilised the following frequency sweep: a 0.200Hz 
base frequency followed by oscillations at 0.4309Hz, 0.9283Hz and 2.000Hz. 
Temperature within the geometry was maintained through the use of the 
inbuilt water bath.
7.4.2 TEG
Prior to any experiments being run, quality control tests were run on each 
of the two channels of the TEG machine. 365/d was transferred via pipette 
from the bulk sample into a TEG cup mounted in the machine. This cup 
was then raised and the experiment begun. All TEG samples were run until 
a value for lysis after 30 mins (LY30) had been recorded.
7.4.3 Sonoclot
A non-activated test cuvette was removed from the packaging and placed 
into one of the holders in the heating unit which makes up the top surface of 
the Sonoclot in order to bring the cuvette to blood temperature prior to the 
experiment commencing. While the cup was being heated a quality control 
(QC) test was run using a QC cuvette, a fresh probe and the provided QC 
oil. This was run using the inbuilt QC test programme on the Sonoclot.
Once the QC test had been successfully completed, the QC cup was dis­
posed of and the probe removed and replaced with a fresh one. The ap­
propriate test regime was then selected from the inbuilt list on the Sonoclot 
machine. The metal stirring rod was removed from the Sonoclot cuvette by 
inverting the cuvette and gently tapping it against the top surface of the
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Sonoclot. This was done to ensure that the contact activation caused by the 
presence of the stirring rod was removed. The cuvette was then placed in 
the holder.
Once the blood had been collected and added to the nanoparticle sus­
pension, 3.65/d was drawn off using a pipette and gently injected into the 
cuvette. The test was then run following the instructions provided by the 
manufacturer. Upon completion of a test, measured values were recorded 
and the used probe and cuvette were removed and disposed of.
7.4.4 Order and Tim ing
The order in which the machines are listed above was the order in which the 
samples were placed in to the machines. Total time from commencement of 
drawing of blood to the starting of each of the tests was as follows: G2 - 40 
seconds, TEG - 50 seconds, Sonoclot - 50 seconds.
7.5 Safety
For all steps involving the handling of nanoparticles both in and out of sus­
pension, and all work undertaken on blood, nitrile gloves were worn and all 
appropriate laboratory safety precautions were followed. All sharps were dis­
posed of in a specific sharps container provided by Morriston Hospital. All 
contaminated materials (gloves, syringes, vials etc) were disposed of using 
the biohazard bin also provided by the hospital. Prior to commencement 
of experiments and upon completion, all surfaces were cleaned with alcohol 
wipes.
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Chapter 8
R esults from A s-Produced  
Single W alled N anotube  
Experim ents
The results for tests on AP-SWNT presented in figure 8.1 show a random 
scatter of points in a band between 63 and 72°, with an average of 67.5° 
corresponding to an average fractal dimension of 1.67. While the values 
recorded for the concentrations are elevated when compared to those for 
untreated whole blood, and markedly higher than the baseline control value 
provided by the pure TBS spike in whole blood, the other values show very 
little variance, preventing any clear conclusions from being drawn.
Both the gel time and G ’ data (figures 8.3 and 8.4 respectively) show 
a peak at 0.001g/l. In the case of the gel time plot 0.001g/l is the only 
concentration at which the recorded gel time of 312 seconds is greater than 
the baseline whole blood and TBS value. In the case of the G’ data, the 
peak value is 375 Pa. All of the G ’ values are raised in comparison to the 
baseline value. This suggests that the inclusion of the nanotubes within the 
clot results in a more elastic structure. These peaks are not seen in the data 
from the TEG or Sonoclot machines.
Both the r-time and k-time plots (figures 8.5 and 8.6 respectively) show 
downward trends with increasing nanotube concentration. The r-time values 
halve over the range, falling from 12 minutes at 0.0001g/l and 15 minutes 
at 0.0005g/l to a minimum of 7.3 minutes at 0.01g/l. This is still over 120 
seconds longer than the maximum gel time recorded on the G2, highlighting 
the difference in sensitivity between the two systems.
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Figure 8.1: Variance in Phase Angle S o f whole blood with 5% spike of As- 
produced Single Walled Nanotubes in TBS. The dashed red line indicates the 
value recorded for whole blood with a 5% spike o f pure TBS.
The reduction in both r- and k-times suggests a prothrom botic state 
resulting in more rapid clot formation. This is supported by an increase in 
cx angle (figure 8.7) from 39.3° to 53.4°, which points to rapid initial clot 
growth.
The data  for both Maximum Amplitude and Lysis Percentage at 30 min­
utes show no obvious trends, suggesting th a t the inclusion of nanotubes 
within the structure has very little effect on the resulting clot dimensions 
and does not inhibit the fibrinolytic process.
The decrease in clotting time as shown by the TEG r-time data  is partially 
supported by a decrease in the Activated Clotting Time recorded on the 
Sonoclot. In the case of this data, the value corresponding to the lowest 
concentration is 124 seconds greater than th a t for a pure TBS addition (572 
seconds compared to 448 seconds), suggesting th a t low concentrations inhibit 
the clotting process. Indeed, only the two highest concentrations (0.005g/l 
and 0.01g/l) exhibit ACT values below th a t of the baseline at 430 seconds 
and 394 seconds. Again, these values are still over 100 seconds greater than 
the gel times recorded by the G2.
"
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Figure 8.2: Variance in Fractal Dimension of whole blood with 5% spike of 
As-produced Single Walled Nanotubes in TBS.
The increasing rapidity of the clot growth as shown by the trends in the 
k-time and a  angle recorded by the TEG is supported by an increase in 
the Sonoclot Clot Rate param eter (figure 8.11). The increase is not linear 
however, with a peak of 4.6 occurring at 0.001g/l.
The Platelet Function data  shows a clear increase from an initial of 1.6, 
equal to tha t of the pure TBS addition, to  a value of 2.6 at the two highest 
concentrations. This would suggest the prothrom botic effect of the nan­
otubes is increased with concentration. Due to  the nature of the platelet 
activation taking place (contact - intrinsic pathway) this would be expected 
as an increase in particle concentration would result in an increase in the 
surface area available for the activation.
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Figure 8.3: Variance in gel time of whole blood with 5% spike of As-produced 
Single Walled Nanotubes in TBS.
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Figure 8.4: Variance in G ' max of whole blood with 5% spike o f As-produced
Single Walled Nanotubes in TBS.
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Figure 8.5: Variance in TEG r time of whole blood with 5% spike of As 
produced Single Walled Nanotubes in TBS.
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Figure 8 .6: Variance in TEG k time of whole blood with 5% spike of As
produced Single Walled Nanotubes in TBS.
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Figure 8.7: Variance in TEG a  angle o f whole blood with 5% spike of As- 
produced Single Walled Nanotubes in TBS.
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Figure 8 .8: Variance in TEG Maximum Amplitude of whole blood with 5%
spike of As-produced Single Walled Nanotubes in TBS.
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Figure 8.9: Variance in TEG LY^q o f whole blood with 5% spike o f As-
produced Single Walled Nanotubes in TBS.
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Figure 8.10: Variance in Sonoclot A C T  of whole blood with 5% spike o f As-
produced Single Walled Nanotubes in TBS.
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Figure 8.11: Variance in Sonoclot Clot Rate of whole blood with 5% spike of 
As-produced Single Walled Nanotubes in TBS.
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Figure 8.12: Variance in Sonoclot Platelet Function o f whole blood with 5%
spike of As-produced Single Walled Nanotubes in TBS.
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Chapter 9
R esults from As-Produced  
M ulti W alled N anotubes 
Experim ents
A decrease in the measured phase angle at the gel point with increasing 
concentration (figure 9.1) gives an increasing fractal dimension (figure 9.2) 
corresponding to an increase in the density of the initial clot due to the fibres 
within the mesh structure becoming finer.
All gel time values are reduced in comparison to the TBS control value, 
and are scattered in a band around 200 seconds suggesting that further con­
centration increases above 0.0001g/l have little effect on the clotting time.
The G ’ values show a rapid decrease from a value of 400 Pa at a con­
centration of 0.0001g/l to 290 Pa at 0.001g/l. The G ’ values then increase 
to 320 Pa at the highest concentration. Indeed, all the concentrations above 
0.0001g/l exhibit G ’ values in a band around 315 Pa.
The r-time values presented in figure 9.5 increase from the initial value of
7.8 minutes at 0.0001g/l to 11.3 minutes at 0.01g/l. All of these values are 
below that of the pure TBS addition. This suggests that while any nanotube 
addition has prothrombotic effects, increasing the concentration of the as- 
produced multi walled nanotubes has an inhibiting effect on the initial fibrin 
formation.
Measured k-times show an increase to a peak of 5.5 minutes at a concen­
tration of 0.001g/l from an initial value of 4.3 minutes at 0.0001g/l. Further 
increases above 0.001g/l result in a sharp decrease in the k-time to a minimum
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Figure 9.1: Variance in Phase Angle S o f whole blood with 5% spike o f As- 
produced Multi Walled Nanotubes in TBS.
of 2.2 minutes. All values are below the baseline for a pure TBS addition 
suggesting th a t any addition is prothrom botic in comparison. However the 
initial increase suggests th a t up to a concentration of 0.001g/l increasing the 
concentration of nanotubes is inhibitive to  the growth of the clot. Further 
increases are massively prothrom botic however.
The a  angle data  supports the second part of the k-time data  but dis­
agrees with the increasing inhibition of clot growth up to a concentration of 
0.001g/l. In this instance there is a decrease in the values from 49.5° to 39° 
with an increase of concentration from 0.0001g/l to 0.0005g/l, followed by a 
rapid linear increase to a maximum value of 73.2°.
The recorded Maximum Amplitude da ta  falls in a band between 52 and 
61.4mm. The data  for lysis percentage after 30 minutes shows a slight in­
crease, but this is well within the normal range stated in chapter 5.6.
The Activated C lotting Time recorded by the Sonoclot shows initial in­
hibition at lower concentrations. The result for the lowest concentration of 
addition is equal to th a t recorded with a pure TBS addition. As the concen­
tration  is then increased the ACT is lengthened to a peak value of 541 seconds
-----
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Figure 9.2: Variance in Fractal Dimension of whole blood with 5% spike of 
As-produced Multi Walled Nanotubes in TBS.
at a concentration of 0.001g/l. Once the concentration passes 0.001g/l the 
effect of the nanotubes is highly prothrom botic, as evidenced by the rapid 
decrease in the ACT values to 376 seconds and 394 seconds at 0.005g/l and 
0.01g/l respectively.
The Clot Rate for the three lowest concentrations of nanotubes was just 
below th a t of the pure TBS addition suggesting a small level of inhibition. 
As with the Activated C lotting Time data, once the concentration passed 
0.001g/l then the nanotubes become increasingly prothrom botic as evidenced 
by a rapid increase to 6.4 and 6 for 0.005g/l and 0.01g/l respectively.
The Platelet Function da ta  shown in figure 9.12 exhibits a rapid increase 
from an initial value of 1.3 at 0.0001g/l to values of 3.2 and 3.1 at 0.005g/l and 
0.01g/l respectively. The two lowest concentrations are below th a t of the pure 
TBS addition, again suggesting th a t low concentrations have an inhibitive 
effect on the growth of the clot through the reduction of the platelet activity. 
The value for the P latelet Function at 0.001g/l is equal to tha t recorded for 
a pure TBS addition a t 1.6. Further increase of concentration then results 
in the nanotubes exhibiting an increasingly prothrom botic effect.
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Figure 9.3: Variance in Gel Time o f whole blood with 5% spike of As-produced 
Multi Walled Nanotubes in TBS.
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Figure 9.4: Variance in G ’ max o f whole blood with 5% spike of As-produced
Multi Walled Nanotubes in TBS.
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Figure 9.5: Variance in TEG r time of whole blood with 5% spike of As 
produced Multi Walled Nanotubes in TBS.
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Figure 9.6: Variance in TEG k time o f whole blood with 5% spike of As
produced Multi Walled Nanotubes in TBS.
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Figure 9.7: Variance in TEG a angle o f whole blood with 5% spike of As- 
produced Multi Walled Nanotubes in TBS.
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Figure 9.8: Variance in TEG Maximum Amplitude of whole blood with 5%
spike o f As-produced Multi Walled Nanotubes in TBS.
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Figure 9.9: Variance in TEG LY 30 o f whole blood with 5% spike of As
produced Multi Walled Nanotubes in TBS.
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Figure 9.10: Variance in Sonoclot A C T  of whole blood with 5% spike of As
produced Multi Walled Nanotubes in TBS.
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Figure 9.11: Variance in Sonoclot Clot Rate of whole blood with 5% spike of 
As-produced Multi Walled Nanotubes in TBS.
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Figure 9.12: Variance in Sonoclot Platelet Function of whole blood with 5%
spike of As-produced Multi Walled Nanotubes in TBS.
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C hapter 10
R esu lts from  D iesel P articu late  
E xperim ents
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Figure 10.1: Variance in Phase Angle 6  o f whole blood with 5% spike of Diesel 
particles in TBS.
The introduction of diesel particles into whole blood at low concentrations 
leads to a reduction in the phase angle at the gel point corresponding to the 
formation of more rigid clots than those formed in the presence of pure TBS 
(figure 10.1). As the concentration of the particles is increased however the 
phase angle increases from in a fairly linear fashion, corresponding to the
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formation of clots with an increasingly loose structure. This may be due to 
the change in the manner in which platelets are able to act as the particulate 
concentration is increased.
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Figure 10.2: Variance in Fractal Dimension of whole blood with 5% spike of 
Diesel particles in TBS.
At the lowest concentrations, the particles are far more widely dispersed 
such tha t the volume of blood per particle is much greater. This enables 
platelets which are activated through contact with the particles (intrinsic 
pathway) to reach more of the surrounding blood and activate thrombin as 
opposed to repeated collisions with particles which may result in the platelet 
becoming bound to a particle and thus having its effectiveness reduced. As 
the fibrin mesh is formed, some of these particles will become trapped within 
the spaces together with platelets and fibrinogen. The trapped particles 
would then serve as activation sites for the platelets within the gaps in the 
m atrix leading to the formation of a much denser structure.
As the concentration of particulates in suspension is increased it may 
be tha t once a threshold level has been passed the particles begin to from 
sweep floes. This would result in particles and the platelets and fibrin strands 
surrounding them settling rapidly out of suspension. If this were to be the 
case then the availability of activated platelets throughout the solution may
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become sporadic, with the largest amount located in the settled layer. This 
would result in the formation of increasingly looser clots as the concentration 
is further increased past the threshold level.
This mechanism is supported by the gel time data presented in figure 
10.3. While all values are markedly below that for the TBS baseline, the gel 
times show a loose upward trend with increasing concentration, suggesting 
increasing thrombosis inhibition.
Despite the increase in gel time and the decrease in fractal dimension, the 
final clot elasticity of the clot as measured by G’ shows a dramatic increase 
with a very tight correlation. This suggests that while the initial clot takes 
longer to form as the particulate concentration is increased, the final clot is 
more elastic.
It may be that the initial clot has taken longer to form due to the manner 
of the fibrin strands formed within the mesh or the manner in which the 
particulates are bound within it. As mentioned earlier in this discussion, the 
binding of particulates within the mesh would enable further activation of 
the platelets and thrombinogen which are also bound. While this activation 
would have little effect on the nature of the incipient clot, it would result in 
increasing clot retraction during the latter stages of formation.
The r time data presented in figure 10.5 drops from a value equal to 
the baseline at the lowest concentration of particulates to 7 minutes at the 
highest concentration. This value is still markedly longer than the gel time 
measured using the rheometer.
The k time data shows a loose upward trend (figure 10.6), with all data 
points below the baseline. This increase fits with the results from the G2 
together with the loose downward trend in the a  angle data (10.7), suggest­
ing that at higher concentrations the diesel particulates may have inhibitive 
properties in the very early stages of thrombosis.
The increased elasticity as measured by the G’ data is mirrored in the 
MA data from the TEG (10.8) which shows a clear upward trend, suggesting 
tha t the increasingly loose structure found in the incipient clot continues to 
the mature clot, resulting in a larger structure. This larger structure may 
also be due to  the particulates interfering with the ability of the platelets to 
effect clot retraction.
Very little variance is in evidence within the lysis data, with all of the
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Figure 10.3: Variance in Gel Time of whole blood with 5% spike of Diesel 
particles in TBS.
data  points remaining within the normal range.
The Activated Clotting Times (ACT) measured by the Sonoclot are 
grouped in a horizontal band with an average slightly above the baseline 
value. Clot Rate data  shows a loose upward trend. This is in agreement 
with the k time and a  angle data.
Inferred Platelet Function is raised on all data  points compared to the 
baseline value. A slight upward trend is visible, although very loose. As such 
it would appear to support the suggestion th a t the diesel particulates may 
inhibit the clot retraction stage while enhancing the contact activation of the 
platelets, resulting in the large, loose structures measured.
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Figure 10.4: Variance in G 1 max of whole blood with 5% spike of Diesel
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Figure 10.5: Variance in TEG r time o f whole blood with 5% spike of Diesel
particles in TBS.
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Figure 10.6: Variance in TEG k time of whole blood with 5% spike o f Diesel 
particles in TBS.
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Figure 10.7: Variance in TEG a  angle of whole blood with 5% spike of Diesel
particles in TBS.
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Figure 10.8: Variance in TEG Maximum Amplitude of whole blood with 5% 
spike of Diesel particles in TBS.
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Figure 10.9: Variance in TEG LY 3 0  of whole blood with 5% spike of Diesel
particles in TBS.
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Figure 10.10: Variance in Sonoclot A C T  of whole blood with 5% spike of 
Diesel particles in TBS.
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Figure 10.11: Variance in Sonoclot Clot Rate of whole blood with 5% spike
of Diesel particles in TBS.
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Figure 10.12: Variance in Sonoclot Platelet Function of whole blood with 5% 
spike of Diesel particles in TBS.
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Chapter 11
R esults from
Carboxyl-Functionalised Single 
W alled N anotube Experim ents
The effect on the nature of the thrombus formed following the inclusion of 
the carboxyl-functionalised single walled nanotubes differ somewhat from 
machine to machine. In the case of the G2, an increase in the phase angle at 
the gel point (and a corresponding decrease in fractal dimension) are evident 
in figures 11.1 and 11.2.
The initial phase angle value measured at a concentration of 0.0001g/l 
was 63°, suggesting that the lower concentration produces a clot that has a 
slightly higher level of structural order than that with an addition of pure 
TBS. Subsequent increasing concentrations exhibit an increase in the phase 
angle up to 68°, a value above that of the pure TBS addition meaning that 
the initial clot has an increasingly loose structure as the concentrations are 
increased.
The gel time data is in a band around 200 seconds, below that of the 
value of the pure TBS addition, showing that despite the effect on the initial 
structure as shown by the phase angle, any addition of these nanotubes is 
prothrombotic, serving to increase the rate of initial platelet activation.
The G ’ values show a marked increase from a minimum of 210 Pa at 
0.0005g/l to a maximum of 320 Pa. The final clot structure is thus less rigid 
in the lower concentration additions than at the higher concentrations. In 
comparison to the baseline value from the pure TBS addition, the struc­
tural elasticity is reduced by all concentrations apart from the highest. This
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suggests an inhibitive function of the nanotubes at lower concentrations.
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Figure 11.1: Variance in Phase Angle S of whole blood with 5% spike of 
Carboxyl-functionalised Single Walled Nanotubes in TBS.
The rate of formation of the initial fibrin strands increases with increas­
ing nanotube concentration as shown by the marked decrease in the r-time 
measured by the TEG. The values drop from 11.5 minutes at 0.0001g/l to
5.9 minutes at 0.01g/l. This partially supports the results from the gel time 
measurements made on the G2 in th a t all data  points show the addition to 
have prothrom botic effects.
An increase in the rate of throm bus formation following the generation 
of the initial fibrin strand is clearly shown through a decrease in the k-time 
from 5 minutes to 2.3 minutes and a corresponding increase in the a  angle 
from 39.3 to 61.3°. This shows tha t the action of the nanotubes is highly 
prothrom botic. However, while the addition of the nanotubes results in a 
faster rate of growth and thus a reduced time for the clot to reach maturity, 
the G ’ data  discussed earlier suggests th a t this enhanced rate of growth 
results in a reduced structural integrity within the clot.
This reduced structural integrity couples with the looser structure of the 
initial clot measured by the phase angle data  results in an increase in the
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Figure 11.2: Variance in Fractal Dimension of whole blood with 5% spike of 
Carboxyl-functionalised Single Walled Nanotubes in TBS.
Maximum Amplitude of the m ature clot measured on the TEG. This change 
in the clot structure has no effect on the lysis as measured by the TEG.
The marked increase in the prothrom botic effect of increasing concen­
trations of the carboxyl-functionalised single-walled nanotubes on the initial 
clot formation as measured on the TEG is also in evidence in the Activated 
Clotting Times measured by the Sonoclot. A decrease from a value of 354 
seconds at a concentration on 0.0001g/l to 305 seconds at the highest con­
centration of 0.01g/l represents a marked increase in the rate at which the 
platelets are activated during the initial stages of thrombosis. This increase 
may well be due to the increase in the solubility of the nanotubes due to the 
addition of the carboxyl molecules.
The increase in the rate of the growth of the clot to m aturity as shown by 
the increase in the k-time and a  angle measured by the TEG is also shown in 
the clot rate da ta  from the Sonoclot with an increase from 4.4 at 0.0001g/l 
to a plateau value of around 6.7 which is reached at 0.0005g/l. The platelet 
function data  is not a distinct linear trend, instead exhibiting a peak of 3.6 
at 0.001g/l. This is followed by a decrease to 2.4 as the concentration is 
increased to 0.01g/l, suggesting tha t the activity of the platelets throughout 
the clot formation from the initial fibrin to m aturity  is enhanced by the
1
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Figure 11.3: Variance in Gel Time o f whole blood with 5% spike of Carboxyl- 
functionalised Single Walled Nanotubes in TBS.
addition of nanotubes up to the concentration of 0.001g/l. Further increases 
in the concentration added then exhibit inhibitory properties. This peak is 
not seen in any of the other data  sets for this type of nanotube.
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Figure 11.4: Variance in G' max of whole blood with 5% spike o f Carboxyl- 
functionalised Single Walled Nanotubes in TBS.
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Figure 11.5: Variance in TEG r time of whole blood with 5% spike of
Carboxyl-functionalised Single Walled Nanotubes in TBS
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Figure 11.6: Variance in TEG k time o f whole blood with 5% spike of
Carboxyl-functionalised Single Walled Nanotubes in TBS
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Figure 11.7: Variance in TEG a angle of whole blood with 5% spike of
Carboxyl-functionalised Single Walled Nanotubes in TBS
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Figure 11.8: Variance in TEG Maximum Ainplitude of whole blood with 5% 
spike of Carboxyl-functionalised Single Walled Nanotubes in TBS
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Figure 11.9: Variance in TEG LY3o of whole blood with 5% spike of Carboxyl-
functionalised Single Walled Nanotubes in TBS
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Figure 11.10: Variance in Sonoclot A C T  of whole blood with 5% spike of 
Carboxyl-functionalised Single Walled Nanotubes in TBS
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Figure 11.11: Variance in Sonoclot Clot Rate of whole blood with 5% spike
of Carboxyl-functionalised Single Walled Nanotubes in TBS
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Figure 11.12: Variance in Sonoclot Platelet Function of whole blood with 5% 
spike o f Carboxyl-functionalised Single Walled Nanotubes in TBS
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Chapter 12
R esults from  
Carboxyl-Functionalised  
M ulti-W alled N anotubes 
Experim ents
The results from the work undertaken with the carboxyl-functionalised multi­
walled nanotubes have provided the clearest data sets of all of the particles 
tested.
The small increase in fractal dimension in the data presented in figure 12.2 
points to an increasing level of structure within the initial clot. This suggests 
that the inclusion of the nanotubes within the blood causes increasingly thin 
fibrin strand formation.
The sharp decrease in the recorded gel time from 250 seconds to 100 
seconds reflects a very high prothrombotic effect in the initial thrombus for­
mation.
Recorded G’ values shown in figure 12.4 start initially below that of the 
TBS control value of 300 Pa with a G’ of 200 Pa recorded following the 
addition of 0.0001g/l. These values increase sharply to 320 Pa at 0.01g/l. 
This shows an initial reduction in the elastic properties of the clot with 
nanotube addition. Increasing G’ with increasing nanotube concentration 
points towards prothrombotic effects of the nanotubes in the later stages of 
clot formation.
A sharp decrease in the r-time values from 13.3 minutes at a concentration
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Figure 12.1: Variance in Phase Angle 6 of whole blood with 5% spike of
Carboxyl-functionalised Multi Walled Nanotubes in TBS.
of 0.0001g/l to  3.3 minutes at 0.01g/l agrees with the rapid reduction seen 
in the gel time measured on the G2. This reduction in the time required for 
the initial fibrin formation is likely due to the increased solubility of these 
nanoparticles enabling a good dispersion throughout the blood sample. As 
such, a very large surface area is available for the contact activation of the 
platelets.
The k-time data  shows a sharp decrease coupled with a sharp increase in 
the a  angle, showing a rapid level of clot growth following the initial fibrin 
formation. The continued high level of increase in the rate of clot growth 
suggest th a t the particles remain in suspension effectively even at the higher 
concentrations enabling continuing platelet activation throughout throm bus 
formation.
The continuing activation throughout the clot formation is supported by 
an increase in the values of maximum amplitude recorded as the nanotube 
concentration is increased. This further suggests th a t the nanotubes are 
effectively suspended throughout the suspension enabling the continued ac­
tivation to occur at the extremities of the clot, thus resulting in the larger 
final clots.
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Figure 12.2: Variance in Fractal Dimension of whole blood with 5% spike of 
Carboxyl-functionalised Multi Walled Nanotubes in TBS.
No trend is evident in the data  recorded for the percentage of lysis.
An increase in the clot size and the level of fine structure within it may 
lead to a reduction in the ability of the body to effectively remove the clot 
resulting in the possibility of dangerous free floating thrombi which could 
potentially lodge in smaller blood vessels downstream from the original clot.
The reduction in the time for the fibrin formation seen in the gel time 
and r-tim e data  is also evident in the Activated Clotting Time measured on 
the Sonoclot with a sharp reduction from 450 seconds to 182 seconds.
The Clot Rate and Platelet Function data  both dramatically increase 
from 3.6 to  12 and from 2 to 4.3 respectively. This supports the findings 
from the k-time and a  angle recorded on the TEG.
I
152
<«d) .3
N anoparric te  C oncen tra tion  (g.l|
Figure 12.3: Variance in Gel Time of whole blood with 5% spike o f Carboxyl-
functionalised Multi Walled Nanotubes in TBS.
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Figure 12.4: Variance in G ’ max of whole blood with 5% spike of Carboxyl-
functionalised Multi Walled Nanotubes in TBS.
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Figure 12.5: Variance in TEG r time of whole blood with 5% spike of
Carboxyl-functionalised Multi Walled Nanotubes in TBS.
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Figure 12.6: Variance in TEG k time o f whole blood with 5% spike of
Carboxyl-functionalised Multi Walled Nanotubes in TBS.
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Figure 12.7: Variance in TEG a angle o f whole blood with 5% spike of
Carboxyl-functionalised Multi Walled Nanotubes in TBS.
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Figure 12.8: Variance in TEG Maximum Amplitude of whole blood with 5%
spike o f Carboxyl-functionalised Multi Walled Nanotubes in TBS.
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Figure 12.9: Variance in TEG LY3q o f whole blood with 5% spike of Carboxyl-
functionalised Multi Walled Nanotubes in TBS.
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Figure 12.10: Variance in Sonoclot A C T  of whole blood with 5% spike of
Carboxyl-functionalised Multi Walled Nanotubes in TBS.
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Figure 12.11: Variance in Sonoclot Clot Rate of whole blood with 5% spike
of Carboxyl-functionalised Multi Walled Nanotubes in TBS.
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Figure 12.12: Variance in Sonoclot Platelet Function of whole blood with 5%
spike of Carboxyl-functionalised Multi Walled Nanotubes in TBS.
Chapter 13 
Conclusions
13.1 Rheology
The assessment of initial clot formation through Gel Point detection using 
oscillatory shear rheometry enables a far more rapid detection of the early 
stages of thrombosis than is possible in either of the clinical haemostasis mea­
surement techniques. The machine is also able to maintain the applied stress 
within the linear range of the system while it undergoes gelation, something 
which neither of the clinical machines is capable of.
However, the rheological system at present does have a number of draw­
backs: a long preparation time; the requirement of compressed air for the 
bearing; and the size of the machine. All of which preclude it from applica­
tion in point of care locations, thus limiting the use of the currently available 
systems to suitable laboratories.
As such further work would be required to develop a rheometer which 
would be suitable for point of care facilities, as it has clear advantages in de­
tecting structural abnormalities in the initial clot. It would also be necessary 
to generate standard procedures within the software for the assessment of 
particular abnormalities or the effect of dilutions as these will alter the ma­
terial properties of the blood sample, thus changing the required frequencies 
for Gel Point detection and the critical stress value.
13.2 Fractal Analysis
The use of the fractal dimension calculated from the phase angle at the Gel 
Point is of vital importance as it enables an assessment of the microstructure
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of the initial clot that would otherwise be impossible. The only other method 
being the use of SEM imaging which requires the clot to be ethanol dried, 
embedded in wax and cleaved into fine sections, a process which means the 
final clot which is imaged may be little resemblance to tha t originally formed.
At present the fractal dimension is limited to the description of the struc­
ture of the initial clot. Development of the work undertaken by Avrami et 
al [36] [37] may enable the structural analysis to be extended to cover the 
manner in which the clot grows to maturity. This clearly presents itself as 
being the next step required to further develop this method of thrombosis 
analysis.
13.3 Carbon Nanoparticles
While all of the nanoparticles examined in this thesis have prothrombotic 
effects when added to whole blood, there is a clear difference in the degree 
to which these effects occur. In the case of the nanotubes this difference 
is linked to the increased solubility of the functionalised nanotubes which 
enables them to more readily become suspended.
The range of nanoparticles investigated in this thesis is necessarily limited 
however. As such a broader range requires investigation with respect to the 
functionalisation of the nanotubes with protein molecules such as heparin. 
The expansion should be tailored towards the nanoparticles, both carbon and 
otherwise, which are at the forefront of the development for uses in targeted 
drug delivery.
13.4 Nanoparticle Characterisation
The characterisation of nanoparticles, both as individual entities and their 
behaviour within any prospective solvent is very important, both to ensure 
that the nanoparticles fall within the suspected size ranges and that the 
proposed solvent produces as stable a suspension as possible.
Further developments in the field of SEM which enable higher resolution 
at lower applied beam strength are of profound importance for the improve­
ment of nanoparticle imaging. At standard beam strengths (above 3kV) the 
nanotubes in particular exhibit charging which can result in the destruction 
of sections of sample.
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In terms of the solvent, a larger number of medical solutions should be 
investigated. This investigation should also include assessment of the effect 
of the solvents on the initial clot formation as measured on the rheometer.
13.5 B lood
Prior to the work presented here, very little had been carried out to assess 
the effects of nanoparticle addition to whole blood in vitro. This is of critical 
importance both to the prospects of the utilisation of nanoparticles for drug 
delivery and in continuing the assessment of the effects of urban particulate 
exposure.
The work presented needs to be expanded to a full clinical study for each 
nanoparticle type with a large volunteer base and should include haemato- 
logical tests such as aPTT to enable a complete assessment of the effects of 
the nanoparticles utilising all standard test procedures applicable.
13.5.1 C lot M easurem ent Techniques 
Sensitivity
It is clearly evident through the measured values of the time taken for the 
initial sample spanning fibrin strands to form that the rheometrical tech­
niques as used on the G2 are far more sensitive than either the Sonoclot of 
the TEG. This is due to a number of factors.
Firstly the G2 is able to maintain the applied force below the critical 
strain value of 2%, the numerical value of which will change as the structure 
of the clot develops. In contrast neither the Sonoclot or the TEG are able to 
do this and as such may well shear apart the earliest formed fibrin strands, 
thus delaying their measurement of the sample spanning network. This also 
means tha t neither of the clinical machines are operating within the linear 
range of the blood sample.
Secondly, while the geometry used to conduct the experiments on the G2 
is completely rigid, the probe used by the Sonoclot is easily deformed, which 
may well allow the growing blood clot to cause an alteration in the shape of 
the probe resulting in the development of inaccuracies.
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Ease of Use
In terms of ease of use the two systems set up as clinical devices, the TEG and 
the Sonoclot, are both far more straightforward to set up and run. This is 
true of the tests and the preparation times. The G2 also requires a knowledge 
of rheometry in order to set up the parameters for the tests.
Finally, the G2 and other similar rheometrical devices are at present too 
bulky to be used for point of care blood analysis due to the requirement for 
pressurised air for the bearings.
13.6 Comparison of N anoparticles’ Effects on 
Throm bosis
13.6.1 Effect on Throm bus Structure  
Initial Thrombus
The fractal dimension derived from the phase angle value at the Gel Point 
is the only relatively noninvasive means by which the microstructure of the 
initial clot can be characterised. A comparison of the alterations in the 
fractal dimension due to the inclusion of the various types of nanoparticles 
will therefore provide a means of assessing the level of effect on the initial 
clot formation of each particle type.
In this case the nanoparticles with the clearest effect on the fractal di­
mension of the initial clot are as-produced multi-walled nanotubes which 
exhibit the most dramatic increase from 1.50 following a 0.0001g/l addition 
to 1.82 following a 0.01g/l addition. This represents an increase in structural 
complexity within the fibrin mesh as the concentration of the nanotubes is 
increased.
The carboxyl-functionalised single-walled nanotubes also exhibit a rise 
in the fractal dimension, although less marked than that found following 
the addition of the as-produced multi-walled nanotubes, meaning that the 
structural complexity increase is reduced.
The next greatest effect is seen from the carboxyl-functionalised multi­
walled nanotubes which show a small increase in fractal dimension from 1.67 
to 1.79. This data set is one of the tightest enabling a ready ascertation 
of the trend. This is also the last of the nanoparticles to exhibit a rise in
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structural complexity with increasing concentration.
D ata points from the as-produced single-walled nanotubes fall in a band 
with no increase or decrease in fractal dimension evident with increasing 
nanoparticle concentration. The average is still raised above that of the 
baseline provided by the pure TBS addition showing that the particles still 
cause a small level of increase in the structural complexity.
In stark contrast to the results from all of the nanoparticles, the addition 
of increasing concentrations of diesel particles leads to a decrease in the 
fractal dimension from 1.75 to 1.56, as the initial clot structure becomes 
increasingly loose.
Therefore, the order of level of effect is as follows:
APMN > SCOOH > MCOOH > APSN > DIESEL
Mature Thrombus
The maximum value of G’ reached by the clot reflects its structural complex­
ity once mature.
The carboxyl-functionalised multi-walled nanotubes clearly have the most 
dramatic effect on the final clot structure, a fact which becomes even more 
apparent as the concentration of the nanotubes is increased with the G’ 
values increasing from 200Pa.s to 370Pa.s.
The addition of diesel particles to the blood, in marked contrast to the 
results from the initial clot, also showed a clear increase in G’, from 310Pa.s 
to 390Pa.s.
Carboxyl-functionalised single-walled nanotubes also exhibit a marked 
increase in the G ’ values, although to a lesser extent than that seen in the data 
for the carboxyl-functionalised multi-walled nanotubes or the diesel particles.
While the results from the as-produced single walled nanotubes are all 
above the TBS baseline, the data points exhibit a peak of 375Pa.s at 0.001g/l. 
The average value of the data points is below that of the nanoparticles already 
described in this section.
The G ’ data from the as-produced multi-walled nanotubes shows a marked 
decrease from 400Pa.s to a final plateau around 310Pa.s.
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The results from both the diesel particulates and the as-produced multi­
walled nanotubes suggest that the initial clot structure as determined by the 
fractal dimension cannot necessarily be used as pointer to the structure of 
the m ature clot in the case of nanoparticle addition.
The order of level of effect on the G’max is:
MCOOH > DIESEL > SCOOH > APSN > APMN
Both the carboxyl-functionalised single-walled nanotubes and carboxyl- 
functionalised multi-walled nanotubes exhibit increases (56.3mm to 59.1mm 
and 59.3mm to 64.7mm respectively) in the maximum amplitude with in­
creasing particle concentration.
As-produced multi-walled nanotubes data reveals a band elevated above 
the TBS baseline, and with an average greater than that of the carboxyl- 
functionalised multi walled nanotubes.
The diesel particles produce a very slight increase from 53.8mm to 59.9mm 
in the measured maximum amplitude as their concentration is increased.
The data for the as-produced single-walled nanotubes shows no obvious 
trend.
The order of the level of effect on the Maximum Amplitude recorded by 
the TEG is:
SCOOH > APMN > MCOOH > DIESEL > APSN
The rate of lysis is an important marker, both of clot stability and there­
fore structure and as a way of showing any effect the nanoparticles may have 
on the fibrinolytic system.
The average of the scattered data of lysis percentage for the carboxyl- 
functionalised single walled nanotubes is the highest, suggesting either a 
small enhancement of the fibrinolytic system or a reduction in the stability 
of the mature clot.
A high average in the lysis values is also seen to a lesser extent in the 
data generated following the addition of the diesel particles.
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The as-produced multi-walled nanotubes, carboxyl-functionalised multi­
walled nanotubes and the as-produced single-walled nanotubes all exhibit 
scattered data with low averages.
The order of the effect on the percentage of lysis after 30 minutes recorded 
by the TEG is:
SCOOH > DIESEL > APMN > MCOOH > APSN
13.6.2 Effect on R ate o f In itial Throm bus Form ation
The time required for initial clot formation is measured by the variables of 
gel time, r-time and activated clotting time on the G2, TEG and Sonoclot 
respectively. A reduction in the time required for the formation of the ini­
tial clot is a clear indicator of a hypercoagulability with the blood due to 
increased levels of activation of the platelets through contact with the added 
nanoparticles.
The most dramatic effect on the gel times following the addition of any of 
the nanoparticles is seen in the data from the experiments using the carboxyl- 
functionalised multi walled nanotubes which show a reduction in gel time 
from 250 seconds to 100 seconds.
Addition of carboxyl-functionalised single-walled nanotubes resulted in 
reduced gel times with an average of 220 seconds except for the addition of 
0.005g/l which exhibited a gel time of 135 seconds.
The as-produced single-walled nanotube additions all resulted in gel times 
below the TBS baseline of 290 seconds apart from a peak at 0.001g/l of 312 
seconds.
As-produced multi-walled nanotubes also caused a reduction in gel times, 
although to a lesser extent than the single-walled.
In contrast to this, the measured gel times following the addition of diesel 
particulates showed an initial large reduction to 160 seconds with an increase 
to a peak of 260 seconds at a concentration of 0.005g/l.
The order of the level of effect on the gel time is:
MCOOH > SCOOH > APSN > APMN > DIESEL
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The TEG machine is the least sensitive to the initial fibrin formation with 
the values for the r-time being markedly higher than those for either the gel 
time or the activated clotting time.
Again the clearest effect was from the addition of the carboxyl-functionalised 
multi walled nanotubes, exhibiting a sharp decrease from 13.3 minutes to 4.3 
minutes with increasing concentration.
Decreases were evident to smaller degree in the data for the carboxyl- 
functionalised single walled nanotubes (11.5 minutes to 5.9 minutes), the 
diesel particulates (15.1 minutes to 6.9 minutes) and the as-produced single 
walled nanotubes (12 minutes to 7.3 minutes).
The r-times recorded following the addition of increasing concentrations 
of as-produced multi walled nanotubes showed an increase from 7.8 minutes 
to 11.3 minutes, reflecting the TEG measuring an inhibitive effect.
The order of the level of effect on the r-time is:
MCOOH > SCOOH > DIESEL > APSN > APMN
The activated clotting time measured by the Sonoclot falls between the 
gel time and the r-time measured by the other machines.
In this case the greatest effect was seen from the carboxyl-functionalised 
multi-walled nanotubes which showed a sharp decrease in the activated clot­
ting times from 450 seconds to 182 seconds with increasing concentration. 
All of the activated clotting times were below the pure TBS value.
A decrease was also evident in the data from the carboxyl-functionalised 
single-walled nanotubes, although smaller than that seen with the carboxyl- 
functionalised multi-walled nanotubes, with the values dropping from 354 
seconds to 305 seconds.
The addition of as-produced single-walled nanotubes also resulted in 
marked decrease with activated clotting times falling from 572 seconds to 
394 seconds. While this decrease is sharper than that of the carboxyl- 
functionalised single-walled nanotubes, at no point do the values cross, mean­
ing that the greater effect is caused by the functionalised nanotubes.
The as-produced multi-walled nanotubes exhibited a slightly decreasing 
trend in the recorded activated clotting times with increasing concentrations.
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The activated clotting times recorded following the addition of increasing 
concentrations of diesel particulates showed no obvious trend.
Therefore, the order of the level of effect on the activated clotting time
is:
SCOOH > MCOOH > APSN > APMN > DIESEL
13.6.3 Effect on Throm bus D evelopm ent
The k-time is a measure of the time taken for the clot to show an impedance 
to the movement of the cuvette equivalent to it having reached a size of 
20mm. As such any reduction of the time would indicate prothrombotic 
effects.
The carboxyl-functionalised multi-walled nanotubes again showed the 
greatest effect with a distinct and tight decrease from 5.8 minutes to 1.7 
minutes with increasing concentration.
A decrease in the k-times from 5 minutes to 2.6 minutes was evident in 
the data from the carboxyl-functionalised single-walled nanotubes.
Decreases in the k-time are also seen in the data collected following the 
addition of as-produced multi- and single walled nanotubes (4.3 minutes to 
2.2 minutes and 7.2 minutes to 3.7 minutes respectively).
The data generated following the addition of diesel particulates to whole 
blood the k-times show an increase from 0.8 minutes to a peak of 4.7 minutes 
at 0.001g/l followed by a decrease to 2 minutes at 0.01g/l to with increas­
ing concentration, again suggesting that the diesel particulates may have an 
inhibitive effect at certain concentrations concentrations.
The order of the level of effect on the k-time is therefore:
MCOOH > SCOOH > APMN > APSN > DIESEL
The a  angle provides a measurement of the rate of clotting through the 
use of a line applied at a tangent to the TEG curve. An increase in the angle 
reflects an increase in the rate of thrombosis.
As with the k-time the most marked increase was seen in the data from 
the addition of the carboxyl-functionalised multi-walled nanotubes: 33.8° to 
67.2°.
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The next most distinct effect was seen following the addition of the as- 
produced multi-walled nanotubes with an increase 49.5° to 73.2°.
A lesser increase is also seen in the data from the carboxyl-functionalised 
single-walled nanotubes.
An slight rise with increasing concentration is evident in the results from 
the as-produced single-walled nanotubes.
The data for the diesel particulates shows a decrease from 80.6° at 0.0001g/l 
to 40.9° at 0.001g/l followed by an increase to 52.9° at 0.01g/l.
The order of the level of effect on the a  angle is:
MCOOH > APMN > SCOOH > APSN > DIESEL
The clot rate as measured by the Sonoclot is taken as the gradient of the 
rapid increase seen in the second stage of the sonoclot signature. As such it 
provided a value for the increase in the impedance of the sonoclot probe as 
the sample clots.
The values for the clot rate measured following the addition of the carboxyl- 
functionalised multi walled nanotubes exhibited a sharp increase from 3.6 to 
12 with increasing concentration again pointing to the highly prothrombotic 
action of these nanoparticles.
Addition of increasing concentrations of carboxyl-funcionalised single walled 
nanotubes also resulted in the measured clot rate rising to a value of 6.7 at 
0.01g/l from 4.4 at 0.0001g/l.
A lesser increase in the clot rate was seen following the addition of as- 
produced multi walled nanotubes, with the values rising from 3.2 to 6.
The addition of diesel particulates caused a similar climb in the clot rate 
with increasing concentration, from 3.4 at 0.0001g/l to 6.2 at 0.01g/l. This 
data is fairly loose.
As-produced single walled nanotubes produced the smallest increase in 
clot rate rising from 3 to 4.3.
Therefore, the order of the level of effect in the clot rate is:
MCOOH > SCOOH > APMN > DIESEL > APSN
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The platelet function is one of the most important variables inferred by 
the sonoclot as it is the activation of the platelets through contact with the 
nanoparticles which causes the prothrombotic effects.
Again the most distinct and rapid rise in platelet function was recorded 
following the addition of increasing concentrations of the carboxyl-functionalised 
multi-walled nanotubes with values climbing from 2 at 0.0001g/l to 4.3 at 
0.01g/l.
The as-produced multi-walled nanotubes produced the next most marked 
increase in platelet function (1.3 to 3.1) with increasing concentration.
Results from the tests on carboxyl-functionalised single-walled nanotubes 
also exhibited a sharp upward trend, although to a lesser extent than the 
particles already mentioned, ranging from 1.9 at 0.0001g/l to 2.4 at 0.01g/l.
The addition of both diesel particulates and as-produced single-walled 
nanotubes resulted in only a slight climb in the inferred platelet function for 
each particle (2 to 2.9 and 1.6 to 2.6 respectively).
Thus, the order of the level of effect on the platelet function is:
MCOOH > APMN > SCOOH > DIESEL > APSN
13.6.4 C onclusions From C om parisons o f N anoparti­
cles
From the work presented above it can be stated that all of the nanoparticles 
examined had a prothrombotic effect on healthy, whole blood under the test 
conditions.
Overall Order of Effect
The comparison of the individual parameters given above enables an assess­
ment of the overall levels of effect of each of the nanoparticles investigated.
MCOOH > SCOOH > LPMN > LPSN > DIESEL
This differs from the hypothesis in that it was expected that the diesel 
particulates would have a greater effect on the clot formation and structure 
than the as-produced nanotubes due to the greater solubility of the diesel 
particulates.
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The reason for the reduced effect of the diesel particles may well lie in 
the inherent structural differences between them and the other nanoparticles. 
While the diesel particulates have a fairly uniform spherical structure, the 
nanotubes are, as per the name, cylindrical. The sizes of the nanotubes 
closely resemble the size and have similar surface roughness to the collagen 
fibres which trigger clotting in the case of vessel injury.
As suggested in the results chapters for the Diesel particles and the as- 
produced nanoparticles, the inhibitive effect as seen at certain concentra­
tions may be due to floe formation and settlement within the asample as 
the nanoparticles agglomerate. This floe formation would result in the con­
centration of both nanoparticles and and cellular bodies such as platelets at 
the bottom of the sample thus preventing an even distribution of thrombin 
generation. This inhibitive effect may be reduced at the highest concentra­
tions due to the simple number of particles in solution resulting in a limited 
amount of movement thus reducing he potential for agglomeration.
A full clinical study with these techniques utilising a broader range of the 
newly developed functionalities of nanotubes such as heparin, a number of 
solvents and a wider spread of concentrations is required.
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